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PROGRAMME
These TWIST sessions are open to 
Lisbon Addictions delegates. TWIST has been 
developed through a participatory process 
as part of the EC co-funded project TWIST 
(Training WIth STakeholders - www.twist-
train.eu) to provide key knowledge on specific 
topics, and support the involvement of early 
stage professionals in the Lisbon Addictions 
Conference.
The Organising Committee is honoured and delighted to welcome you to the second European Conference on 
Addictive Behaviours and Dependencies – Lisbon Addictions 2017.
We are confident that this year’s event will build on the success of the first Lisbon Addictions, which took place in 
September 2015. Originally planned as a small, one-off event to support networking across European addiction 
professionals, we were taken by surprise by the enthusiasm that the Conference generated. Participants told us 
that it provided a unique and valuable opportunity for discourse and networking across the different disciplines 
involved in this challenging and dynamic area. We have therefore made Lisbon Addictions a biennial event – and 
one we hope you will always want to prioritise in your busy agendas.
We wanted to make this year’s conference bigger and better. Our vision for Lisbon Addictions 2017 is to provide 
a European focused Conference but with an international perspective. We are therefore extremely pleased to 
welcome more than 1 200 participants from over 71 countries to Lisbon. We wanted to have a conference that 
spanned all aspects of the addictions field and, once again, we have been impressed with the interest shown and 
overwhelmed by the quality and diversity of the submissions made. Over the next three days you will have the 
opportunity to select from over 500 oral presentations, view over 200 posters and hear from over 20 keynote 
speakers representing some of the most eminent scientists and practitioners working in the addiction field today.
We hope Lisbon Addictions 2017 will help build future collaborations between professionals both within Europe 
and beyond. We offer a particularly warm welcome to the young career professionals who are attending this 
event and will participate in the TWIST key knowledge dissemination sessions, many of which are open to all 
delegates. 
We are lucky to hold this year’s event in the excellent facilities of Lisbon’s Congress Centre which provides 
the opportunity to hold large major sessions as well as smaller venues for more intensive and participatory 
discussions. 
Finally, we warmly welcome you to the beautiful historic but also increasingly dynamic city of Lisbon, now one 
of Europe’s leading destinations. We hope you will find the city an inspiring place to build the bridges that will 
allow us to collectively respond to the challenges the addictions arena presents us with. 
Bem-vindos a Lisboa!
WELCOME MESSAGE
– For last minute changes consult the App:
– WiFi access for conference participants:
   Network:   Addictions2017
   Password:  Addictions2017
 
 DAY 1  TUESDAY 24 OCTOBER 
 
08:00 Arrival and registration 
 
09:00 – 10:00 INAUGURAL SESSIONS Science speaks to policy Auditorium II Policy speaks to science Auditorium I 
 
10:00 – 10:30 PLENARY SESSION I   CHALLENGES FOR LISBON ADDICTIONS 2017 Auditorium I 
10:30 – 11:00 Opening ceremony 
 
11:00 – 11:30 Coffee break 
 
11:30 – 13:00 PARALLEL SESSIONS   
PAPER SESSIONS STRUCTURED SESSIONS POSTER 
SESSIONS 
 Pavilions 
4 and 5  
TWIST 
1 Alcohol – informing prevention and policy  Auditorium III 
2 The measurement of problems and trends  Room 1.08 
3 A focus on pharmacotherapy  Auditorium II 
4 Ageing and intergenerational issues  Auditorium VIII 
5 Gambling – behavioural insights  Room 5B 
6 Concepts and constructs  Room 1.15  
1 Social cognition and interaction in substance addiction  Room 1.09 
2 Early warning for new psychoactive substances (NPS)  Auditorium IV 
3 The Portuguese decriminalisation model: a comprehensive approach   
 Room 5A 
4 Symposium on the future of addiction research: an overview                
 Auditorium I 
Treatment of problem 
drug use  Room 5C 
Publish safely and 
professionally: publishing 
addiction science in 
practice Room 1.06 
 
Lunch boxes available between 12:30 and 14:00 
 
13:15 – 14:15 PARALLEL SESSIONS    
PAPER SESSIONS STRUCTURED SESSIONS POSTER 
SESSIONS 
 Pavilions 
4 and 5 
7 New psychoactive substances (NPS) – a challenge for 
responses  Auditorium II 
8 Inequalities  Room 5B 
9 Holistic approaches  Room 1.05 
10 Impact of regulations  Auditorium IV 
11 Therapy for nicotine addiction  Room 5C 
5 Setting standards in the addiction field: a view from Europe  Room 5A 
6 European quality standards in drug demand reduction: how to monitor implementation?            
 Room 1.15 
7 Gambling and gaming 2.0: one and the same?  Auditorium III 
8 Global surveillance of prescription drug misuse: multi-system data networks throughout Europe, 
the United Kingdom and North America  Auditorium VIII 
9 No one gets left behind: addressing the hidden burden of hepatitis C related advanced liver 
disease in PWID in the community in Dublin, Ireland  Room 1.07 
10 Political and ethical implications of the brain disease model of addiction  Room 1.08 
11 Advancing theory and treatment approaches for males in substance use treatment who 
perpetrate intimate partner violence (IPV)  Room 1.09 
47 Advancing hepatitis C care in people with opioid use disorders (OUD)  Room 1.06 
TWIST (08:30 – 10:00)  Drug-related infectious diseases  Room 5C 
1
OVERVIEW
1 4 : 3 0  –  1 6 : 0 0  
P A R A L L E L  S E S S I O N S    
P A P E R  S E S S I O N S   S T R U C T U R E D  S E S S I O N S  P O S T E R  
S E S S I O N S  
  P a v i l i o n s  
4  a n d  5  
T W I S T  
1 2  A d d r e s s i n g  s m o k i n g  a n d  r e l a t e d  b e h a v i o u r s    A u d i t o r i u m  I I  
1 3  A l c o h o l  –  a s s e s s m e n t    R o o m  5 C  
1 4  A d d i c t i o n  –  t h e  l i n k  w i t h  c r i m e  a n d  o f f e n d i n g    R o o m  1 . 1 5  
1 5  I m p r o v i n g  r e s p o n s e s  t o  h e p a t i t i s  C  v i r u s  ( H C V )    R o o m  1 . 0 9  
1 6  D r u g  u s e  a n d  i n f e c t i o u s  d i s e a s e s :  r e v i e w i n g  t h e  e v i d e n c e    R o o m  1 . 0 5  
1 7  P e r s p e c t i v e s  o n  p o l i c y    R o o m  5 B  
1 8  N e w  p s y c h o a c t i v e  s u b s t a n c e s  –  t r e n d s  a n d  d e v e l o p m e n t s    R o o m  5 A  
1 9  P r e v e n t i o n  –  t h e o r y  a n d  p r a c t i c e    A u d i t o r i u m  I  
2 0  I n t e g r a t i n g  c a r e  m o d e l s  a n d  p a r t n e r s h i p s    A u d i t o r i u m  I I I  
1 2  C a n n a b i s  a n d  d r i v i n g  –  f e e d b a c k  f r o m  t h e  i n t e r n a t i o n a l  s y m p o s i u m  
  A u d i t o r i u m  V I I I  
D e f i n i n g  a n d  
d i a g n o s i n g  
a d d i c t i o n            
  A u d i t o r i u m  I V  
 
1 6 : 0 0  –  1 6 : 3 0  C o f f e e  b r e a k  
 
1 6 : 3 0  –  1 8 : 0 0  
P A R A L L E L  S E S S I O N S    
P A P E R  S E S S I O N S   S T R U C T U R E D  S E S S I O N S  P O S T E R  
S E S S I O N S  
  P a v i l i o n s  
4  a n d  5  
T W I S T  
2 1  M o v i n g  i n t e r v e n t i o n s  o n l i n e    R o o m  5 C  
2 2  A  f o c u s  o n  m e t h o d o l o g y    R o o m  1 . 0 7  
2 3  N e u r o s c i e n c e  –  n e w  f i n d i n g s    R o o m  5 A  
2 4  A l c o h o l  –  i s s u e s  f o r  t r e a t m e n t    A u d i t o r i u m  V I I I  
2 5  L o c a l  p e r s p e c t i v e s  –  l o c a l  r e s p o n s e s    R o o m  1 . 1 5  
 
1 3  A n a b o l i c  a n d r o g e n i c  s t e r o i d s  ( A A S )  a n d  a s s o c i a t e d  d r u g s :  n e w  
i n s i g h t s  i n t o  t h e  e x t e n t  o f  u s e ,  h a r m s  a n d  r e s p o n s e s    A u d i t o r i u m  I I  
1 4  P r e v a l e n c e  o f  a l c o h o l ,  t o b a c c o  a n d  d r u g  u s e  i n  t h e  m e d i t e r r a n e a n  
r e g i o n  a m o n g  s c h o o l  a g e d  c h i l d r e n  –  t h e  M E D S P A D  n e t w o r k                 
  A u d i t o r i u m  I I I  
1 5  O p e n  d i s c u s s i o n  o n  t h e  f u t u r e  o f  a d d i c t i o n  r e s e a r c h    A u d i t o r i u m  I  
1 6  A T T U N E :  u n d e r s t a n d i n g  p a t h w a y s  t o  s t i m u l a n t  u s e :  a  m i x e d -
m e t h o d s  e x a m i n a t i o n  o f  t h e  i n d i v i d u a l ,  s o c i a l  a n d  c u l t u r a l  f a c t o r s  
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 DAY 2 WEDNESDAY 25 OCTOBER 
 
09:00 – 10:30 PLENARY SESSION II MEASURING ADDICTIONS — A QUESTION OF SCALE  Auditorium I 
 
10:30 – 11:00 Coffee break 
 
11:00 – 12:30 PARALLEL SESSIONS   
PAPER SESSIONS STRUCTURED SESSIONS POSTER 
SESSIONS 
 Pavilions 
4 and 5 
26 Cannabis – shifts in the regulatory framework  Auditorium II 
27 Understanding drug-related mortality  Room 5A 
28 Alcohol – targeting the young  Room 1.09 
29 Improving responses to opioid users and people who inject drugs 
(PWID)  Room 5C 
30 Market developments and their impact  Auditorium VIII 
20 20 years of ESPAD: trends in adolescents´ substance use and risk behaviours, what have 
we learnt?  Auditorium III  
21 How the opioid problem is changing: the role of misused medicines and the 
emergence of novel synthetic opioids  Auditorium I 
22 Wastewater-based drug epidemiology of illicit drugs, new psychoactive substances and 
the misuse of medication as a supplement to traditional data-sources  Auditorium IV 
23 Review of the effectiveness of treatment alternatives to incarceration for drug-involved 
persons  Room 5B 
24 Online surveys of drug users: proceed with caution  Room 1.15 
 
Lunch boxes available between 12:30 and 14:00 
 
12:45 – 14:15 SPONSORED SESSIONS  COPOLAD  Auditorium III ERANID  Room 5A RARHA  Room 5B 
 
12:45 – 14:15 PARALLEL SESSIONS   
PAPER SESSIONS STRUCTURED SESSIONS POSTER 
SESSIONS 
 Pavilions 
4 and 5 
31 Spotlight on the misuse of medicines  Auditorium II 
32 New methods  Room 1.08 
33 Focus on pregnancy and the neonate  Room 1.09 
34 Drug use and migration  Room 1.05 
35 Crime and violence  Room 5C 
36 Opiate Substitution Therapy (OST) and mortality  Room 1.15 








TWIST (12:30 – 13:30)  Sexuality, chemsex and club drugs 
– what are the priorities?  Auditorium VIII 
D A Y  1
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14:30 – 16:00 
PARALLEL SESSIONS   
PAPER SESSIONS  STRUCTURED SESSIONS POSTER 
SESSIONS 
 Pavilions 
4 and 5 
TWIST 
12 Addressing smoking and related behaviours  Auditorium II 
13 Alcohol – assessment  Room 5C 
14 Addiction – the link with crime and offending  Room 1.15 
15 Improving responses to hepatitis C virus (HCV)  Room 1.09 
16 Drug use and infectious diseases: reviewing the evidence  Room 1.05 
17 Perspectives on policy  Room 5B 
18 New psychoactive substances – trends and developments  Room 5A 
19 Prevention – theory and practice  Auditorium I 
20 Integrating care models and partnerships  Auditorium III 
12 Cannabis and driving – feedback from the international symposium 
 Auditorium VIII 
Defining and 
diagnosing 
addiction           
 Auditorium IV 
 
16:00 – 16:30 Coffee break 
 
16:30 – 18:00 
PARALLEL SESSIONS   
PAPER SESSIONS  STRUCTURED SESSIONS POSTER 
SESSIONS 
 Pavilions 
4 and 5 
TWIST 
21 Moving interventions online  Room 5C 
22 A focus on methodology  Room 1.07 
23 Neuroscience – new findings  Room 5A 
24 Alcohol – issues for treatment  Auditorium VIII 
25 Local perspectives – local responses  Room 1.15 
 
13 Anabolic androgenic steroids (AAS) and associated drugs: new 
insights into the extent of use, harms and responses  Auditorium II 
14 Prevalence of alcohol, tobacco and drug use in the mediterranean 
region among school aged children – the MEDSPAD network                
 Auditorium III 
15 Open discussion on the future of addiction research  Auditorium I 
16 ATTUNE: understanding pathways to stimulant use: a mixed-
methods examination of the individual, social and cultural factors 
shaping illicit stimulant use across Europe  Room 5B 
17 Biomarkers in addiction: the experience of the Spanish network on 
addiction research  Room 1.05 
18 Lessons learned from the recent HIV outbreaks in Europe among 
people who inject drugs  Room 1.06 
19 Addiction in daily life: mobile assessment and treatment                  
 Room 1.09 
Drug policy 
developments   
 Auditorium IV 
 
18:00 Cocktail in the Conference venue 
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D A Y  2
 14:30 – 16:00 
PARALLEL SESSIONS   
PAPER SESSIONS STRUCTURED SESSIONS POSTER 
SESSIONS 
 Pavilions 
4 and 5 
TWIST 
37 The constructs of addiction  Room 5C 
38 Evaluating impact  Auditorium IV 
39 Developing effective drug treatment  Auditorium II 
40 Perspectives on harm reduction  Auditorium III 
41 Responding in the prison setting  Auditorium VIII 
42 Alcohol – social contexts  Room 5B 
26 Targeting hard-to-reach client groups for addiction aid in Switzerland 
– good practice in international perspective  Room 1.05 
27 Voices from the margins  Room 1.09 
28 Harm reduction for people who inject drugs in Europe: findings from 
three major European projects  Room 1.15 
29 Health and social responses to drug problems in Europe: current  
state-of-the-art and future opportunities  Room 5A 
30 Assessment of risky cannabis use and related consequences               
 Room 1.08 
Neuroscience  
 Auditorium I 
 
16:00 – 16:30 
Coffee break 
 
16:30 – 18:00 PLENARY SESSION III BOUNDARIES OF ADDICTION  Auditorium I 
 2017 EMCDDA Scientific award ceremony 
 
19:30 – 22:30 




 DAY 3  THURSDAY 26 OCTOBER 
 
09:00 – 10:30 PLENARY SESSION IV CHALLENGES AHEAD  Auditorium I 
 
10:30 – 11:00 Coffee break 
 
11:00 – 12:30 PARALLEL SESSIONS   
PAPER SESSIONS STRUCTURED SESSIONS POSTER 
SESSIONS 
 Pavilions 
4 and 5 
43 Illuminating the darknet and online markets  Auditorium I 
44 Gambling – assessment  Room 1.05 
45 Understanding health consequences  Room 5C 
46 Innovations in practice  Room 1.09 
47 The importance of gender  Auditorium II 
31 Promoting a new era in global training and education of addiction professionals: the 
International Consortium of Universities for Drug Demand Reduction  Room 1.06 
32 Costs of drug treatment  Room 5A 
33 Why are there more drug-related deaths: challenges for monitoring, understanding and 
preventing – examples from Europe  Auditorium IV 
34 Addressing the unmet reproductive health needs of women with addiction  Room 1.07 
35 Best practices in hepatitis C virus (HCV) prevention, management and treatment among 
people who inject drugs  Auditorium III 
36 Drug research and drug monitoring in prison  Room 5B 
37 Nightlife: no risk no fun? challenges for drug prevention and trendspotting  Room 1.08 
 
Lunch boxes available between 12:30 and 14:00 
 
12:45 – 14:15 SPONSORED SESSIONS MSD  Room 1.07 
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PAPER SESSIONS STRUCTURED SESSIONS POSTER 
SESSIONS 
 Pavilions 
4 and 5 
48 Reducing risks  Room 5A 
49 Spotlight on drug consumption rooms  Auditorium I 
50 Analysis to inform service development and delivery  Room 5B 
51 Improving the evidence base on hepatitis C virus (HCV)                    
 Auditorium II 
52 Innovating monitoring  Auditorium IV 
38 Ayahuasca – why is classification so important?  Room 1.06 
39 Prevention: from evidence to action – how we are working  Room 1.05 
40 The universal prevention curriculum (UPC) adaptation in Europe: introduction and 
discussion on substantial content  Auditorium III 
41 Promoting the use of evidence-based programmes in Europe: a European registry          
 Room 5C 
42 Anonymous collecting and testing of new psychoactive substances samples as a part  of 
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4 3  R e c o n c e p t u a l i z i n g  t h e  e t i o l o g y  o f  s u b s t a n c e  u s e :  i m p l i c a t i o n s  f o r  p r e v e n t i o n  a n d  
t r e a t m e n t    R o o m  1 . 0 9  
4 4  C o n t i n u u m  o f  c a r e  i n  t h e  p r i s o n  s e t t i n g ?  R e s p o n s e s  t o  d r u g - r e l a t e d  i n f e c t i o n  
t r a n s m i s s i o n  i n  p r i s o n s  –  e x a m p l e s  f r o m  E u r o p e    A u d i t o r i u m  I I I  
4 5  C r y s t a l  m e t h  a n d  t h e  f a m i l y  –  s t r e s s ,  s t r a i n ,  a n d  i n t e r v e n t i o n s    R o o m  1 . 0 5  
4 6  M u l t i d i s c i p l i n a r y  w o r k  i n  a  s c i e n t i f i c  s o c i e t y  o f  a d d i c t i o n s    R o o m  1 . 0 6  
 
1 6 : 0 0  –  1 6 : 3 0  C o f f e e  b r e a k  
 




D A Y  3
 14:30 – 16:00 
PARALLEL SESSIONS   
PAPER SESSIONS STRUCTURED SESSIONS POSTER 
SESSIONS 
 Pavilions 
4 and 5 
53 Interconnected problems – spotlight  on comorbidity  Room 5B 
54 Innovative methods in drug detection  Room 5A 
55 Gambling – informing interventions  Auditorium IV 
56 Innovation in harm reduction  Auditorium II 
57 The challenge of responding in recreational settings  Room 5C 
43 Reconceptualizing the etiology of substance use: implications for prevention and 
treatment  Room 1.09 
44 Continuum of care in the prison setting? Responses to drug-related infection 
transmission in prisons – examples from Europe  Auditorium III 
45 Crystal meth and the family – stress, strain, and interventions  Room 1.05 
46 Multidisciplinary work in a scientific society of addictions  Room 1.06 
 
16:00 – 16:30 Coffee break 
 
16:30 Wrap up and Closing session  Auditorium I 
  
 
– For last minute changes consult the App:
– Follow the tracks:
Issues in focus
Measurement, epidemiology and reviews
Extending the evidence base
Lessons from practice
Substance, set, and setting
These TWIST sessions are open to 
Lisbon Addictions delegates. TWIST has been 
developed through a participatory process 
as part of the EC co-funded project TWIST 
(Training WIth STakeholders - www.twist-
train.eu) to provide key knowledge on specific 
topics, and support the involvement of early 
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0 8 : 0 0  
A r r i v a l  a n d  r e g i s t r a t i o n  
  
 
0 9 : 0 0  –  1 0 : 0 0  
I N A U G U R A L  S E S S I O N S   
 
S c i e n c e  s p e a k s  t o  p o l i c y  C h a i r :  A l i s o n  R i t t e r ,  A u s t r a l i a  P o l i c y  s p e a k s  t o  s c i e n c e  C h a i r :  W e r n e r  S i p p ,  G e r m a n y  
 
A u d i t o r i u m  I I  A u d i t o r i u m  I  
 
 
A l e x a n d r e  Q u i n t a n i l h a ,  C h a i r ,  P a r l i a m e n t a r y  C o m m i s s i o n  o n  E d u c a t i o n  a n d  
S c i e n c e ,  P o r t u g a l  
H e n r i e t t a  B o w d e n - J o n e s ,  I m p e r i a l  C o l l e g e  L o n d o n ,  U n i t e d  K i n g d o m  
J a l l a l  T o u f i q ,  T h e  M o r o c c a n  O b s e r v a t o r y  o n  D r u g s  a n d  A d d i c t i o n ,  M o r o c c o  
 
C h l o é  C a r p e n t i e r ,  U n i t e d  N a t i o n s  O f f i c e  o n  D r u g s  a n d  C r i m e  
T o r b j ø r n  B r e k k e ,  P o m p i d o u  G r o u p  
V l a d i m i r  P o z n y a k ,  W o r l d  H e a l t h  O r g a n i z a t i o n  
U t e  S t i e g e l ,  E u r o p e a n  C o m m i s s i o n  
 
1 0 : 0 0  –  1 0 : 3 0  
P L E N A R Y  S E S S I O N  I  C H A L L E N G E S  F O R  L I S B O N  A D D I C T I O N S  2 0 1 7  
C h a i r s :  A l e x i s  G o o s d e e l ,  E M C D D A  a n d  J o ã o  G o u l ã o ,  S I C A D  
 
A u d i t o r i u m  I  
 
W e r n e r  S i p p ,  F o r m e r  P r e s i d e n t  I n t e r n a t i o n a l  N a r c o t i c s  C o n t r o l  B o a r d ,  G e r m a n y   
A l i s o n  R i t t e r ,  N a t i o n a l  D r u g  a n d  A l c o h o l  R e s e a r c h  C e n t r e ,  A u s t r a l i a  
 
1 0 : 3 0  –  1 1 : 0 0  
O P E N I N G  C E R E M O N Y  
 
A u d i t o r i u m  I  
 
 
J o ã o  G o u l ã o ,  G e n e r a l - D i r e c t o r  –  G e n e r a l - D i r e c t o r a t e  f o r  I n t e r v e n t i o n  o n  A d d i c t i v e  B e h a v i o u r s  a n d  D e p e n d e n c i e s  ( S I C A D )  
A l e x i s  G o o s d e e l ,  D i r e c t o r  –  E u r o p e a n  M o n i t o r i n g  C e n t r e  f o r  D r u g s  a n d  D r u g  A d d i c t i o n  ( E M C D D A )  
V y t e n i s  A n d r i u k a i t i s ,  E U  C o m m i s s i o n e r  f o r  H e a l t h  a n d  F o o d  S a f e t y  ( V i d e o  m e s s a g e )  
J o h n  R y a n ,  D i r e c t o r a t e - G e n e r a l  f o r  H e a l t h  a n d  F o o d  S a f e t y  –  E u r o p e a n  C o m m i s s i o n  
U t e  S t i e g e l ,  D i r e c t o r a t e - G e n e r a l  f o r  M i g r a t i o n  a n d  H o m e  A f f a i r s  –  E u r o p e a n  C o m m i s s i o n  
F e r n a n d o  A r a ú j o ,  P o r t u g u e s e  S e c r e t a r y  o f  S t a t e  A s s i s t a n t  a n d  o f  H e a l t h  
 
1 1 : 0 0  –  1 1 : 3 0  
C o f f e e  b r e a k  
 
 
T W I S T  
S E S S I O N  
( 0 8 : 3 0  –  1 0 : 0 0 )  
R o o m  5 C  
−  D r u g - r e l a t e d  
i n f e c t i o u s  
d i s e a s e s .  M i k e  
C a t c h p o l e ,  
E C D C  
D A Y  1   T U E S D A Y  2 4  O C T O B E R   
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DAY 1
11:30 – 13:00 PARALLEL SESSIONS   
PAPER SESSION 1 
Alcohol – informing prevention and policy  
Chair: Gilberto Gerra, UNODC 
PAPER SESSION 2 
The measurement of problems and trends 
Chair: Ludwig Kraus, Germany 
PAPER SESSION 3 
A focus on pharmacotherapy 
Chair: John Strang, United Kingdom 
Auditorium III Room 1.08 Auditorium II 
− Law of alcohol. Two sides of the coin: consumers 
and retailers. Elsa Lavado, Portugal 
− Alcohol marketing: how to regulate? A 
comparative analysis. Marieke Vlaemynck, Belgium 
− Attitudes towards alcohol policy across Europe, 
results of the RARHA SEAS study.  Jacek 
Moskalewicz, Poland and Zsuzsanna Elekes, 
Hungary 
− Alcohol marketing in Portugal: alcohol industry 
and government strategies in the 21st century. 
Hilson Cunha Filho, Portugal 
− Alcohol and other drug use among the working 
population in Belgium: prevalence and job related 
consequences. Marie-Claire Lambrechts, Belgium 
− Measuring problematic cannabis use in the general 
population: conception, use and future of the cannabis 
abuse screening test (CAST). Stéphane Legleye, France 
− Changes in cultural patterns of drugs use throughout 
three generations of the Portuguese population – 1950, 
1975 and 2000. Casimiro Balsa, Portugal 
− Cannabis epidemic or return of opoid problems or 
decrease of high risk drug use among young adults in 
Austria. Martin Busch, Austria 
− Longitudinal trajectories of polydrug use among 
adolescents: two years follow-up. Víctor Martínez-Loredo, 
Spain 
− Treatment demand indicator: experience of its 
implementation in Nigeria. Dominique Lopez, India 
− Exploration of the benefits of methadone treatment for dual users of heroin   
and crack who inject or have previously injected drugs – preliminary findings. 
Felicia Heidebrecht, United Kingdom 
− Response to treatment among indigenous people receiving injectable 
diacetylmorphine or hydromorphone in a randomized controlled trial for the 
treatment of long-term opioid-dependence. Heather Palis, Canada 
− Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent 
patients on heroin-assisted treatment: a randomised, double-blind, placebo-
controlled trial. Mascha Nuijten, presented by Peter Blanken, Netherlands 
(EMCDDA 2017 Scientific Award) 
− Take-home naloxone: pharmacokinetics of a novel nasal spray in development  
in Europe. Rebecca McDonald, United Kingdom 
− The impact of benzodiazepine use in patients enrolled in opioid agonist therapy  
in Ontario. Joseph Eibl, Canada 
PAPER SESSION 4 
Ageing and intergenerational issues 
Chair: Amy Porath, Canada 
PAPER SESSION 5 
Gambling – behavioural insights 
Chair: Michael Farrell, Australia 
PAPER SESSION 6 
Concepts and constructs 
Chair: Vladimir Poznyak, WHO 
Auditorium VIII Room 5B Room 1.15 
− Opioid treatment outcomes in older adults: a review of the 
literature. Anne Marie Carew, Ireland 
− Case management for older drug users. Martin Schmid, 
Germany 
− Ageing drug users a new challenge for drug treatment 
programmes in Slovenia. Milan Krek, Slovenia 
− Explanations for intergenerational transference of addiction: 
perspective of the person with parent(s) who suffer from 
addiction. Margreet van der Meer, Netherlands 
− Children of parents who use substance: parents who use and 
grandparents who care, perspectives of needs, risks and 
protective factors. Karen Galligan, Ireland 
− Problem gambling in adolescence: an analysis conducted from the 
actor’s perspective. Annie-Claude Savard, Canada 
− Factors contributing to the normalisation of gambling: a qualitative 
study of international gambling experts. Samantha Thomas, 
Australia 
− How do gambling products which are provided in ‘family friendly’ 
venues, shape young people’s gambling consumption intentions? A 
qualitative study of children in Australia. Amy Bestman, Australia 
− Female pathological gamblers: characteristics and obstacles for 
treatment. Andrea Wöhr, Germany 
− Online sports betting advertising and gambling disorder: a content 
analysis approach. Hibai Lopez-Gonzalez, United Kingdom 
− A transdiagnostic dimensional approach to addiction: an 
international Delphi consensus study. Murat Yücel, 
Australia 
− Putting the brain in its place: arguments from ethics and 
philosophy of science. Jaakko Kuorikoski and Susanne 
Uusitalo, Finland 
− Non problematic illicit drug use: a less known but not less 
important phenomenon. Olga Cruz, Portugal 
− Constructing alcohol-related problems – attitudes of 
social workers and their clients. Elina Renko, Finland 
− Emotion regulation, attachment and addictive behaviors. 
Paula Jauregui, Spain 
9
D A Y  1
S T R U C T U R E D  S E S S I O N  1  
S o c i a l  c o g n i t i o n  a n d  i n t e r a c t i o n  i n  
s u b s t a n c e  a d d i c t i o n  
C h a i r s :  B o r i s  Q u e d n o w ,  S w i t z e r l a n d  
a n d  A n t o n i o  V e r d e j o - G a r c i a ,  A u s t r a l i a  
S T R U C T U R E D  S E S S I O N  2  
E a r l y  w a r n i n g  f o r  n e w  p s y c h o a c t i v e  
s u b s t a n c e s  ( N P S )  
C h a i r s :  D a v i d  W o o d ,  U n i t e d  K i n g d o m  a n d  
A n a  G a l l e g o s ,  E M C D D A  
S T R U C T U R E D  S E S S I O N  3  
T h e  P o r t u g u e s e  d e c r i m i n a l i s a t i o n  m o d e l :  a  
c o m p r e h e n s i v e  a p p r o a c h  
C h a i r :  S o f i a  A l b u q u e r q u e ,  P o r t u g a l  
S T R U C T U R E D  S E S S I O N  4  
S y m p o s i u m  o n  t h e  f u t u r e  o f  a d d i c t i o n  
r e s e a r c h :  a n  o v e r v i e w  
C h a i r :  E i l i s h  G i l v a r r y ,  U n i t e d  K i n g d o m  
 
T W I S T  
S E S S I O N  
( 1 1 : 3 0  –  1 3 : 0 0 )  
R o o m  5 C  
−  T r e a t m e n t  o f  
p r o b l e m  d r u g  
u s e .  T h o m a s  
C l a u s e n  a n d  I v a r  
S k e i e ,  N o r w a y ,  
a n d  C h r i s t i a n  
T j a g v a d ,  
D e n m a r k  
R o o m  1 . 0 9  A u d i t o r i u m  I V  R o o m  5 A  A u d i t o r i u m  I  
 
−  D o s e - r e l a t e d  e f f e c t s  o f  
m e t h a m p h e t a m i n e  u s e  o n  s o c i a l  
c o g n i t i o n .  A n t o n i o  V e r d e j o - G a r c i a ,  
A u s t r a l i a  
−  M i n d - r e a d i n g  i m p a i r m e n t  i n  c r a c k -
c o c a i n e  u s e r s :  a n  f M R I  s t u d y  o f  t h e  
m o d e r a t o r  e f f e c t s  o f  e a r l y  l i f e  s t r e s s .  
R o d r i g o  G r a s s i - O l i v e i r a ,  B r a z i l  
−  E m o t i o n ,  a l c o h o l  a n d  a d d i c t i o n .  
S a l v a t o r e  C a m p a n e l l a ,  B e l g i u m  
−  C o m p a s s i o n  a n d  s o c i a l  c o g n i t i o n  i n  
h e r o i n  u s e r s :  d e s c r i b i n g  d e f i c i t s  a n d  
d e v e l o p i n g  t r e a t m e n t s .  C e l i a  
M o r g a n ,  U n i t e d  K i n g d o m  
−  E f f e c t s  o f  n o n - m e d i c a l  p r e s c r i p t i o n  
o p i o i d  u s e  o n  s o c i a l  c o g n i t i o n  a n d  
s o c i a l  p a i n .  S a r a  K r o l l ,  S w i t z e r l a n d  
−  T h e  E U  e a r l y  w a r n i n g  s y s t e m :  2 0  y e a r s  o f  
m o n i t o r i n g  n e w  p s y c h o a c t i v e  s u b s t a n c e s  
i n  E u r o p e .  R a c h e l  C h r i s t i e ,  E M C D D A  
−  V i a b i l i t y  o f  a n  e a r l y  w a r n i n g  s y s t e m  
( V I E W S )  s t u d y :  t r i a n g u l a t i o n  o f  d a t a  o n  
d r u g  u s e  a n d  h a r m s  i n  A u s t r a l i a .  A m y  
P e a c o c k ,  A u s t r a l i a  
−  U n i t e d  S t a t e s  n a t i o n a l  d r u g  e a r l y  w a r n i n g  
s y s t e m  ( N D E W S ) :  e v o l v i n g  d r u g  e a r l y  
w a r n i n g  s y s t e m s  i n  a  n e w  w o r l d  o f  d r u g  
p r o d u c t i o n ,  d i s t r i b u t i o n ,  a n d  u s e .  E r i n  
A r t i g i a n i ,  U n i t e d  S t a t e s  
−  D e t e c t i o n  a n d  a c t i v i t y  p r o f i l i n g  o f  
s y n t h e t i c  c a n n a b i n o i d s  a n d  t h e i r  
m e t a b o l i t e s  w i t h  a  n e w l y  d e v e l o p e d  
b i o a s s a y .  A n n e l i e s  C a n n a e r t ,  B e l g i u m   
( E M C D D A  2 0 1 7  S c i e n t i f i c  A w a r d )  
−  T h e  v a l u e  o f  e a r l y  w a r n i n g :  C a r f e n t a n i l  –  a  
c a s e  s t u d y .  H e l g i  D a n i e l s s o n ,  E M C D D A  
−  D e c r i m i n a l i s a t i o n  p o l i c y  a n d  t h e  r o l e  o f  
t h e  C o m m i s s i o n s  f o r  t h e  D i s s u a s i o n  o f  
D r u g  A d d i c t i o n .  A m é r i c o  G e g a l o t o ,  
P o r t u g a l  
−  G u i d e l i n e s  f o r  d i s s u a s i o n  i n t e r v e n t i o n :  a  
h e a l t h  a n d  p r e v e n t i v e  a p p r o a c h .  R a q u e l  
L o p e s ,  P o r t u g a l  
−  T h e  d i s s u a s i o n  i n t e r v e n t i o n  a t  t h e  
C o m m i s s i o n s  f o r  t h e  D i s s u a s i o n  o f  D r u g  
A d d i c t i o n  o f  P o r t o :  p r i o r i t y  g r o u p s  a n d  
t h e  r o l e  o f  e x t e r n a l  s t a k e h o l d e r s .   
P u r i f i c a ç ã o  A n j o s ,  P o r t u g a l  
−  P o r t u g u e s e  C o m m i s s i o n s  f o r  t h e  
D i s s u a s i o n  o f  D r u g  A d d i c t i o n :  
p e r s p e c t i v e s  o f  i n d i c t e d  d r u g  u s e r s  o n  
t h e i r  r o l e  i n  d r u g  u s e .  L u d m i l a  C a r a p i n h a ,   
P o r t u g a l  
−  D r u g  u s e r s ’  a s s e s s m e n t  o f  t h e  
e n f o r c e m e n t  o f  P o r t u g u e s e  d r u g  
d e c r i m i n a l i s a t i o n  l a w  a n d  p r e d i c t o r s  o f  
d r u g  u s e .  J o r g e  Q u i n t a s ,  P o r t u g a l  
−  U s i n g  a r t i f i c i a l  i n t e l l i g e n c e  f o r  d a t a  
s y n t h e s i s  a n d  i n t e r p r e t a t i o n :  T h e  H u m a n  
B e h a v i o u r  C h a n g e  P r o j e c t .  S u s a n  M i c h i e ,  
U n i t e d  K i n g d o m   
−  B a y e s i a n  ‘ m u l t i - p a r a m e t e r  e v i d e n c e  
s y n t h e s i s ’  i n  a d d i c t i o n s  r e s e a r c h .  H a y l e y  
J o n e s ,  U n i t e d  K i n g d o m  
−  A  s y s t e m  f o r  i m p r o v i n g  t r a n s p a r e n c y  i n  
a n a l y s i n g  q u a l i t a t i v e  d a t a .  J o a n n e  N e a l e ,  
U n i t e d  K i n g d o m  
−  ‘ D r i n k i n g  o c c a s i o n s ’  a s  t h e  u n i t  o f  a n a l y s i s  
f o r  u n d e r s t a n d i n g  a l c o h o l  c o n s u m p t i o n .  
J o h n  H o l m e s ,  U n i t e d  K i n g d o m  
−  I m p r o v i n g  r e p l i c a b i l i t y  i n  a d d i c t i o n  
r e s e a r c h .  R o b e r t  W e s t ,  U n i t e d  K i n g d o m  
 
T W I S T  
W O R K S H O P  
( 1 1 : 3 0  –  1 3 : 0 0 )  
R o o m  1 . 0 6  
−  P u b l i s h  s a f e l y  
a n d  
p r o f e s s i o n a l l y :  
p u b l i s h i n g  
a d d i c t i o n  
s c i e n c e  i n  
p r a c t i c e .  R i c h a r d  
P a t e s  a n d  
M i c h a l  M i o v s k ý ,  
I S A J E  
 





13:15 – 14:15 PARALLEL SESSIONS   
 
PAPER SESSION 7 
New psychoactive substances (NPS) – a 
challenge for responses 
Chair: Michal Miovský, Czech Republic 
PAPER SESSION 8 
Inequalities 
Chair: Tony Duffin, Ireland 
PAPER SESSION 9 
Holistic approaches  
Chair: Catherine Moury, Portugal 
PAPER SESSION 10 
Impact of regulations 
Chair: Lotta Lampela, European 
External Action Service 
PAPER SESSION 11 
Therapy for nicotine addiction 
Chair: Ann McNeill, United Kingdom 
Auditorium II Room 5B Room 1.05 Auditorium IV Room 5C 
− The German new psychoactive 
substance law (NPSG): perceived and 
expected outcomes in the first stage of 
implementation. Tessa-Virginia 
Hannemann, Germany 
− New psychoactive substances: current 
health-related practices and challenges 
in responding to use and harms in 
Europe. Alessandro Pirona, EMCDDA 
− Responses to the problem of ‘legal 
highs’ in Poland and their consequences. 
Krzysztof Krajewski, Poland 
− A review of the factors 
associated with mothers 
who use substances 
losing care of their 
children. Martha Canfield, 
United Kingdom 
− Understanding addiction: 
a health inequalities and 
social harms perspective. 
Aileen O´Gorman, United 
Kingdom 
− Patient centered care for 
injectable opioid assisted 
treatment. Kirsten Marchand, 
Canada 
− Boxing clever: evaluation of a 
community based inter-agency 
education and fitness substance 
use intervention program. Sarah 
Morton, Ireland 
− Efficacy of case management for 
persons with substance use 
disorders: a Cochrane update. 
Wouter Vanderplasschen, Belgium 
− Implications of monitoring alcohol 
marketing for public health and 
policy. Carina Ferreira-Borges, 
Portugal 
− Evaluating the effect of full 
legalization on the medical 
cannabis market in Colorado: 
implications for prescription policy. 
Davide Fortin, France 
− To use or not to use? An 
exploration of cannabis use 
motives and constraints. Liz 
Temple, Australia 
− The efficacy of behavioural activation and 
contingency management for cigarette 
smokers with depression: a randomized 
controlled trial. Alba González-Roz, Spain 
− The effects of prescribing varenicline on 
longer-term health outcomes: an 
observational cohort study using electronic 
medical records. Kyla Thomas, United Kingdom 
− Predicting treatment outcome: an examination 
of the mechanism of action of two pre-quit 
smoking cessation pharmacotherapies. Stuart 
Ferguson, Australia 
STRUCTURED SESSION 5 
Setting standards in the addiction 
field: a view from Europe 
Chairs: Antoni Gual, Spain and Geert 
Dom, Belgium 
STRUCTURED SESSION 6 
European quality standards in drug 
demand reduction: how to monitor 
implementation? 
Chair: Marica Ferri, EMCDDA 
STRUCTURED SESSION 7 
Gambling and gaming 2.0: one and the same? 
Chair: Sylvia Kairouz, Canada 
STRUCTURED SESSION 8 
Global surveillance of prescription drug misuse: 
multi-system data networks throughout Europe, the 
United Kingdom and North America 
Chair: Jody Green, United States/Canada 
Room 5A Room 1.15 Auditorium III Auditorium VIII 
− An empirical basis to diagnose 
gambling and gaming disorders in 
ICD-11. Karl Mann, Germany  
− An overview of European Addiction 
Clinical guidelines. Conor Farren, 
Ireland 
− The legal status of medical and 
recreational use of cannabis 
throughout Europe. Jørgen Bramness, 
Norway 
− The role of standards on quality of 
treatment of drug use. Lubomir 
Okruhlica, Slovakia 
− Experiences of implementation of EU 
Prevention Quality Standards. Harry 
Sumnall, United Kingdom 
− Role of training for the implementation of 
quality standards and how to design 
monitoring. Matej Košir, Slovenia 
− Reframing the gambling field: epistemological and 
methodological shifts in the study of the 
gambling/gaming convergence. Sylvia Kairouz, Canada 
− Business models of gaming and gambling and how they 
converge. Ingo Fiedler, Germany 
− Overlapping between gambling and some form of 
gaming in the Internet world: first results of a cross-
national survey. Jean-Michel Costes, France 
− Spectrum model of social casino gaming/gambling: 
understanding the convergence. Jennifer Reynolds, 
Canada 
− The evolution of the opioid abuse epidemic in 
North America. Richard Dart, United States/Canada 
− The landscape of prescription drug misuse in the 
U.K. David Wood, United Kingdom 
− The European experience: prescription drug 
misuse in France, Germany, Italy and Spain. Jody 
Green, United States/Canada 
− Experience of the EURO-DEN Plus: ED 
presentations with acute toxicity related to misuse 
of ‘licensed medicines’. Paul Dargan, United 
Kingdom 
11
STRUCTURED SESSION 1 
Social cognition and interaction in 
substance addiction 
Chairs: Boris Quednow, Switzerland 
and Antonio Verdejo-Garcia, Australia 
STRUCTURED SESSION 2 
Early warning for new psychoactive 
substances (NPS) 
Chairs: David Wood, United Kingdom and 
Ana Gallegos, EMCDDA 
STRUCTURED SESSION 3 
The Portuguese decriminalisation model: a 
comprehensive approach 
Chair: Sofia Albuquerque, Portugal 
STRUCTURED SESSION 4 
Symposium on the future of addiction 
research: an overview 




(11:30 – 13:00) 
Room 5C 
− Treatment of 
problem drug 
use. Thomas 





Room 1.09 Auditorium IV Room 5A Auditorium I 
 
− Dose-related effects of 
methamphetamine use on social 
cognition. Antonio Verdejo-Garcia, 
Australia 
− Mind-reading impairment in crack-
cocaine users: an fMRI study of the 
moderator effects of early life stress. 
Rodrigo Grassi-Oliveira, Brazil 
− Emotion, alcohol and addiction. 
Salvatore Campanella, Belgium 
− Compassion and social cognition in 
heroin users: describing deficits and 
developing treatments. Celia 
Morgan, United Kingdom 
− Effects of non-medical prescription 
opioid use on social cognition and 
social pain. Sara Kroll, Switzerland 
− The EU early warning system: 20 years of 
monitoring new psychoactive substances 
in Europe. Rachel Christie, EMCDDA 
− Viability of an early warning system 
(VIEWS) study: triangulation of data on 
drug use and harms in Australia. Amy 
Peacock, Australia 
− United States national drug early warning 
system (NDEWS): evolving drug early 
warning systems in a new world of drug 
production, distribution, and use. Erin 
Artigiani, United States 
− Detection and activity profiling of 
synthetic cannabinoids and their 
metabolites with a newly developed 
bioassay. Annelies Cannaert, Belgium  
(EMCDDA 2017 Scientific Award) 
− The value of early warning: Carfentanil – a 
case study. Helgi Danielsson, EMCDDA 
− Decriminalisation policy and the role of 
the Commissions for the Dissuasion of 
Drug Addiction. Américo Gegaloto, 
Portugal 
− Guidelines for dissuasion intervention: a 
health and preventive approach. Raquel 
Lopes, Portugal 
− The dissuasion intervention at the 
Commissions for the Dissuasion of Drug 
Addiction of Porto: priority groups and 
the role of external stakeholders.  
Purificação Anjos, Portugal 
− Portuguese Commissions for the 
Dissuasion of Drug Addiction: 
perspectives of indicted drug users on 
their role in drug use. Ludmila Carapinha,  
Portugal 
− Drug users’ assessment of the 
enforcement of Portuguese drug 
decriminalisation law and predictors of 
drug use. Jorge Quintas, Portugal 
− Using artificial intelligence for data 
synthesis and interpretation: The Human 
Behaviour Change Project. Susan Michie, 
United Kingdom  
− Bayesian ‘multi-parameter evidence 
synthesis’ in addictions research. Hayley 
Jones, United Kingdom 
− A system for improving transparency in 
analysing qualitative data. Joanne Neale, 
United Kingdom 
− ‘Drinking occasions’ as the unit of analysis 
for understanding alcohol consumption. 
John Holmes, United Kingdom 
− Improving replicability in addiction 




(11:30 – 13:00) 
Room 1.06 











Lunch boxes available between 12:30 and 14:00 
 
  
D A Y  1
S T R U C T U R E D  S E S S I O N  9  
N o  o n e  g e t s  l e f t  b e h i n d :  a d d r e s s i n g  t h e  h i d d e n  
b u r d e n  o f  h e p a t i t i s  C  r e l a t e d  a d v a n c e d  l i v e r  d i s e a s e  
i n  P W I D  i n  t h e  c o m m u n i t y  i n  D u b l i n ,  I r e l a n d   
C h a i r :  J o h n  L a m b e r t ,  I r e l a n d  
S T R U C T U R E D  S E S S I O N  1 0  
P o l i t i c a l  a n d  e t h i c a l  i m p l i c a t i o n s  
o f  t h e  b r a i n  d i s e a s e  m o d e l  o f  
a d d i c t i o n  
C h a i r :  A n n a  A l a n k o ,  F i n l a n d  
S T R U C T U R E D  S E S S I O N  1 1  
A d v a n c i n g  t h e o r y  a n d  t r e a t m e n t  a p p r o a c h e s  f o r  m a l e s  i n  s u b s t a n c e  u s e  
t r e a t m e n t  w h o  p e r p e t r a t e  i n t i m a t e  p a r t n e r  v i o l e n c e  ( I P V )   
C h a i r :  G a i l  G i l c h r i s t ,  U n i t e d  K i n g d o m  
S T R U C T U R E D  S E S S I O N  4 7  
A d v a n c i n g  h e p a t i t i s  C  c a r e  i n  p e o p l e  
w i t h  o p i o i d  u s e  d i s o r d e r s  ( O U D )  
C h a i r :  C a r l o s  R o n c e r o ,  S p a i n  
R o o m  1 . 0 7  R o o m  1 . 0 8  R o o m  1 . 0 9  R o o m  1 . 0 6  
−  H e p C h e c k :  T o  e n h a n c e  H C V  s c r e e n i n g  o f  P W I D .  
J o h n  L a m b e r t ,  I r e l a n d  
−  I n t e g r a t i n g  h e p a t i t i s  C  t r e a t m e n t  i n  p r i m a r y  
c a r e .  W a l t e r  C u l l e n ,  I r e l a n d  
−  H e p f r i e n d :  D e v e l o p i n g  a n d  c o s t  e v a l u a t i n g  a  
c o m m u n i t y  p e e r  s u p p o r t  m o d e l  t o  i m p r o v e  
a c c e s s  t o  H C V  t r e a t m e n t s  f o r  P W I D .  L a r  M u r p h y ,  
I r e l a n d  
−  P o p u l a r  p r o m i s e s  o f  p r o g r e s s :  
t h e  a r t i c u l a t i o n  o f  B D M A  i n  t h e  
m e d i a .  A n n a  A l a n k o  a n d  
M a t i l d a  H e l l m a n ,  F i n l a n d   
−  T h e  B D M A :  E t h i c a l  a n d  
e p i s t e m o l o g i c a l  q u e s t i o n s  a n d  
c o n s i d e r a t i o n s .  J a a k k o  
K u o r i k o s k i  a n d  S u s a n n e  
U u s i t a l o ,  F i n l a n d  
−  G a m b l i n g  a n d  t h e  b r a i n .  J a n n e  
N i k k i n e n ,  F i n l a n d  
−  I n t r o d u c i n g  t h e  A d v a n c e  P r o g r a m m e .  G a i l  G i l c h r i s t ,  U n i t e d  K i n g d o m  
−  T h e  i n t e r p l a y  b e t w e e n  s u b s t a n c e  u s e  a n d  I P V  p e r p e t r a t i o n :  a  m e t a -
e t h n o g r a p h y .  A m y  J o h n s o n ,  U n i t e d  K i n g d o m  
−  E n g l i s h  s u b s t a n c e - u s i n g  p e r p e t r a t o r s ’  a n d  t h e i r  e x / c u r r e n t - p a r t n e r s ’  
n a r r a t i v e s  o f  w h a t  c o n t r i b u t e s  t o  I P V .  F i n d i n g s  f r o m  q u a l i t a t i v e  
i n t e r v i e w s .  J u l i e t  H e n d e r s o n ,  U n i t e d  K i n g d o m  
−  D e t e r m i n i n g  t h e  e f f i c a c y  o f  a n  i n t e r v e n t i o n  t o  r e d u c e  I P V  p e r p e t r a t i o n  
b y  m e n  w h o  m i s u s e  s u b s t a n c e s :  a  s y s t e m a t i c  r e v i e w  a n d  m e t a -
a n a l y s i s .  G a i l  G i l c h r i s t ,  U n i t e d  K i n g d o m   
−  H o w  b e s t  t o  r e s p o n d  t o  I P V - P :  s u m m a r i s i n g  t h e  c o n t e n t  o f  a  n e w l y  
d e v e l o p e d  i n t e g r a t e d  i n t e r v e n t i o n  t o  a d d r e s s  b o t h  s u b s t a n c e  u s e  a n d  
I P V - P  a n d  p r e s e n t a t i o n  o f  a  c a p a b i l i t i e s  f r a m e w o r k  f o r  w o r k i n g  
e f f e c t i v e l y  a n d  s a f e l y  w i t h  m e n  w h o  p e r p e t r a t e  I P V  i n  s u b s t a n c e  u s e  
t r e a t m e n t .  G a i l  G i l c h r i s t ,  U n i t e d  K i n g d o m  
−  B a r r i e r s  t o  t r e a t m e n t  f o r  H C V  i n  
O U D .  W h a t  m a t t e r s  m o s t ?  N a t  
W r i g h t ,  U n i t e d  K i n g d o m  
−  P r a c t i c a l  s t e p s  f o r  H C V  c a r e  i n  O U D  
p o p u l a t i o n s :  R e s u l t s  o f  a  p r o g r a m  
t o  d e v e l o p  a  b e s t  p r a c t i c e  g u i d e .  
C a r l o s  R o n c e r o ,  S p a i n  
−  A  v i s i o n  f o r  H C V  a n d  O U D  i n  
E u r o p e .  W h a t  s h o u l d  t h e  o v e r a l l  
s t r a t e g y  l o o k  l i k e ?  F e l i c e  N a v a ,  I t a l y  
 
1 4 : 3 0  –  1 6 : 0 0  
P A R A L L E L  S E S S I O N S   
 
P A P E R  S E S S I O N  1 2  
A d d r e s s i n g  s m o k i n g  a n d  r e l a t e d  
b e h a v i o u r s   
C h a i r :  R o b e r t  W e s t ,  U n i t e d  K i n g d o m  
P A P E R  S E S S I O N  1 3  
A l c o h o l  –  a s s e s s m e n t  
C h a i r :  H å k a n  L e i f m a n ,  S w e d e n  
P A P E R  S E S S I O N  1 4  
A d d i c t i o n  –  t h e  l i n k  w i t h  c r i m e  a n d  
o f f e n d i n g  
C h a i r :  C h l o é  C a r p e n t i e r ,  U N O D C  
P A P E R  S E S S I O N  1 5  
I m p r o v i n g  r e s p o n s e s  t o  h e p a t i t i s  C  v i r u s  ( H C V )  
C h a i r :  L a r a  T a v o s c h i ,  E C D C  
A u d i t o r i u m  I I  R o o m  5 C  R o o m  1 . 1 5  R o o m  1 . 0 9  
−  R e l a t i v e  r e i n f o r c i n g  e f f i c a c y  o f  
c i g a r e t t e s  a m o n g  d e p r e s s e d  a n d  
n o n - d e p r e s s e d  s m o k e r s .  A l b a  
G o n z á l e z - R o z ,  S p a i n  
−  A r e  s m o k i n g  a n d  e - c i g a r e t t e  u s e  
p r o s p e c t i v e l y  a s s o c i a t e d  w i t h  o n e  
a n o t h e r ?  A  l o n g i t u d i n a l  s t u d y  o f  
y o u n g  p e o p l e  i n  G r e a t  B r i t a i n .  
K a t h e r i n e  E a s t ,  U n i t e d  K i n g d o m  
−  V a l i d a t i o n  o f  a l c o h o l  c o n s u m p t i o n  s e l f - r e p o r t s  i n  t h e  
M u n i c h  c o m p o s i t e  i n t e r n a t i o n a l  d i a g n o s t i c  i n t e r v i e w  
( M - C I D I ) .  S ö r e n  K u i t u n e n - P a u l ,  G e r m a n y  
−  S c r e e n i n g  f o r  m o d e r a t e / h i g h  r i s k  a l c o h o l  u s e  a m o n g  
o p i o i d  d e p e n d e n t  p a t i e n t s  o n  b u p r e n o r p h i n e  
m a i n t e n a n c e :  a  c l i n i c a l  a n d  a l c o h o l - b i o m a r k e r  s t u d y .  
S u r e s h  T h a p a l i y a ,  N e p a l  
−  Е m o t i o n  r e g u l a t i o n  a n d  c o g n i t i v e  c o n t r o l  i n  p a t i e n t s  
w i t h  a l c o h o l  d e p e n d e n c e .  S v e t l a n a  K l i m a n o v a ,  R u s s i a  
−  A d d i c t i o n ,  c o m o r b i d i t y  a n d  c r i m i n a l  
r e c i d i v i s m  o f  f e m a l e  s y s t e m a t i c  
o f f e n d e r s .  E r i c  B l a a u w ,  N e t h e r l a n d s  
−  P r e d i c t i n g  o f f e n d i n g  a f t e r  r e s i d e n t i a l  
r e h a b i l i t a t i o n .  B i r g i t t e  T h y l s t r u p ,  D e n m a r k  
−  ‘ Y o u ,  o f  a l l  p e o p l e ’ :  i n t e r v i e w s  w i t h  t e n  
n u r s e s  w h o  l o s t  t h e i r  m e d i c a l  l i c e n s e  d u e  
t o  p r e s c r i p t i o n  d r u g  u s e  a n d  t h e f t  f r o m  
t h e  w o r k  p l a c e .  O d a  S j o v o l l ,  N o r w a y  
−  E f f i c a c y  a n d  s a f e t y  o f  s o f o s b u v i r / v e l p a t a s v i r  i n  
p e o p l e  w i t h  c h r o n i c  h e p a t i t i s  C  v i r u s  i n f e c t i o n  a n d  
r e c e n t  i n j e c t i n g  d r u g  u s e :  t h e  s i m p l i f y  s t u d y .  J a s o n  
G r e b e l y ,  A u s t r a l i a  
−  H e p a t i t i s  a n t i b o d y  a n d  R N A  p r e v a l e n c e  a m o n g  
o p i a t e  s u b s t i t u t e d  p a t i e n t s  i n  G e r m a n y :  
e p i d e m i o l o g i c a l  d a t a  c o l l e c t e d  u n d e r  r e a l  l i f e  
p r a c t i c e  c i r c u m s t a n c e s .  B e r n d  S c h u l t e ,  G e r m a n y  
−  P r i s o n  h i s t o r y  a n d  d r u g - r e l a t e d  p r o b l e m s  i n  p e o p l e  
1 2
DAY 1
STRUCTURED SESSION 9 
No one gets left behind: addressing the hidden 
burden of hepatitis C related advanced liver disease 
in PWID in the community in Dublin, Ireland  
Chair: John Lambert, Ireland 
STRUCTURED SESSION 10 
Political and ethical implications 
of the brain disease model of 
addiction 
Chair: Anna Alanko, Finland 
STRUCTURED SESSION 11 
Advancing theory and treatment approaches for males in substance use 
treatment who perpetrate intimate partner violence (IPV)  
Chair: Gail Gilchrist, United Kingdom 
STRUCTURED SESSION 47 
Advancing hepatitis C care in people 
with opioid use disorders (OUD) 
Chair: Carlos Roncero, Spain 
Room 1.07 Room 1.08 Room 1.09 Room 1.06 
− HepCheck: To enhance HCV screening of PWID. 
John Lambert, Ireland 
− Integrating hepatitis C treatment in primary 
care. Walter Cullen, Ireland 
− Hepfriend: Developing and cost evaluating a 
community peer support model to improve 
access to HCV treatments for PWID. Lar Murphy, 
Ireland 
− Popular promises of progress: 
the articulation of BDMA in the 
media. Anna Alanko and 
Matilda Hellman, Finland  
− The BDMA: Ethical and 
epistemological questions and 
considerations. Jaakko 
Kuorikoski and Susanne 
Uusitalo, Finland 
− Gambling and the brain. Janne 
Nikkinen, Finland 
− Introducing the Advance Programme. Gail Gilchrist, United Kingdom 
− The interplay between substance use and IPV perpetration: a meta-
ethnography. Amy Johnson, United Kingdom 
− English substance-using perpetrators’ and their ex/current-partners’ 
narratives of what contributes to IPV. Findings from qualitative 
interviews. Juliet Henderson, United Kingdom 
− Determining the efficacy of an intervention to reduce IPV perpetration 
by men who misuse substances: a systematic review and meta-
analysis. Gail Gilchrist, United Kingdom  
− How best to respond to IPV-P: summarising the content of a newly 
developed integrated intervention to address both substance use and 
IPV-P and presentation of a capabilities framework for working 
effectively and safely with men who perpetrate IPV in substance use 
treatment. Gail Gilchrist, United Kingdom 
− Barriers to treatment for HCV in 
OUD. What matters most? Nat 
Wright, United Kingdom 
− Practical steps for HCV care in OUD 
populations: Results of a program 
to develop a best practice guide. 
Carlos Roncero, Spain 
− A vision for HCV and OUD in 
Europe. What should the overall 
strategy look like? Felice Nava, Italy 
 
14:30 – 16:00 
PARALLEL SESSIONS  
 
PAPER SESSION 12 
Addressing smoking and related 
behaviours  
Chair: Robert West, United Kingdom 
PAPER SESSION 13 
Alcohol – assessment 
Chair: Håkan Leifman, Sweden 
PAPER SESSION 14 
Addiction – the link with crime and 
offending 
Chair: Chloé Carpentier, UNODC 
PAPER SESSION 15 
Improving responses to hepatitis C virus (HCV) 
Chair: Lara Tavoschi, ECDC 
Auditorium II Room 5C Room 1.15 Room 1.09 
− Relative reinforcing efficacy of 
cigarettes among depressed and 
non-depressed smokers. Alba 
González-Roz, Spain 
− Are smoking and e-cigarette use 
prospectively associated with one 
another? A longitudinal study of 
young people in Great Britain. 
Katherine East, United Kingdom 
− Validation of alcohol consumption self-reports in the 
Munich composite international diagnostic interview 
(M-CIDI). Sören Kuitunen-Paul, Germany 
− Screening for moderate/high risk alcohol use among 
opioid dependent patients on buprenorphine 
maintenance: a clinical and alcohol-biomarker study. 
Suresh Thapaliya, Nepal 
− Еmotion regulation and cognitive control in patients 
with alcohol dependence. Svetlana Klimanova, Russia 
− Addiction, comorbidity and criminal 
recidivism of female systematic 
offenders. Eric Blaauw, Netherlands 
− Predicting offending after residential 
rehabilitation. Birgitte Thylstrup, Denmark 
− ‘You, of all people’: interviews with ten 
nurses who lost their medical license due 
to prescription drug use and theft from 
the work place. Oda Sjovoll, Norway 
− Efficacy and safety of sofosbuvir/velpatasvir in 
people with chronic hepatitis C virus infection and 
recent injecting drug use: the simplify study. Jason 
Grebely, Australia 
− Hepatitis antibody and RNA prevalence among 
opiate substituted patients in Germany: 
epidemiological data collected under real life 
practice circumstances. Bernd Schulte, Germany 
− Prison history and drug-related problems in people − Young adults report increased 
pleasure from using e-cigarettes and 
smoking tobacco cigarettes when 
drinking alcohol. Johannes Thrul, 
United States 
− Nunc est bibendum! The effects of placebo and 
moderate dose alcohol on attentional bias, inhibitory 
control and subjective craving. Adam McNeill, United 
Kingdom 
− Neuropsychological performance in patients with SUD 
with and without mood disorders. Irma Höijer, Finland 
− ´ If the person doesn’t drink they are one 
person, if they drink they are another´. 
How men in treatment for substance use 
in England and Brazil account for 
perpetrating intimate partner violence. 
Martha Canfield, United Kingdom 
who inject drugs – associations of HIV and HCV 
with prison history in the European Union and 
beyond. Lucas Wiessing, EMCDDA 
− Modelling the impact of interventions targeting 
high-risk populations on the general hepatitis 
epidemic in resource-limited settings. Aaron Lim, 
United Kingdom 
PAPER SESSION 16 
Drug use and infectious diseases: reviewing the evidence 
 Chair: Jean-Luc Sion, European Commission 
PAPER SESSION 17 
Perspectives on policy  
Chair: Pedro Moitinho de Almeida, Portugal 
PAPER SESSION 18 
New psychoactive substances – trends and developments 
Chair: Paul Dargan, United Kingdom 
Room 1.05 Room 5B Room 5A 
− Injecting and sexual risk-taking amongst people who inject drugs: a 
global review. Amy Peacock, Australia 
− Needle syringe programmes and opioid substitution therapy for 
prevention HCV transmission among people who inject drugs: Cochrane 
systematic review. Matthew Hickman, United Kingdom 
− Recent incarceration and risk of hepatitis C and HIV transmission amongst 
people who inject drugs: a systematic review and meta-analysis. Jack 
Stone, United Kingdom 
− A systematic review and meta-analysis of psychosocial interventions to 
reduce drug and sexual blood borne virus risk behaviours among people 
who inject drugs. Gail Gilchrist, United Kingdom 
− HIV prevention, treatment and care for people who inject drugs: a 
systematic review of coverage of interventions. Sarah Larney, Australia 
− Developing an evidence informed local drug strategy: 
identifying the prevalence, risks and protective factors 
for children of parents who use drugs. Catherine 
Comiskey, Ireland 
− Estimating the current and potential future impact of the 
Mexican drug law reform on HIV incidence among 
people who inject drugs (PWID) in Tijuana, Mexico, using 
mathematical modelling. Annick Borquez, United States  
− Evaluation of drug laws and policies by means of new 
indicators and data regarding minor subjects, PDUs and 
arrested dealers. Carla Rossi, Italy 
− UN drug agenda post 2019. Danilo Ballotta, EMCDDA 
− New psychoactive substance use among regular 
psychostimulant users in Australia, 2010–2017. Rachel 
Sutherland, Australia 
− New trends in drug use in Germany? The use of new 
psychoactive substances and methamphetamine in five 
federal states. Elena Gomes de Matos, Germany 
− New psychoactive substances (NPS) in Portugal – trends 
and approaches. Susana Henriques, Portugal 
− French media and new psychoactive substances: is a new 
discourse emerging? Julie-Emilie Adès, France 
PAPER SESSION 19 
Prevention – theory and practice 
 Chair: Zili Sloboda, United States 
PAPER SESSION 20 
Integrating care models and partnerships  
Chair: Henk Garretsen, Netherlands 
STRUCTURED SESSION 12  
Cannabis and driving – feedback from the 
international symposium 




(14:30 – 16:00) 
Auditorium I Auditorium III Auditorium VIII  Auditorium IV 
− Online prevention of substance abuse among students with 
eCHUG-D. Marion Laging, Germany 
− Prevention systems in Europe: how can they be 
described, assessed and improved. Gregor Burkhart, 
EMCDDA 
− High school finalists trip: preventing risk behaviour with 
young people. Irma Brito, Portugal 
− Multi-setting community-based interventions to reduce 
population level harms arising from alcohol and other drug use. 
Emily Stockings, Australia  
− Successful application of a cross-sectoral integrated care approach 
to addiction and homeless services: the experience from southern 
Ireland. Joe Kirby and Jo-Hanna Ivers, Ireland  
− Heplink: integrating hepatitis C treatment in primary care. Walter 
− Informing an evidence-based cannabis and 
driving policy. Kim Wolff, United Kingdom 
− Cannabis and driving: a case study of 
Colorado. Glenn Davis, United States 
− Cannabis and driving: a case study of 
Washington State. Darrin Grondel, United 
States 
 







D A Y  1
−  U n d e r s t a n d i n g  a n d  i n t e r v e n i n g  o n  a d d i c t i o n  s t i g m a .  
K a r s t e n  L u n z e ,  U n i t e d  S t a t e s  
−  L e a r n i n g  f r o m  s u c c e s s :  t h e  i m p l e m e n t a t i o n  a n d  s c i e n t i f i c  
e v a l u a t i o n  o f  t h e  I s r a e l i  n a t i o n a l  c o m p r e h e n s i v e  p r o g r a m  
t o  r e d u c e  a l c o h o l  p r o b l e m  d r i n k i n g  a m o n g  c h i l d r e n  a n d  
y o u t h  2 0 1 0 – 2 0 1 6 .  Y o s s i  H a r e l - F i s c h ,  I s r a e l  
C u l l e n ,  I r e l a n d  
−  E x p l o r i n g  f a s t  t r a c k  o p i a t e  a g o n i s t  t r e a t m e n t  ( O A T )  f o r  h o m e l e s s ,  
A m e r i c a n ,  o p i a t e  m i s - u s e r s .  M a r c i a  T a n u r ,  U n i t e d  S t a t e s   
−  T h e  n e w  p r i v a t i z e d  m a r k e t  f o r  a l c o h o l  a n d  d r u g  t r e a t m e n t  –  
g r o w i n g  c h a l l e n g e s  i n  r e g a r d  t o  i n c o n s i s t e n t  p r i n c i p l e s  a n d  
f u m b l i n g  s t e e r i n g  m o d e l s .  J e s s i c a  S t o r b j ö r k ,  S w e d e n  
−  C a n n a b i s  a n d  d r i v i n g :  a  c a s e  s t u d y  o f  t h e  
N e t h e r l a n d s .  J a n  R a m a e k e r s ,  N e t h e r l a n d s  
−  L e s s o n s  t o  b e  c o n s i d e r e d  w h e n  m o v i n g  t o  
a  l e g a l  c a n n a b i s  m a r k e t .  A m y  P o r a t h  a n d  
D o u g  B e i r n e s s ,  C a n a d a  
 
1 6 : 0 0  –  1 6 : 3 0  C o f f e e  b r e a k  
 
1 6 : 3 0  –  1 8 : 0 0  
P A R A L L E L  S E S S I O N S   
 
P A P E R  S E S S I O N  2 1  
M o v i n g  i n t e r v e n t i o n s  o n l i n e  
C h a i r :  M i c h a e l  S c h a u b ,  S w i t z e r l a n d  
P A P E R  S E S S I O N  2 2  
A  f o c u s  o n  m e t h o d o l o g y  
C h a i r :  M a r g r i e t  v a n  L a a r ,  
N e t h e r l a n d s  
P A P E R  S E S S I O N  2 3  
N e u r o s c i e n c e  –  n e w  f i n d i n g s  
C h a i r :  A n t o n i o  V e r d e j o - G a r c i a ,  A u s t r a l i a  
P A P E R  S E S S I O N  2 4  
A l c o h o l  –  i s s u e s  f o r  t r e a t m e n t  
C h a i r :  E i l i s h  G i l v a r r y ,  U n i t e d  K i n g d o m  
P A P E R  S E S S I O N  2 5  
L o c a l  p e r s p e c t i v e s  –  
l o c a l  r e s p o n s e s  
C h a i r :  C e e s  G o o s ,  H o l l a n d  
R o o m  5 C  R o o m  1 . 0 7  R o o m  5 A  A u d i t o r i u m  V I I I  R o o m  1 . 1 5  
−  O n l i n e  p r o b l e m  g a m b l e r s ’  m o t i v a t i o n  
t o  c h a n g e :  a  q u a l i t a t i v e  s t u d y  w i t h  
i m p l i c a t i o n s  f o r  t h e  d e s i g n  o f  o n l i n e  
i n t e r v e n t i o n s .  A y n a  J o h a n s e n ,  
N o r w a y  
−  A s s e s s i n g  r e a d i n e s s  t o  i m p l e m e n t  
w e b - b a s e d  i n t e r v e n t i o n s  f o r  t h e  
p r e v e n t i o n  a n d / o r  r e d u c t i o n  o f  
s u b s t a n c e  u s e  a t  t e n  u n i v e r s i t i e s  i n  
G e r m a n y  –  r e s u l t s  o f  t h e  D I O S -
p r o j e c t .  C l a u d i a  P i s c h k e ,  G e r m a n y  
−  C h a r a c t e r i s t i c s  o f  g a m b l e r s  u s i n g  a  
n a t i o n a l  h e l p - l i n e  f o r  p r o b l e m  
g a m b l i n g  i n  F r a n c e  b e t w e e n  2 0 1 0  
a n d  2 0 1 5 .  S t é p h a n e  D a r b e d a ,  F r a n c e  
−  Y o u T u b e  p r e s e n c e  o f  a n  a d d i c t i o n  
m e d i c i n e  s e r v i c e :  w h a t  w o r k s ?  
G e r a r d  C a l z a d a ,  S w i t z e r l a n d  
−  B e y o n d  i n f o r m e d  c o n s e n t :  e t h i c a l  
d i l e m m a s  i n  a  c l i n i c a l  t r i a l  t e s t i n g  
t h e  e f f e c t i v e n e s s  o f  i n j e c t a b l e  
o p i o i d  a s s i s t e d  t r e a t m e n t  f o r  
l o n g - t e r m  o p i o i d  d e p e n d e n c e .  
K i r s t e n  M a r c h a n d ,  C a n a d a  
−  D i f f e r e n t  m o d e s  o f  d a t a  c o l l e c t i o n ,  
d i f f e r e n t  r e s u l t s .  C l a r a  V i t a l ,  
P o r t u g a l  
−  T h e  a b s u r d i t y  o f  a s k i n g  t h e  p e o p l e  
a b o u t  o p i n i o n s  t h e y  d o  n o t  y e t  
h a v e .  A l f r e d  U h l ,  A u s t r i a  
−  E t h i c a l  i n q u i r y  i n t o  c a n n a b i s  p i l o t  
p r o j e c t s .  S u s a n n e  U u s i t a l o ,  F i n l a n d  
−  T h e  u s e  o f  l i c i t  a n d  i l l i c i t  d r u g s  a n d  
t h e  w o r k p l a c e :  d e f i n i n g  a  m o d e l  o f  
s u r v e y  q u e s t i o n n a i r e .  C l á u d i a  
U r b a n o ,  P o r t u g a l  
−  A l t e r a t i o n  t o  h i p p o c a m p a l  v o l u m e  a n d  
s h a p e  i n  c a n n a b i s  d e p e n d e n c e :  a  
m u l t i s i t e  s t u d y .  Y a n n  C h y e ,  A u s t r a l i a  
−  L o c o m o t o r  s e n s i t i z a t i o n  t o  c o c a i n e  a n d  
m e t h a m p h e t a m i n e  i n  d r o s o p h i l a  
m e l a n o g a s t e r .  R o z i  A n d r e t i c  W a l d o w s k i ,  
C r o a t i a  
−  U s i n g  f u n c t i o n a l  n e a r  i n f r a r e d  
s p e c t r o s c o p y  t o  i d e n t i f y  n e u r a l  a c t i v i t y  
d u r i n g  c u e - e l i c i t e d  i n  a  r e a l - l i f e  s e t t i n g .  
F l o r a  C o l l e d g e ,  S w i t z e r l a n d  
−  A c c u m u l a t i o n  o f  h i g h l y  s t a b l e  δ f o s b -
i s o f o r m s  a n d  i t s  t a r g e t s  i n s i d e  t h e  
r e w a r d  s y s t e m  o f  c h r o n i c  d r u g  a b u s e r s .  
M o n i k a  S e l t e n h a m m e r ,  A u s t r i a  
−  D e p e n d e n t  a n a b o l i c - a n d r o g e n i c  s t e r o i d  
u s e r s  h a v e  l a r g e r  n u c l e u s  a c c u m b e n s  
v o l u m e  a n d  t h i n n e r  c o r t e x  c o m p a r e d  t o  
n o n - d e p e n d e n t  u s e r s .  L i s a  E v j u  H a u g e r ,  
N o r w a y  
−  I s  d i a l e c t i c a l  b e h a v i o r  t h e r a p y  s k i l l s  t r a i n i n g  
a  t h e r a p e u t i c  a l t e r n a t i v e  i n  a l c o h o l  u s e  
d i s o r d e r  a n d  p e r s o n a l i t y  d i s o r d e r s  
c o m o r b i d i t y  t r e a t m e n t ?  M a r c o  C a v i c c h i o l i ,  
I t a l y  
−  W i l l  t h i s  a d u l t  p a t i e n t  g o  i n t o  s e v e r e  
a l c o h o l  w i t h d r a w a l ?  S y s t e m a t i c  r e v i e w  a n d  
m e t a - a n a l y s i s .  J a n  K l i m a s ,  I r e l a n d  
−  O u t p a t i e n t  a d d i c t i o n  t r e a t m e n t  f o r  a l c o h o l  
u s e  d i s o r d e r :  w h a t  m a k e s  p a t i e n t s  w h o  
d r o p p e d  o u t  d i f f e r e n t  f r o m  t h o s e  w h o  d i d  
n o t ?  V i n c e n t  W a g n e r ,  F r a n c e  
−  E f f e c t i v e n e s s  o f  b r i e f  i n t e r v e n t i o n  f o r  
m o d e r a t e / h i g h  r i s k  a l c o h o l  u s e  a m o n g  
p a t i e n t s  o n  b u p r e n o r p h i n e  m a i n t e n a n c e :  a  
c l i n i c a l  a n d  a l c o h o l - b i o m a r k e r  s t u d y .  
S u r e s h  T h a p a l i y a ,  N e p a l  
−  C h a r a c t e r i s t i c s  a n d  s i g n i f i c a n c e  o f  
p r o f e s s i o n a l - l e d  s u p p o r t  g r o u p s  i n  t h e  
t r e a t m e n t  o f  a l c o h o l i s m .  A n a  O p a č i ć  a n d  
T e r e z a  O r e b ,  C r o a t i a  
−  W h y  g e t t i n g  s o b e r  i s n ´ t  
e n o u g h ?  M u l t i p l e  
a d d i c t i o n s  a m o n g  t h e  h a r d  
t o  r e a c h  p o p u l a t i o n  i n  t h e  
‘ l a r g e s t  o p e n  d r u g  s c e n e ’  i n  
I s r a e l .  H a g i t  B o n n y - N o a c h ,  
I s r a e l  
−  I n t e r a c t i o n  a n d  i n t e r p l a y  
b e t w e e n  r a p i d  a s s e s s m e n t  
a n d  a  l o c a l  d r u g  m o n i t o r .  
L i v  F l e s l a n d ,  N o r w a y  
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DAY 1
− Understanding and intervening on addiction stigma. 
Karsten Lunze, United States 
− Learning from success: the implementation and scientific 
evaluation of the Israeli national comprehensive program 
to reduce alcohol problem drinking among children and 
youth 2010–2016. Yossi Harel-Fisch, Israel 
Cullen, Ireland 
− Exploring fast track opiate agonist treatment (OAT) for homeless, 
American, opiate mis-users. Marcia Tanur, United States  
− The new privatized market for alcohol and drug treatment – 
growing challenges in regard to inconsistent principles and 
fumbling steering models. Jessica Storbjörk, Sweden 
− Cannabis and driving: a case study of the 
Netherlands. Jan Ramaekers, Netherlands 
− Lessons to be considered when moving to 
a legal cannabis market. Amy Porath and 
Doug Beirness, Canada 
 
16:00 – 16:30 Coffee break 
 
16:30 – 18:00 
PARALLEL SESSIONS  
 
PAPER SESSION 21 
Moving interventions online 
Chair: Michael Schaub, Switzerland 
PAPER SESSION 22 
A focus on methodology 
Chair: Margriet van Laar, 
Netherlands 
PAPER SESSION 23 
Neuroscience – new findings 
Chair: Antonio Verdejo-Garcia, Australia 
PAPER SESSION 24 
Alcohol – issues for treatment 
Chair: Eilish Gilvarry, United Kingdom 
PAPER SESSION 25 
Local perspectives – 
local responses 
Chair: Cees Goos, Holland 
Room 5C Room 1.07 Room 5A Auditorium VIII Room 1.15 
− Online problem gamblers’ motivation 
to change: a qualitative study with 
implications for the design of online 
interventions. Ayna Johansen, 
Norway 
− Assessing readiness to implement 
web-based interventions for the 
prevention and/or reduction of 
substance use at ten universities in 
Germany – results of the DIOS-
project. Claudia Pischke, Germany 
− Characteristics of gamblers using a 
national help-line for problem 
gambling in France between 2010 
and 2015. Stéphane Darbeda, France 
− YouTube presence of an addiction 
medicine service: what works? 
Gerard Calzada, Switzerland 
− Beyond informed consent: ethical 
dilemmas in a clinical trial testing 
the effectiveness of injectable 
opioid assisted treatment for 
long-term opioid dependence. 
Kirsten Marchand, Canada 
− Different modes of data collection, 
different results. Clara Vital, 
Portugal 
− The absurdity of asking the people 
about opinions they do not yet 
have. Alfred Uhl, Austria 
− Ethical inquiry into cannabis pilot 
projects. Susanne Uusitalo, Finland 
− The use of licit and illicit drugs and 
the workplace: defining a model of 
survey questionnaire. Cláudia 
Urbano, Portugal 
− Alteration to hippocampal volume and 
shape in cannabis dependence: a 
multisite study. Yann Chye, Australia 
− Locomotor sensitization to cocaine and 
methamphetamine in drosophila 
melanogaster. Rozi Andretic Waldowski, 
Croatia 
− Using functional near infrared 
spectroscopy to identify neural activity 
during cue-elicited in a real-life setting. 
Flora Colledge, Switzerland 
− Accumulation of highly stable δfosb-
isoforms and its targets inside the 
reward system of chronic drug abusers. 
Monika Seltenhammer, Austria 
− Dependent anabolic-androgenic steroid 
users have larger nucleus accumbens 
volume and thinner cortex compared to 
non-dependent users. Lisa Evju Hauger, 
Norway 
− Is dialectical behavior therapy skills training 
a therapeutic alternative in alcohol use 
disorder and personality disorders 
comorbidity treatment? Marco Cavicchioli, 
Italy 
− Will this adult patient go into severe 
alcohol withdrawal? Systematic review and 
meta-analysis. Jan Klimas, Ireland 
− Outpatient addiction treatment for alcohol 
use disorder: what makes patients who 
dropped out different from those who did 
not? Vincent Wagner, France 
− Effectiveness of brief intervention for 
moderate/high risk alcohol use among 
patients on buprenorphine maintenance: a 
clinical and alcohol-biomarker study. 
Suresh Thapaliya, Nepal 
− Characteristics and significance of 
professional-led support groups in the 
treatment of alcoholism. Ana Opačić and 
Tereza Oreb, Croatia 
− Why getting sober isn´t 
enough? Multiple 
addictions among the hard 
to reach population in the 
‘largest open drug scene’ in 
Israel. Hagit Bonny-Noach, 
Israel 
− Interaction and interplay 
between rapid assessment 
and a local drug monitor. 
Liv Flesland, Norway 
STRUCTURED SESSION 13 
Anabolic androgenic steroids (AAS) and 
associated drugs: new insights into the 
extent of use, harms and responses 
Chair: James McVeigh, United Kingdom  
STRUCTURED SESSION 14 
Prevalence of alcohol, tobacco and drug use 
in the mediterranean region among school 
aged children – the MEDSPAD network 
Chair: Richard Muscat, Malta 
STRUCTURED SESSION 15 
Open discussion on the future of 
addiction research 
Chair: Christine Timko, United States 
STRUCTURED SESSION 16 
ATTUNE: understanding pathways to stimulant use: a mixed-
methods examination of the individual, social and cultural factors 
shaping illicit stimulant use across Europe 
Chair: Marcus Martens, Germany 
Auditorium II Auditorium III Auditorium I Room 5B 
− AAS and substance use among prisoners: 
findings from a Norwegian national prison 
Survey. Ingrid Havnes, Norway 
− A typology of AAS use by men in fitness 
and strength-training environments. 
Dimitris Liokaftos, Denmark 
− An investigation of cognitive functions in 
long-term AAS using and non-using 
weightlifters. Astrid Bjørnebekk, Norway 
− Injection related harms and infections 
among people injecting AAS and 
associated drugs in the United Kingdom. 
Vivian Hope, United Kingdom 
− Treatment and information needs among 
AAS users with health problems. Christine 
Wisløff, Norway 
− Discussant: Marie Claire Van Hout, United 
Kingdom 
− MedSPAD Network history. Florence 
Mabileau, Pompidou Group 
− MedSPAD Regional key findings. Elisa 
Benedetti, Italy 
− Legal, social and economic aspects that 
impact on prevalence. Salah Abdennouri, 
Consultant, Yossi Harel-Fisch, Israel, Jallal 
Toufiq, Morocco, and Hajer Aounallah-
Skhiri, Tunisia 
− Panel discussion: Meni Malliori, Greece, 
Florence Mabileau, Pompidou Group, 
Sabrina Molinaro, Italy, and Richard 
Muscat, Malta 
− Using Artificial Intelligence for data 
synthesis and interpretation: The 
Human Behaviour Change Project. 
Felix Naughton, United Kingdom 
− Bayesian ‘multi-parameter evidence 
synthesis’ in addictions research. 
Hayley Jones, United Kingdom 
− A system for improving 
transparency in analysing qualitative 
data. Caitlin Notley, United Kingdom  
− Drinking occasions as the unit of 
analysis for understanding alcohol 
consumption. Paul Toner, United 
Kingdom 
− Improving replicability in addiction 
research. Tom Freeman, United 
Kingdom 
− Introduction to the EU ATTUNE study: an overview of the mixed 
method design and its rationale. Marcus Martens, Germany 
− Which individual, social and environmental influences shape 
different pathways of amphetamine type stimulant use over the 
life course? A systematic review and thematic synthesis of the 
qualitative literature. Amy O´Donnell and Michelle Addison, 
United Kingdom  
− ATS users’ experiences of transitions into diverse patterns of 
stimulant use: results from in-depth qualitative interviews in 
five EU countries. Roman Gabrhelik, Czech Republic, Heike 
Zurhold, Germany and Michal Szulawski, Poland  
− Exploring trajectories of amphetamine use from the life event 
and substance use charts applied in qualitative interviews with 
stimulant and non-stimulant users. Nienke Liebregts and Katrin 
Schiffer, Netherlands 
− Design, methods and instruments of the forthcoming 
quantitative study arm: structured questionnaire of 2000 ATS 
users across Europe. Magdalena Rowicka, Poland and Moritz 
Rosenkranz, Germany 
STRUCTURED SESSION 17 
Biomarkers in addiction: the experience of the Spanish 
network on addiction research 
Chair: Fernando Rodriguez de Fonseca, Spain 
STRUCTURED SESSION 18 
Lessons learned from the recent HIV outbreaks in Europe 
among people who inject drugs 
Chairs: Don Des Jarlais, United States and Vana Sypsa, Greece 
STRUCTURED SESSION 19 
Addiction in daily life: mobile assessment and 
treatment  
Chair: Ingmar Franken, Netherlands 
 TWIST 
SESSION 
(16:30 – 18:00) 
Room 1.05 Room 1.06 Room 1.09 
 
Auditorium IV 
− Acylethanolamides and chemokines as biomarkers of 
addiction: a link to neuroinflammation? Fernando Rodriguez 
de Fonseca, Spain 
− Serotonergic biomarkers in substance dependent patients 
with comorbid depression. Marta Torrens, Spain 
− Changes in the serum metabolites of tryptophan in 
− Lessons learned from the recent snow blow related HIV 
outbreak in Dublin. Margaret Fitzgerald, Ireland 
− The HIV outbreak among PWID in Romania 2012–2016. 
Cristina Fierbinteanu, Romania 
− An outbreak of HIV infection among people who inject drugs 
in Glasgow (United Kingdom). Andrew McAuley, United 
− Cognitive measures in EMA research. Andy 
Jones, United Kingdom 
− The use of EMA in a clinical trial. Ilse Verveer, 
Netherlands 
− Smartphone apps for the treatment of 
addictive disorders. Yasser Khazaal, 
 







D A Y  1
a b s t i n e n t  c o c a i n e  a n d  a l c o h o l  u s e r s  a n d  t h e i r  r e l a t i o n s h i p  
w i t h  c o - m o r b i d  d i s o r d e r s .  R e b e c a  V i d a l  C a s a d o ,  S p a i n  
−  P s y g e n e t  a  n e w  t o o l  t o  i n v e s t i g a t e  g e n e t i c  t a r g e t s  i n  d r u g  
a d d i c t i o n .  O l g a  V a l v e r d e ,  S p a i n  
−  S t r e s s  a n d  n e u r o i m m u n e  r e s p o n s e  a s  b i o m a r k e r s  o f  c o c a i n e  
a n d  a l c o h o l  u s e  d i s o r d e r s .  M a r t a  R o d r i g u e z - A r i a s ,  S p a i n  
K i n g d o m  
−  A n  o u t b r e a k  o f  H I V  i n f e c t i o n  a m o n g  p e o p l e  w h o  i n j e c t  d r u g s  
i n  A t h e n s ,  G r e e c e :  r a p i d  i n t e r v e n t i o n  a n d  l e s s o n s  l e a r n e d .  
V a n a  S y p s a ,  G r e e c e  
−  I n j e c t i o n  o f  c o c a i n e  i s  a s s o c i a t e d  w i t h  r e c e n t  H I V  o u t b r e a k  i n  
p e o p l e  w h o  i n j e c t  d r u g s  i n  L u x e m b o u r g .  C a r o l e  D e v a u x ,  
L u x e m b o u r g  
S w i t z e r l a n d   
−  D i s c u s s a n t s :  I n g m a r  F r a n k e n ,  N e t h e r l a n d s  
a n d  M a t t  F i e l d ,  U n i t e d  K i n g d o m  
 
1 8 : 0 0  C o c k t a i l  i n  t h e  C o n f e r e n c e  v e n u e  
  
1 6
abstinent cocaine and alcohol users and their relationship 
with co-morbid disorders. Rebeca Vidal Casado, Spain 
− Psygenet a new tool to investigate genetic targets in drug 
addiction. Olga Valverde, Spain 
− Stress and neuroimmune response as biomarkers of cocaine 
and alcohol use disorders. Marta Rodriguez-Arias, Spain 
Kingdom 
− An outbreak of HIV infection among people who inject drugs 
in Athens, Greece: rapid intervention and lessons learned. 
Vana Sypsa, Greece 
− Injection of cocaine is associated with recent HIV outbreak in 
people who inject drugs in Luxembourg. Carole Devaux, 
Luxembourg 
Switzerland  
− Discussants: Ingmar Franken, Netherlands 
and Matt Field, United Kingdom 
 
18:00 Cocktail in the Conference venue 
  
 
 DAY 2 WEDNESDAY 25 OCTOBER 
 
09:00 – 10:30 PLENARY SESSION II MEASURING ADDICTIONS — A QUESTION OF SCALE Chair: Sabrina Molinaro, Italy 
 
Auditorium I 
 Global burden of addictions. Louisa Degenhardt, Australia 
Addiction-related crime and ‘harms to the society’. Letizia Paoli, Belgium 
Opioids: update on new developments in the USA. Christopher Jones, United States 
 
10:30 – 11:00 Coffee break 
 
11:00 – 12:30 PARALLEL SESSIONS   
PAPER SESSION 26 
Cannabis – shifts in the 
regulatory framework  
Chair: Liesbeth Vandam, EMCDDA 
PAPER SESSION 27 
Understanding drug-related 
mortality 
Chair: Thomas Clausen, Norway 
PAPER SESSION 28 
Alcohol – targeting the young 
Chair: Fabrizio Faggiano, Italy 
PAPER SESSION 29 
Improving responses to opioid users      
and people who inject drugs (PWID) 
Chair: Álvaro Lopes, Portugal 
PAPER SESSION 30 
Market developments and their 
impact 
Chair: Peter Reuter, United States 
Auditorium II Room 5A Room 1.09 Room 5C Auditorium VIII 
− Understanding the new cannabis 
regulatory frameworks. Ivana 
Obradovic, France 
− Relation of legalization of 
cannabis for medical purposes 
and adolescent use in the 
United States. William Crano, 
United States 
− Cannabis as medicine in 
Germany. Ingo Ilja Michels, 
Germany 
− Worldwide drug use 
decriminalization practices: a 
scoping review. Marta Pinto, 
Portugal 
− A work in progress: understanding 
the development of the cannabis 
social club model in Belgium and 
its current key features. Mafalda 
Pardal, Belgium 
− Mortality risk during and after 
opioid substitution treatment: 
systematic review and meta-
analysis of cohort studies. Marica 
Ferri, EMCDDA 
− Trends in injector deaths in Ireland, 
as recorded by the national drug-
related deaths index, 1998-2014. 
Therese Lynn, Ireland 
− Mortality and causes of death 
among polydrug users. Karoliina 
Karjalainen, Finland 
− Rates, causes and predictors of 
death among drug users in France: 
invisibility of fatal overdoses. 
Anne-Claire Brisacier, France 
− Rates, characteristics and circums-
tances of methamphetamine-
related deaths: a national 7 year 
study. Shane Darke, Australia 
− Attentional bias between light and 
heavy drinking college students. 
Alexandra Ghita, Spain 
− Sensation seeking and adolescent 
alcohol use: exploring the mediating 
role of unstructured socializing with 
peers. Sharon Sznitman, Israel 
− Prevention of alcohol abuse in college 
students. Carla Rocha, Portugal 
− Alcohol: raising awareness and 
action research on heavy episodic 
drinking among low income youth 
and young adults in southern 
Europe. Helena Carvalho, Portugal 
− Associations between personal and 
perceived peer use and attitudes 
towards substance use among German 
university students: findings of a multi-
centre cluster-controlled intervention 
trial. Stefanie Maria Helmer, Germany 
− Establishing a postal based harm 
reduction service for hard-to-reach 
injecting drug users. Thomas Nefau, France 
− Diagnosis and treatment of HCV infection: 
a tool of engagement for people who 
inject drugs (PWID). David Truong, Canada 
− The German legal system and the 
regulatory approach governing the 
substitution treatment for opioid addicts in 
Germany – regulations at the federal level: 
the revision of Germany’s legal framework. 
Kenan Maric-Horstmeyer, Germany 
− The German medical association’s revised 
guidelines for OST: legal framework, 
treatment regulations and scientific 
rationale. Wilfried Kunstmann, Germany 
− Towards a long-term perspective: analysis 
of treatment participation in opioid 
substitution therapy in four European 
regions. Carlos Nordt, Switzerland 
− Are changes in cannabis potency 
associated with subsequent admissions 
to drug treatment? Tom Freeman, United 
Kingdom 
− The displacement of illicit drug markets 
from the Netherlands to Belgium: 
perception or reality? Freja de Middeleer, 
Belgium 
− Impact of the change in poppers 
regulation on their use in France. Cécile 
Chevallier, France 
− A dramatic increase in cannabis use 
among young and adult populations in 
Israel: the ‘normalization’ effects of the 
intense public debates regarding 
cannabis legalization and medicalization. 
Yossi Harel-Fisch, Israel 
− User characteristics and effect profiles of 
butane hash oil: an extremely high-potency 
cannabis concentrate. Gary Chan, Australia 
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S T R U C T U R E D  S E S S I O N  2 0  
2 0  y e a r s  o f  E S P A D :  t r e n d s  i n  a d o l e s c e n t s ´  
s u b s t a n c e  u s e  a n d  r i s k  b e h a v i o u r s ,  w h a t  
h a v e  w e  l e a r n t ?  
C h a i r :  J u l i a n  V i c e n t e ,  E M C D D A  
S T R U C T U R E D  S E S S I O N  2 1  
H o w  t h e  o p i o i d  p r o b l e m  i s  c h a n g i n g :  
t h e  r o l e  o f  m i s u s e d  m e d i c i n e s  a n d  t h e  
e m e r g e n c e  o f  n o v e l  s y n t h e t i c  o p i o i d s  
C h a i r s :  P a u l  G r i f f i t h s ,  E M C D D A  a n d  
M o i r a  O ’ B r i e n ,  N I D A  
S T R U C T U R E D  S E S S I O N  2 2  
W a s t e w a t e r - b a s e d  d r u g  e p i d e m i o l o g y  o f  
i l l i c i t  d r u g s ,  n e w  p s y c h o a c t i v e  s u b s t a n c e s  
a n d  t h e  m i s u s e  o f  m e d i c a t i o n  a s  a  
s u p p l e m e n t  t o  t r a d i t i o n a l  d a t a - s o u r c e s  
C h a i r :  B a r b a r a  K a s p r z y k - H o r d e r n ,  U n i t e d  
K i n g d o m  
S T R U C T U R E D  S E S S I O N  2 3  
R e v i e w  o f  t h e  e f f e c t i v e n e s s  o f  
t r e a t m e n t  a l t e r n a t i v e s  t o  
i n c a r c e r a t i o n  f o r  d r u g - i n v o l v e d  
p e r s o n s   
C h a i r :  t b c  
S T R U C T U R E D  S E S S I O N  2 4  
O n l i n e  s u r v e y s  o f  d r u g  u s e r s :  
p r o c e e d  w i t h  c a u t i o n  
C h a i r :  B e a u  K i l m e r ,  U n i t e d  
S t a t e s  
A u d i t o r i u m  I I I  A u d i t o r i u m  I  A u d i t o r i u m  I V  R o o m  5 B  R o o m  1 . 1 5  
−  A r e  t h e  t i m e s  a - c h a n g i n ?  T r e n d s  i n  
a d o l e s c e n t  s u b s t a n c e  u s e  i n  E u r o p e .  
L u d w i g  K r a u s ,  G e r m a n y  
−  I s  t h e r e  a  l i n k  b e t w e e n  p e r c e i v e d  
a v a i l a b i l i t y  a n d  u s e  o f  a l c o h o l ,  c a n n a b i s  
a n d  c i g a r e t t e s  a m o n g  y o u n g  p e o p l e  i n  
E u r o p e  –  c r o s s - c o u n t r y  a n d  w i t h i n  
c o u n t r y  a n a l y s e s  o f  t h e  2 0 1 5  E S P A D -
d a t a .  H å k a n  L e i f m a n ,  S w e d e n  
−  S t u d e n t s  a t  r i s k  o f  s u b s t a n c e  u s e :  l a t e n t  
c l a s s  r i s k  a n d  p r o t e c t i v e  f a c t o r  p r o f i l e s .  
P a v l a  C h o m y n o v a ,  C z e c h  R e p u b l i c  
−  U n d e r s t a n d i n g  t h e  u s e  o f  N P S  b y  
E u r o p e a n  s t u d e n t s  i n  t h e  c o n t e x t  o f  
p o l y s u b s t a n c e  u s e .  H a r r y  S u m n a l l ,  
U n i t e d  K i n g d o m  
−  D o  m i s u s e r s  o f  m e d i c i n a l  p s y c h o t r o p i c  
d r u g s  f o r m  a  d i s t i n c t i v e  g r o u p  a m o n g  
t h e  a d o l e s c e n t - s t u d e n t  p o p u l a t i o n  i n  
E u r o p e ?  A  l a t e n t  c l a s s  a n a l y s i s .  
A n a s t a s i o s  F o t i o u ,  G r e e c e   
−  G a m b l i n g ,  o n l i n e  g a m i n g  a n d  i l l i c i t  
s u b s t a n c e  u s e  a m o n g  E u r o p e a n  
s t u d e n t s :  A  c r o s s - n a t i o n a l  c o m p a r i s o n .  
S a b r i n a  M o l i n a r o ,  I t a l y  
−  M i s u s e  o f  p r e s c r i p t i o n  o p i o i d s  i n  
E u r o p e :  a n  o v e r v i e w  o f   e v i d e n c e  a n d  
h o w  i t  r e l a t e s  t o  p r e s c r i b i n g  p r a c t i c e  
f r o m  a  E u r o p e a n  p e r s p e c t i v e .  C a t h y  
S t a n n a r d ,  U n i t e d  K i n g d o m  
−  T h e  U S  o p i o i d  e p i d e m i c :  a  p e r s p e c t i v e  
o n  t r e n d s  a n d  r e s p o n s e s  f r o m  t h e  U . S .  
N a t i o n a l  D r u g  E a r l y  W a r n i n g  S y s t e m .  
E r i n  A r t i g i a n i ,  U n i t e d  S t a t e s  
−  A u s t r a l i a n  e x p e r i e n c e  w i t h  o p i o i d s .  
M i c h a e l  F a r r e l l ,  A u s t r a l i a  
−  N e w  s y n t h e t i c  o p i o i d s  i n  E u r o p e :  
p e r s p e c t i v e  f r o m  t h e  E U  E a r l y  
W a r n i n g  S y s t e m .  R i t a  J o r g e ,  E M C D D A  
−  R e v i e w  o f  t h e  e x i s t i n g  E u r o p e a n  
n e t w o r k  w i t h  s u m m a r y  o f  a l l  d a t a ,  a n d  
o v e r v i e w  o f  f u t u r e  i n t e r n a t i o n a l  
p r o g r a m s .  K e v i n  T h o m a s ,  A u s t r a l i a  
−  C o m p a r i s o n  o f  d a t a  f r o m  W B E  w i t h  
o t h e r  s o u r c e s :  A  s u m m a r y  o f  f i n d i n g s .  
F r e d e r i c  B e e n ,  B e l g i u m  
−  D e t e c t i o n  o f  n e w  p s y c h o a c t i v e  
s u b s t a n c e s  ( N P S )  u s e  a c r o s s  E u r o p e .  
S a r a  C a s t i g l i o n i ,  I t a l y  
−  T h e  u s e  o f  W B E  f o r  t h e  d e t e c t i o n  o f  t h e  
m i s u s e  o f  m e d i c a t i o n .  J ø r g e n  B r a m n e s s ,  
N o r w a y  
−  R e v i e w  o f  t h e  u n c e r t a i n t i e s  i n  W B E .  
C h r i s t o p h  O r t ,  S w i t z e r l a n d  
 
−  I n t e r - A m e r i c a n  D r u g  A b u s e  
C o n t r o l  C o m m i s s i o n  ( C I C A D ) / O A S  
s u p p o r t  t o  n a t i o n a l  a n d  l o c a l  
g o v e r n m e n t s  i n  e s t a b l i s h i n g  d r u g  
t r e a t m e n t  c o u r t s  i n  L a t i n  A m e r i c a  
a n d  t h e  C a r i b b e a n .  A n t o n i o  
L o m b a ,  C I C A D / O A S  
−  T h e  P o r t u g u e s e  s y s t e m  o f  
c o m m u n i t y  r e i n t e g r a t i o n  o f  d r u g -
i n v o l v e d  o f f e n d e r s  f r o m  1 9 9 8  u n t i l  
2 0 1 5 .  J o ã o  P e d r o  A u g u s t o ,  
P o r t u g a l  
−  I n c a r c e r a t i o n  o f  d r u g - i n v o l v e d  
o f f e n d e r s  i n  t h e  C z e c h  R e p u b l i c  
a n d  i n  E u r o p e ,  a n d  n e e d  f o r  
t r e a t m e n t - b a s e d  a l t e r n a t i v e s .  
M i c h a l  M i o v s k ý ,  C z e c h  R e p u b l i c  
−  A l t e r n a t i v e s  t o  i n c a r c e r a t i o n  
d e v e l o p e d  t h r o u g h  T A S C  
p r o g r a m s  i n  t h e  U . S .  M e l o d y  
H e a p s ,  U n i t e d  S t a t e s  
−  R e v i e w  o f  t h e  e f f e c t i v e n e s s  o f  
t r e a t m e n t  a l t e r n a t i v e s  t o  
i n c a r c e r a t i o n  f o r  d r u g - i n v o l v e d  
p e r s o n s .  R o g e r  P e t e r s ,  U n i t e d  
S t a t e s  
−  E u r o p e a n  W e b  S u r v e y  o n  
D r u g s :  p a t t e r n s  o f  u s e .  N i c o l a  
S i n g l e t o n  a n d  J o ã o  M a t i a s ,  
E M C D D A  
−  F a c e b o o k  a d s  f o r  r e c r u i t m e n t  
f o r  o n l i n e  d r u g  s u r v e y s :  t h e  
H o l y  G r a i l ?  D i j a n a  J e r k o v i ć ,  
C r o a t i a  
−  T h e  G l o b a l  D r u g  S u r v e y  
( G D S ) :  H o w  o n l i n e  m e t h o d s  
a n d  i n d e p e n d e n c e  o f f e r  
a l t e r n a t i v e  p e r s p e c t i v e s  o n  
d r u g  u s e .  A d a m  W i n s t o c k ,  
U n i t e d  K i n g d o m  a n d  L a r i s s a  
M a i e r ,  S w i t z e r l a n d  
−  R e l i a b i l i t y  a n d  v a l i d i t y  i s s u e s  
i n  t h e  E u r o p e a n  W e b  S u r v e y  
i n  t h e  C z e c h  R e p u b l i c .  
K a t e r i n a  S k a r u p o v a ,  C z e c h  
R e p u b l i c  
−  E s t i m a t i n g  c a n n a b i s  d e m a n d :  
u s e  o f  o n l i n e  s u r v e y s  t o  
c a p t u r e  u s e  p a t t e r n s .  
M a r g r i e t  v a n  L a a r ,  
N e t h e r l a n d s  
 






STRUCTURED SESSION 20 
20 years of ESPAD: trends in adolescents´ 
substance use and risk behaviours, what 
have we learnt? 
Chair: Julian Vicente, EMCDDA 
STRUCTURED SESSION 21 
How the opioid problem is changing: 
the role of misused medicines and the 
emergence of novel synthetic opioids 
Chairs: Paul Griffiths, EMCDDA and 
Moira O’Brien, NIDA 
STRUCTURED SESSION 22 
Wastewater-based drug epidemiology of 
illicit drugs, new psychoactive substances 
and the misuse of medication as a 
supplement to traditional data-sources 
Chair: Barbara Kasprzyk-Hordern, United 
Kingdom 
STRUCTURED SESSION 23 
Review of the effectiveness of 
treatment alternatives to 
incarceration for drug-involved 
persons  
Chair: tbc 
STRUCTURED SESSION 24 
Online surveys of drug users: 
proceed with caution 
Chair: Beau Kilmer, United 
States 
Auditorium III Auditorium I Auditorium IV Room 5B Room 1.15 
− Are the times a-changin? Trends in 
adolescent substance use in Europe. 
Ludwig Kraus, Germany 
− Is there a link between perceived 
availability and use of alcohol, cannabis 
and cigarettes among young people in 
Europe – cross-country and within 
country analyses of the 2015 ESPAD-
data. Håkan Leifman, Sweden 
− Students at risk of substance use: latent 
class risk and protective factor profiles. 
Pavla Chomynova, Czech Republic 
− Understanding the use of NPS by 
European students in the context of 
polysubstance use. Harry Sumnall, 
United Kingdom 
− Do misusers of medicinal psychotropic 
drugs form a distinctive group among 
the adolescent-student population in 
Europe? A latent class analysis. 
Anastasios Fotiou, Greece  
− Gambling, online gaming and illicit 
substance use among European 
students: A cross-national comparison. 
Sabrina Molinaro, Italy 
− Misuse of prescription opioids in 
Europe: an overview of  evidence and 
how it relates to prescribing practice 
from a European perspective. Cathy 
Stannard, United Kingdom 
− The US opioid epidemic: a perspective 
on trends and responses from the U.S. 
National Drug Early Warning System. 
Erin Artigiani, United States 
− Australian experience with opioids. 
Michael Farrell, Australia 
− New synthetic opioids in Europe: 
perspective from the EU Early 
Warning System. Rita Jorge, EMCDDA 
− Review of the existing European 
network with summary of all data, and 
overview of future international 
programs. Kevin Thomas, Australia 
− Comparison of data from WBE with 
other sources: A summary of findings. 
Frederic Been, Belgium 
− Detection of new psychoactive 
substances (NPS) use across Europe. 
Sara Castiglioni, Italy 
− The use of WBE for the detection of the 
misuse of medication. Jørgen Bramness, 
Norway 
− Review of the uncertainties in WBE. 
Christoph Ort, Switzerland 
 
− Inter-American Drug Abuse 
Control Commission (CICAD)/OAS 
support to national and local 
governments in establishing drug 
treatment courts in Latin America 
and the Caribbean. Antonio 
Lomba, CICAD/OAS 
− The Portuguese system of 
community reintegration of drug-
involved offenders from 1998 until 
2015. João Pedro Augusto, 
Portugal 
− Incarceration of drug-involved 
offenders in the Czech Republic 
and in Europe, and need for 
treatment-based alternatives. 
Michal Miovský, Czech Republic 
− Alternatives to incarceration 
developed through TASC 
programs in the U.S. Melody 
Heaps, United States 
− Review of the effectiveness of 
treatment alternatives to 
incarceration for drug-involved 
persons. Roger Peters, United 
States 
− European Web Survey on 
Drugs: patterns of use. Nicola 
Singleton and João Matias, 
EMCDDA 
− Facebook ads for recruitment 
for online drug surveys: the 
Holy Grail? Dijana Jerković, 
Croatia 
− The Global Drug Survey 
(GDS): How online methods 
and independence offer 
alternative perspectives on 
drug use. Adam Winstock, 
United Kingdom and Larissa 
Maier, Switzerland 
− Reliability and validity issues 
in the European Web Survey 
in the Czech Republic. 
Katerina Skarupova, Czech 
Republic 
− Estimating cannabis demand: 
use of online surveys to 
capture use patterns. 
Margriet van Laar, 
Netherlands 
 




12:45 – 14:15 SPONSORED SESSIONS COPOLAD (Cooperation Programme 
between Latin America, the Caribbean and 
the European Union on Drugs Policies) 
ERANID (European 
Research Area Network   
on Illicit Drugs) 
RARHA (Reducing Alcohol 
Related Harm) 
  
Auditorium III Room 5A Room 5B 
− Next challenges for Drugs Observatories 
in providing information relevant for 
evidence-based policy making 
− Results of ERANID, its 
Strategic Research 
Agenda and projects 
− Member States work 
together on Reducing 
Alcohol Related Harm 
 
12:45 – 14:15 PARALLEL SESSIONS   
 
TWIST DISCUSSION 
(12:30 – 13:30) 
Auditorium VIII 
− Sexuality, chemsex and club drugs 
– what are the priorities? Owen 
Bowden-Jones, United Kingdom 
PAPER SESSION 31 
Spotlight on the misuse of 
medicines 
Chair: Jørgen Bramness, Norway 
PAPER SESSION 32 
New methods 
Chair: Lies Gremeaux, Belgium 
PAPER SESSION 33 
Focus on pregnancy and         
the neonate 
Chair: Gabriele Fischer, Austria 
PAPER SESSION 34 
Drug use and migration  
Chair: Antonio Lomba, 
OAS/CICAD 
PAPER SESSION 35 
Crime and violence 
Chair: Mário João Dias, Portugal 
Auditorium II Room 1.08 Room 1.09 Room 1.05 Room 5C 
− A case study of anabolic-
androgenic steroid dependence 
and treatment experiences. Ingrid 
Havnes and Johan Nygaard, 
Norway 
− Is misuse of benzodiazepines 
among high-risk drug users an 
overlooked public health issue? 
Dominique Lopez, India 
− Medication use and misuse among 
illicit drug users in France. Aurélie 
Lermenier-Jeannet, France 
− Orienting the appropriate treatment 
of pain in detained drug users: 
indications from a retrospective 
study. Felice Nava, Italy 
− Gabapentin diversion and misuse 
in the United States from a law 
enforcement perspective: diversion 
rates 2002–2015 and qualitative 
research findings. Mance Buttram, 
United States 
− New perspectives for knowledge 
generation and exploitation using web 
surveys: the example of volume 
estimation in wastewater epidemiology. 
Robin Udrisard, Switzerland 
− High risk drug use and new 
psychoactive substances in Europe. 
Jane Mounteney, EMCDDA  
− Innovations in online drug forum 
sentiment analysis to monitor new 
psychoactive substances: the case of 4-
FA in the Netherlands. Matthijs Blankers, 
Netherlands 
− National estimation of the prevalence 
of problem drug use: revisiting and 
extending multiplier methods in a 
multi-parameter evidence synthesis 
framework. Hayley Jones, United Kingdom 
− Development of a national wastewater 
drug monitoring program in Australia. 
Jake O’Brien, Australia 
− Follow up of opioid exposed 
newborns until 3 years of age. 
Anna Maria Vella, Malta 
− Alcohol drinking in pregnancy: 
some predictors among 
Portuguese women. Ludmila 
Carapinha, Portugal 
− Cannabis use during 
pregnancy and risk of adverse 
birth outcomes: a longitudinal 
cohort study. Svetlana 
Skurtveit, Norway 
− Neonatal outcomes after fetal 
exposure to opioid 
maintenance treatment. Marte 
Handal, Norway 
− Can you develop problems 
with khat? Cross-sectional and 
longitudinal studies to 
determine the potential for 
clinically meaningful khat use 
disorder and withdrawal 
syndromes. Raimondo Bruno, 
Australia 
− Social profiles, drug use 
practices and HCV exposure of 
Russian-speaking migrants in 
France. Marie Jauffret-Roustide, 
France 
− The representation of non-
Belgians in national drug 
treatment. Eva Blomme, 
Belgium 
− How ethnic is social recovery in 
problem users with a migration 
background. Charlotte de Kock, 
Belgium 
− Violence, fraud, legal risks and avoidance 
strategies in small-scale drug markets. 
Results from social research in Germany. 
Bernd Werse, Germany 
− Cash and carry: the high cost of currency 
smuggling in the drug trade. Melvin Soudijn, 
Netherlands (EMCDDA 2017 Scientific 
Award) 
− The prevalence and factors associated with 
ever perpetrating intimate partner violence 
by men receiving substance use treatment in 
Brazil and England: a cross-cultural 
comparison. Gail Gilchrist, United Kingdom 
− Intimate partner violence in the past 12 
months among men receiving treatment for 
substance use: prevalence, men´s explanations 
and substances used at the time of the 
incident. Martha Canfield, United Kingdom 
− Substance abuse and violent crime: an 
analysis of the psychopharmacological 
model in a sample of United States inmates. 
Michele Pich, United States 
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1 4 : 3 0  –  1 6 : 0 0  
P A R A L L E L  S E S S I O N S   
 
P A P E R  S E S S I O N  3 7  
T h e  c o n s t r u c t s  o f  a d d i c t i o n  
C h a i r :  G e r h a r d  B ü h r i n g e r ,  G e r m a n y  
P A P E R  S E S S I O N  3 8  
E v a l u a t i n g  i m p a c t  
C h a i r :  L a u r a  d ’ A r r i g o ,  F r a n c e  
P A P E R  S E S S I O N  3 9  
D e v e l o p i n g  e f f e c t i v e  d r u g  t r e a t m e n t  
C h a i r :  G r a ç a  V i l a r ,  P o r t u g a l  
R o o m  5 C  A u d i t o r i u m  I V  A u d i t o r i u m  I I  
−  I m p l i c i t  a s s o c i a t i o n s  i n  m a l e  a n d  f e m a l e  g a m e r s  a c r o s s  f o u r  
d i f f e r e n t  o n l i n e  g a m e s  a r e  l i n k e d  t o  s y m p t o m s  o f  i n t e r n e t  
g a m i n g  d i s o r d e r .  C h r i s t i a n  L a i e r ,  G e r m a n y  
−  P s y c h o l o g i c a l  a n d  n e u r o b i o l o g i c a l  m e c h a n i s m s  u n d e r l y i n g  t h e  
a d d i c t i v e  u s e  o f  s p e c i f i c  i n t e r n e t  a p p l i c a t i o n s .  M a t t h i a s  B r a n d ,  
G e r m a n y  
−  I m p l i c i t  a s s o c i a t i o n  a n d  c r a v i n g  t o w a r d s  s h o p p i n g  c u e s  i n  
b u y i n g  d i s o r d e r .  P a t r i c k  T r o t z k e ,  G e r m a n y  
−  T h e  p r o b l e m  w i t h  ' r e s p o n s i b l e  g a m b l i n g ' :  a  s t u d y  o f  a t t i t u d e s  
t o w a r d s  a n d  e x p e r i e n c e s  o f  p e r s o n a l  r e s p o n s i b i l i t y  d i s c o u r s e s  
i n  p e o p l e  e x p e r i e n c i n g  g a m b l i n g  a d d i c t i o n .  H e l e n  M i l l e r ,  
A u s t r a l i a  
−  E m o t i o n a l  c h a r a c t e r i s t i c s  o f  g a m b l e r s ’  r e l a t i v e s .  P a u l a  
J a u r e g u i ,  S p a i n  
−  T h e  e v a l u a t i o n  o f  t h e  a l c o h o l  l a w  2 0 0 9  i n  B e l g i u m .  T i n a  V a n  
H a v e r e ,  B e l g i u m  
−  A d a p t i o n  o f  t h e  a s s i s t  m o d e l  o f  i n f o r m a l  p e e r - l e d  
i n t e r v e n t i o n  d e l i v e r y  t o  t h e  t a l k  t o  f r a n k  d r u g  p r e v e n t i o n  
p r o g r a m m e  i n  U n i t e d  K i n g d o m  s e c o n d a r y  s c h o o l s  
( A S S I S T + F R A N K ) :  a  p i l o t  c l u s t e r  r a n d o m i s e d  c o n t r o l l e d  t r i a l .  
J a m e s  W h i t e ,  U n i t e d  K i n g d o m  
−  A s s e s s m e n t  o f  d r u g  t r e a t m e n t  i n  C r o a t i a  –  r e s u l t s  f r o m  C A T S  
( C r o a t i a n  A d d i c t i o n  T r e a t m e n t  S u r v e y )  a n d  i t s  i m p l i c a t i o n  o n  
n e w  n a t i o n a l  d r u g  p o l i c y  s t r a t e g y .  Z r i n k a  C a v a r ,  C r o a t i a  
−  A n  a p p r o a c h  t o  d i s i n v e s t m e n t  i n  t h e  f i e l d  o f  d r u g  a b u s e .  
A n t o n e l l a  C a m p o s e r a g n a ,  I t a l y  
−  D o e s  e x p o s u r e  t o  o p i o i d  s u b s t i t u t i o n  t r e a t m e n t  a t  p r i s o n  
r e l e a s e  r e d u c e  t h e  r i s k  o f  d e a t h ?  A  p r o s p e c t i v e ,  o b s e r v a t i o n a l  
s t u d y  i n  E n g l a n d .  M a t t h e w  H i c k m a n ,  U n i t e d  K i n g d o m  
 
−  L a r g e  v a r i a t i o n  i n  m e a s u r e s  u s e d  t o  a s s e s s  o u t c o m e s  o f  o p i o i d  
d e p e n d e n c e  t r e a t m e n t :  a  s y s t e m a t i c  r e v i e w  o f  l o n g i t u d i n a l  
o b s e r v a t i o n a l  s t u d i e s .  L u c a s  W i e s s i n g ,  E M C D D A  
−  E x t r i n s i c  a n d  i n t r i n s i c  f a c t o r s  i n  d r u g  t r e a t m e n t  o u t c o m e s  f o r  
p e r s o n s  i n  t h e  c r i m i n a l  j u s t i c e  s y s t e m :  t h e  r o l e s  o f  m o t i v a t i o n  
a n d  l e g a l  c o e r c i o n .  S t e v e n  B e l e n k o ,  U n i t e d  S t a t e s  
−  R e a s o n s  f o r  a b s t a i n i n g  i n  p e r s o n s  w i t h  l o n g - t e r m  s u b s t a n c e  
u s e  d i s o r d e r s :  a  q u a l i t a t i v e  s t u d y .  H e n n i n g  P e t t e r s e n ,  N o r w a y  
−  U t i l i s a t i o n  o f  s p e c i a l i s t  p s y c h i a t r i c  h e a l t h  c a r e  s e r v i c e s  –  1 5  y e a r s  
f o l l o w - u p  o f  a  N o r w e g i a n  O M T - c o h o r t .  B e n t  M o n s b a k k e n ,  
N o r w a y  
−  P r o f i l e s  o f  i n d i v i d u a l s  i d e n t i f i e d  a s  h a v i n g  a  s u b s t a n c e  u s e  
d i s o r d e r  a n d  t y p e s  o f  s e r v i c e s  r e c e i v e d .  S e r g e  B r o c h u ,  C a n a d a  
P A P E R  S E S S I O N  3 6  
O p i a t e  S u b s t i t u t i o n  T h e r a p y  ( O S T )  a n d  m o r t a l i t y   
C h a i r :   D o m i n g o s  D u r a n ,  P o r t u g a l  
S T R U C T U R E D  S E S S I O N  2 5  
T a k e - h o m e  n a l o x o n e :  t a k i n g  d r u g  u s e r s  s e r i o u s l y  
C h a i r :  T h o m a s  C l a u s e n ,  N o r w a y   
R o o m  1 . 1 5  A u d i t o r i u m  I  
−  M o r t a l i t y  a n d  c a u s e s  o f  d e a t h  i n  a n  a g e i n g  N o r w e g i a n  O M T  c o h o r t .  I v a r  S k e i e ,  N o r w a y  
−  M o r t a l i t y  a n d  c a u s e s  o f  d e a t h  i n  t h e  N o r w e g i a n  n a t i o n a l  O M T - p r o g r a m m e  i n  t h e  y e a r s  
2 0 1 4  a n d  2 0 1 5 .  A n n e  B e c h ,  N o r w a y  
−  E s t i m a t i n g  t h e  p o t e n t i a l  i m p a c t  o f  p r o v i d i n g  H I V  t r e a t m e n t  a n d  o p i o i d  a g o n i s t  t h e r a p y  
( O A T )  i n  p r i s o n  a n d  u p o n  r e l e a s e  o n  H I V  i n c i d e n c e  a m o n g  p e o p l e  w h o  i n j e c t  d r u g s  ( P W I D )  
i n  T i j u a n a ,  M e x i c o .  A n n i c k  B o r q u e z ,  U n i t e d  S t a t e s  
−  O p i o i d  o v e r d o s e  m o r t a l i t y  t r e n d s  i n  A u s t r a l i a .  A m a n d a  R o x b u r g h ,  A u s t r a l i a  
−  E v a l u a t i n g  t h e  i m p a c t  o f  o p i o i d  s u b s t i t u t i o n  t r e a t m e n t  o n  m o r t a l i t y  –  a  C P R D  c o h o r t  s t u d y  
c o m p a r i n g  c o m m u n i t y  p r e s c r i b i n g  o f  b u p r e n o r p h i n e  a n d  m e t h a d o n e  i n  t h e  U n i t e d  
K i n g d o m .  M a t t h e w  H i c k m a n ,  U n i t e d  K i n g d o m  
−  O v e r d o s e  d e a t h s ;  d i v e r g i n g  t r e n d s  a m o n g  h e t e r o g e n e o u s  g r o u p s  o f  v i c t i m s .  I s a b e l l e  G i r a u d o n ,  
E M C D D A  
−  N e w  n o n - i n j e c t a b l e  n a l o x o n e  p r o d u c t s :  g l o b a l  o v e r v i e w .  R e b e c c a  M c D o n a l d ,  U n i t e d  K i n g d o m  
−  E x p e r i e n c e s  f r o m  a  n a t i o n a l  o v e r d o s e  p r e v e n t i o n  s t r a t e g y :  n a s a l  n a l o x o n e  d i s t r i b u t i o n  a n d  l e s s o n s  
l e a r n e d .  P h i l i p p  L o b m a i e r ,  N o r w a y  
−  O p t - o u t  v s  o p t - i n :  s h o u l d  t a k e - h o m e  n a l o x o n e  b e  r e q u i r e d  a s  a  s a f e  c l i n i c a l  p r a c t i c e ?  J o h n  S t r a n g ,  
U n i t e d  K i n g d o m  
−  T a k e - h o m e  n a l o x o n e  a s  i n t e g r a l  p a r t  o f  t o o l k i t s  f o r  p u b l i c  h e a l t h  p r o v i d e r s ;  p r i o r i t i e s  a c r o s s  
s e t t i n g s .  D a g m a r  H e d r i c h ,  E M C D D A  





14:30 – 16:00 
PARALLEL SESSIONS  
 
PAPER SESSION 37 
The constructs of addiction 
Chair: Gerhard Bühringer, Germany 
PAPER SESSION 38 
Evaluating impact 
Chair: Laura d’Arrigo, France 
PAPER SESSION 39 
Developing effective drug treatment 
Chair: Graça Vilar, Portugal 
Room 5C Auditorium IV Auditorium II 
− Implicit associations in male and female gamers across four 
different online games are linked to symptoms of internet 
gaming disorder. Christian Laier, Germany 
− Psychological and neurobiological mechanisms underlying the 
addictive use of specific internet applications. Matthias Brand, 
Germany 
− Implicit association and craving towards shopping cues in 
buying disorder. Patrick Trotzke, Germany 
− The problem with 'responsible gambling': a study of attitudes 
towards and experiences of personal responsibility discourses 
in people experiencing gambling addiction. Helen Miller, 
Australia 
− Emotional characteristics of gamblers’ relatives. Paula 
Jauregui, Spain 
− The evaluation of the alcohol law 2009 in Belgium. Tina Van 
Havere, Belgium 
− Adaption of the assist model of informal peer-led 
intervention delivery to the talk to frank drug prevention 
programme in United Kingdom secondary schools 
(ASSIST+FRANK): a pilot cluster randomised controlled trial. 
James White, United Kingdom 
− Assessment of drug treatment in Croatia – results from CATS 
(Croatian Addiction Treatment Survey) and its implication on 
new national drug policy strategy. Zrinka Cavar, Croatia 
− An approach to disinvestment in the field of drug abuse. 
Antonella Camposeragna, Italy 
− Does exposure to opioid substitution treatment at prison 
release reduce the risk of death? A prospective, observational 
study in England. Matthew Hickman, United Kingdom 
 
− Large variation in measures used to assess outcomes of opioid 
dependence treatment: a systematic review of longitudinal 
observational studies. Lucas Wiessing, EMCDDA 
− Extrinsic and intrinsic factors in drug treatment outcomes for 
persons in the criminal justice system: the roles of motivation 
and legal coercion. Steven Belenko, United States 
− Reasons for abstaining in persons with long-term substance 
use disorders: a qualitative study. Henning Pettersen, Norway 
− Utilisation of specialist psychiatric health care services – 15 years 
follow-up of a Norwegian OMT-cohort. Bent Monsbakken, 
Norway 
− Profiles of individuals identified as having a substance use 
disorder and types of services received. Serge Brochu, Canada 
PAPER SESSION 36 
Opiate Substitution Therapy (OST) and mortality  
Chair:  Domingos Duran, Portugal 
STRUCTURED SESSION 25 
Take-home naloxone: taking drug users seriously 
Chair: Thomas Clausen, Norway  
Room 1.15 Auditorium I 
− Mortality and causes of death in an ageing Norwegian OMT cohort. Ivar Skeie, Norway 
− Mortality and causes of death in the Norwegian national OMT-programme in the years 
2014 and 2015. Anne Bech, Norway 
− Estimating the potential impact of providing HIV treatment and opioid agonist therapy 
(OAT) in prison and upon release on HIV incidence among people who inject drugs (PWID) 
in Tijuana, Mexico. Annick Borquez, United States 
− Opioid overdose mortality trends in Australia. Amanda Roxburgh, Australia 
− Evaluating the impact of opioid substitution treatment on mortality – a CPRD cohort study 
comparing community prescribing of buprenorphine and methadone in the United 
Kingdom. Matthew Hickman, United Kingdom 
− Overdose deaths; diverging trends among heterogeneous groups of victims. Isabelle Giraudon, 
EMCDDA 
− New non-injectable naloxone products: global overview. Rebecca McDonald, United Kingdom 
− Experiences from a national overdose prevention strategy: nasal naloxone distribution and lessons 
learned. Philipp Lobmaier, Norway 
− Opt-out vs opt-in: should take-home naloxone be required as a safe clinical practice? John Strang, 
United Kingdom 
− Take-home naloxone as integral part of toolkits for public health providers; priorities across 
settings. Dagmar Hedrich, EMCDDA 
− Drug user’s experience with take-home naloxone; ‘how I saved my friend’; Short film 
 
PAPER SESSION 40 
Perspectives on harm reduction 
Chair: Xavier Majó i Roca, Spain 
PAPER SESSION 41 
Responding in the prison setting 
Chair: Lars Møller, WHO Europe 
PAPER SESSION 42 
Alcohol – social contexts 
Chair: John Holmes, United Kingdom 
Auditorium III Auditorium VIII Room 5B 
− Residential eviction and syringe sharing among a prospective 
cohort of street-involved youth. Andreas Pilarinos, Canada 
− The needle exchange debate in Stockholm city council and 
Swedish parliament during the 21st century. Lena Eriksson, Sweden 
− The acceptability and feasibility of a brief psychosocial 
intervention to reduce blood borne virus risk behaviours among 
people who inject drugs: a randomised control feasibility trial of 
a psychosocial intervention. Gail Gilchrist, United Kingdom 
− The cost-effectiveness of needle and syringe provision in 
preventing transmission of hepatitis C virus in people who 
inject drugs. Zoe Ward, United Kingdom 
− Evaluation of a drug checking integrated service: boom festival 
2016. Helena Valente, Portugal 
− The perfect storm: incarceration and the high-risk environment 
perpetuating transmission of HIV, hepatitis C virus, and 
tuberculosis in Eastern Europe and Central Asia. Frederick Altice, 
United States (EMCDDA 2017 Scientific Award) 
− Anger management in detained addicts for prevention of both 
crime and drug use: a controlled cognitive behavioral trial in an 
attenuate custody prison: a preliminary study. Felice Nava, Italy 
− Drug use in prison: the role of peer educators (8 years of 
intervention in a Portuguese prison setting). Andreia Nisa, 
Portugal 
− The use of NPS in prison in Europe: what do we know? 
Consequences and responses. Linda Montanari, EMCDDA 
− Assessing the social acceptability of harm reduction scale-up in 
French prison settings: results from the ANRS-pride research. 
Marie Jauffret-Roustide, France 
− Improving the identification and treatment of problem 
drug and alcohol users in somatic healthcare – a cross-
sectional comparative study. Danil Gamboa, Norway 
− Estimating alcohol annual consumption on the basis of 
population survey. Janusz Sierosławski, Poland 
− Context of daily drinking in 18 European countries. 
Findings of the RARHA SEAS project. Katarzyna Okulicz, 
Poland 
− Energy drink and alcohol mixed energy drink use among 
high school adolescents: association with risk taking 
behavior, social characteristics. Sabrina Molinaro, Italy 
− Factors related to binge drinking in adolescence: 
integrative literature review. Tereza Barroso, Portugal 
STRUCTURED SESSION 26 
Targeting hard-to-reach client groups for addiction aid in 
Switzerland – good practice in international perspective 
Chair: Petra Baumberger, Switzerland 
STRUCTURED SESSION 27 
Voices from the margins 
Chair: Sarah Galvani, United Kingdom 
STRUCTURED SESSION 28 
Harm reduction for people who inject drugs in Europe: findings from 
three major European projects 
Chair: Mika Salminen, Finland 
Room 1.05 Room 1.09 Room 1.15 
− Improvement of the support for addicted persons’ relatives 
– Recommendations. Petra Baumberger, Switzerland 
− Hard-to-reach target groups in addiction aid – What efforts 
are already taken and what need for action remains? 
Stefanie Knocks, Switzerland 
− SafeZone.ch – online counselling on addiction. Salomé 
Steinle, Switzerland 
− Indebtedness process among problematic gamblers. Oscar 
Ruiz, Switzerland 
− Transitions to long term recovery: developing identities 
and sustainable change. Jo Ashby, United Kingdom 
− Developing methodological identities: co-production in 
addiction research. Lucy Webb, United Kingdom 
− New psychoactive substances, new drug user identities 
and new service provider challenges. Rob Ralphs, United 
Kingdom 
− Who supports dying substance users? Drug using 
identities and end of life care. Sarah Galvani, United 
Kingdom 
− Health outcomes for clients of needle and syringe programs in 
prisons: a systematic review. Heino Stöver, Germany 
− No one gets left behind: addressing the hidden burden of hepatitis C 
related advanced liver disease in PWID in the community. John 
Lambert, Ireland  
− Community HIV testing in PWID: data from the COBATEST network. 
Laura Fernandez Lopez, Spain 
− Pilot condom distribution in a Czech prison. Viktor Mravčík, Czech 
Republic 
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S T R U C T U R E D  S E S S I O N  2 9  
H e a l t h  a n d  s o c i a l  r e s p o n s e s  t o  d r u g  p r o b l e m s  i n  E u r o p e :  c u r r e n t  s t a t e - o f - t h e - a r t  a n d  
f u t u r e  o p p o r t u n i t i e s  
C h a i r :  W a y n e  H a l l ,  A u s t r a l i a  
S T R U C T U R E D  S E S S I O N  3 0  
A s s e s s m e n t  o f  r i s k y  c a n n a b i s  u s e  a n d  r e l a t e d  c o n s e q u e n c e s  
C h a i r :  H u g o  L ó p e z - P e l a y o ,  S p a i n   
 
T W I S T  
S E S S I O N  
( 1 4 : 3 0  –  1 6 : 0 0 )  
R o o m  5 A  R o o m  1 . 0 8  
 
A u d i t o r i u m  I  
P a n e l  d i s c u s s i o n :  
−  A  f r a m e w o r k  f o r  d e v e l o p i n g  h e a l t h  a n d  s o c i a l  r e s p o n s e s  t o  d r u g  p r o b l e m s .  N i c o l a  
S i n g l e t o n ,  E M C D D A  
−  R e s p o n d i n g  t o  p r o b l e m s  a s s o c i a t e d  w i t h  d i f f e r e n t  p a t t e r n s  o f  d r u g  u s e  b o t h  o l d  a n d  
n e w .  D a g m a r  H e d r i c h ,  E M C D D A  
−  R e s p o n d i n g  t o  t h e  n e e d s  o f  p a r t i c u l a r  g r o u p s .  M a r i c a  F e r r i ,  E M C D D A  
−  R e s p o n d i n g  i n  s p e c i f i c  s e t t i n g s .  A l e s s a n d r o  P i r o n a ,  E M C D D A  
−  I m p r o v i n g  i m p l e m e n t a t i o n  –  t h e  r o l e  o f  e v i d e n c e ,  q u a l i t y  s t a n d a r d s  a n d  m o n i t o r i n g .  
H a r r y  S u m n a l l ,  U n i t e d  K i n g d o m  
−  D e f i n i t i o n s  o f  r i s k y  a n d  p r o b l e m a t i c  c a n n a b i s  u s e :  a  s y s t e m a t i c  r e v i e w .  C r i s t i n a  
C a s a j u a n a ,  S p a i n  
−  A s s e s s m e n t  o f  c a n n a b i s  u s e  d i s o r d e r s :  a  s y s t e m a t i c  r e v i e w  o f  s c r e e n i n g  a n d  
d i a g n o s t i c  i n s t r u m e n t s .  H u g o  L ó p e z - P e l a y o ,  S p a i n  
−  S t a n d a r d  J o i n t  U n i t  a s  a  t o o l  f o r  a s s e s s i n g  r i s k y  c a n n a b i s  u s e .  A n t o n i  G u a l ,  S p a i n  
−  W e i g h i n g  t h e  e v i d e n c e :  a  s y s t e m a t i c  r e v i e w  o n  l o n g - t e r m  n e u r o c o g n i t i v e  e f f e c t s  
o f  c a n n a b i s  u s e  i n  a b s t i n e n t  a d o l e s c e n t s  a n d  a d u l t s .  F l o r i a n  G a n z e r ,  G e r m a n y   
−  D i s c u s s a n t :  M e r c è  B a l c e l l s ,  S p a i n  
 
−  N e u r o s c i e n c e .  
F e r n a n d o  
R o d r i g u e z  d e  
F o n s e c a  a n d  O l g a  
V a l v e r d e  
G r a n a d o s ,  S p a i n  
 
1 6 : 0 0  –  1 6 : 3 0  
C o f f e e  b r e a k  
 
1 6 : 3 0  –  1 8 : 0 0  
P L E N A R Y  S E S S I O N  I I I  B O U N D A R I E S  O F  A D D I C T I O N  
C h a i r :  C a t h e r i n e  C o m i s k e y ,  I r e l a n d  
 
A u d i t o r i u m  I  
 
N e w  v i s t a s  i n  b a s i c ,  p r e c l i n i c a l  a n d  t r a n s l a t i o n a l  a d d i c t i o n  r e s e a r c h .  R a i n e r  S p a n a g e l ,  G e r m a n y  
E c o n o m i c  a n d  c o n f l i c t  b a s e d  r a p i d  m a s s  p o p u l a t i o n  m o v e m e n t  i n t o  E u r o p e :  t h e  s e c u r i t y  a n d  p u b l i c  h e a l t h  i m p l i c a t i o n s  f o r  f u t u r e  E U  d r u g s  p o l i c y .  M a r i e  C l a i r e  V a n  H o u t ,  
U n i t e d  K i n g d o m  
D e c r e a s i n g  l i f e  e x p e c t a n c y  d e s p i t e  g a i n s  i n  c a n c e r  a n d  c a r d i o - v a s c u l a r  d i s e a s e  m o r t a l i t y ?   T h e  r o l e  o f  a d d i c t i o n s  i n  p u b l i c  h e a l t h  i n  h i g h - i n c o m e  c o u n t r i e s .  J ü r g e n  R e h m ,  
G e r m a n y / C a n a d a  ( E U F A S - E A R  a w a r d  a d d r e s s )  
 
2 0 1 7  E M C D D A  S c i e n t i f i c  a w a r d  c e r e m o n y  
 
1 9 : 3 0  –  2 2 : 3 0  







09:00 – 10:30 PLENARY SESSION IV CHALLENGES AHEAD Chair: Kerstin Stenius, Finland 
 Auditorium I 
 Extending definitions in addiction. Joël Billieux, Luxembourg 
Challenges ahead for tobacco policies. Ann McNeill, United Kingdom 
Challenges ahead for cannabis policies. Rosalie Liccardo Pacula, United States 
 
10:30 – 11:00 Coffee break 
 
11:00 – 12:30 PARALLEL SESSIONS   
PAPER SESSION 43 
Illuminating the darknet and  
online markets 
Chair: Ioanna Giasemi, Cyprus 
PAPER SESSION 44 
Gambling – assessment 
Chair: Jean-Michel Costes, France 
PAPER SESSION 45 
Understanding health consequences 
Chair: Karsten Lunze, United States 
PAPER SESSION 46 
Innovations in practice 
Chair: Richard Pates, United Kingdom 
PAPER SESSION 47 
The importance of gender 
Chair: Meni Malliori, Greece 
Auditorium I Room 1.05 Room 5C Room 1.09 Auditorium II 
− Forensic drug intelligence and 
the rise of darknet marketplaces. 
Marie Morelato, Australia 
− Four years of monitoring 
cryptomarkets on the darknet. 
Amanda Roxburgh, Australia 
− “This place is like the jungle”. 
Discussion about NPS on a 
cryptomarket. Sara Rolando, Italy 
− Purity, adulteration and price of 
drugs bought on-line versus off-
line in the Netherlands. Peggy 
van der Pol, Netherlands 
− The role of the ‘dark web’ in the 
trade of illicit drugs and the role 
of the Netherlands on these 
marketplaces. Stijn Hoorens, 
Belgium 
− Role of emotion dysregulation as a 
predictor of pathological gambling 
and comorbid disorders. Paula 
Jauregui, Spain 
− Trajectories of gambling behaviour 
and gambling problems in 
outpatient care – results from an 
ongoing study. Ludwig Kraus, 
Germany 
− Gambling in Croatia (pilot project 
countries). Zrinka Puharić, Croatia 
− Core gambling-related traits and 
their relationships with gambling 
behavior patterns and severity: an 
exploratory study with Ecuadorian 
gamblers. María Fernanda Jara 
Rizzo, Spain 
− Association of problem gambling 
with type of gambling. Elisa 
Benedetti, Italy 
− The use of alcohol and drugs and its 
relation to the workplace. Cláudia 
Urbano, Portugal 
− Cognitive bias modification targeting 
the cannabis and alcohol 
consumption of youth in juvenile 
detention centers. Hans van der 
Baan, Netherlands 
− One-year sobriety improves 
satisfaction with life, executive 
functions and psychological distress 
among patients with polysubstance 
use disorder. Egon Hagen, Norway 
− Making cannabis safer: striking the 
balance between THC and CBD. Amir 
Englund, United Kingdom 
− Symptoms and correlates of 
emergency medical treatment 
following the use of MDMA (2014–
2016). Larissa Maier, Switzerland 
− Experiential avoidance and emotional 
dysregulation as therapeutic dimensions in 
alcohol use disorder treatment: findings 
based on 3-months dialectical behavior 
therapy skills training. Marco Cavicchioli, Italy 
− Clinical strategies for engaging families of 
patients in substance addiction treatment 
programs: results from an exploratory study 
with leading family therapists in the United 
States. Sebastian Perumbilly, United States 
− Building a bridge between prevention 
research and practice: conclusions from the 
long-term development and implementation 
of the rebound life skills and drug education 
programme. Maximilian von Heyden, 
Germany 
− Development of therapeutic alliance and 
outcomes from the perspective of drug users 
undergoing treatment in a therapeutic 
community. Luís Janeiro, Portugal 
− Insecure attachment and 
female drug use. Efrat 
Fridman, United States 
− Men’s and women’s response 
to treatment in a randomized 
controlled trial of injectable 
opioid assisted treatment for 
severe opioid use disorder. 
Heather Palis, Canada 
− Experiences and barriers of 
female drug users on alcohol 
and drug prevention and 
treatment in Belgium. Julie 
Schamp, Belgium 
− Suicidal ideation among 
long-term opioid users: its 
risk factors and the role of 
gender. Kirsten Marchand, 
Canada 
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STRUCTURED SESSION 29 
Health and social responses to drug problems in Europe: current state-of-the-art and 
future opportunities 
Chair: Wayne Hall, Australia 
STRUCTURED SESSION 30 
Assessment of risky cannabis use and related consequences 




(14:30 – 16:00) 




− A framework for developing health and social responses to drug problems. Nicola 
Singleton, EMCDDA 
− Responding to problems associated with different patterns of drug use both old and 
new. Dagmar Hedrich, EMCDDA 
− Responding to the needs of particular groups. Marica Ferri, EMCDDA 
− Responding in specific settings. Alessandro Pirona, EMCDDA 
− Improving implementation – the role of evidence, quality standards and monitoring. 
Harry Sumnall, United Kingdom 
− Definitions of risky and problematic cannabis use: a systematic review. Cristina 
Casajuana, Spain 
− Assessment of cannabis use disorders: a systematic review of screening and 
diagnostic instruments. Hugo López-Pelayo, Spain 
− Standard Joint Unit as a tool for assessing risky cannabis use. Antoni Gual, Spain 
− Weighing the evidence: a systematic review on long-term neurocognitive effects 
of cannabis use in abstinent adolescents and adults. Florian Ganzer, Germany  









16:00 – 16:30 
Coffee break 
 
16:30 – 18:00 
PLENARY SESSION III BOUNDARIES OF ADDICTION 




New vistas in basic, preclinical and translational addiction research. Rainer Spanagel, Germany 
Economic and conflict based rapid mass population movement into Europe: the security and public health implications for future EU drugs policy. Marie Claire Van Hout, 
United Kingdom 
Decreasing life expectancy despite gains in cancer and cardio-vascular disease mortality?  The role of addictions in public health in high-income countries. Jürgen Rehm, 
Germany/Canada (EUFAS-EAR award address) 
 
2017 EMCDDA Scientific award ceremony 
 
19:30 – 22:30 
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S T R U C T U R E D  S E S S I O N  3 1  
P r o m o t i n g  a  n e w  e r a  i n  g l o b a l  t r a i n i n g  a n d  e d u c a t i o n  o f  
a d d i c t i o n  p r o f e s s i o n a l s :  t h e  I n t e r n a t i o n a l  C o n s o r t i u m  o f  
U n i v e r s i t i e s  f o r  D r u g  D e m a n d  R e d u c t i o n  
C h a i r :  M i c h a l  M i o v s k ý ,  C z e c h  R e p u b l i c  
S T R U C T U R E D  S E S S I O N  3 2  
C o s t s  o f  d r u g  t r e a t m e n t  
C h a i r :  C l á u d i a  C o s t a  S t o r t i ,  E M C D D A  
S T R U C T U R E D  S E S S I O N  3 3  
W h y  a r e  t h e r e  m o r e  d r u g - r e l a t e d  d e a t h s :  
c h a l l e n g e s  f o r  m o n i t o r i n g ,  u n d e r s t a n d i n g  
a n d  p r e v e n t i n g  –  e x a m p l e s  f r o m  E u r o p e  
C h a i r :  I s a b e l l e  G i r a u d o n ,  E M C D D A  
S T R U C T U R E D  S E S S I O N  3 4  
A d d r e s s i n g  t h e  u n m e t  r e p r o d u c t i v e  
h e a l t h  n e e d s  o f  w o m e n  w i t h  a d d i c t i o n  
C h a i r :  J a n - P e t e r  S i e d e n t o p f ,  G e r m a n y  
R o o m  1 . 0 6  R o o m  5 A  A u d i t o r i u m  I V  R o o m  1 . 0 7  
I n t r o d u c t i o n  a n d  o p e n i n g  t h e  s y m p o s i u m .  C h a r l o t t e  S i s s o n ,  
U n i t e d  S t a t e s  
−  U T C  c u r r i c u l u m .  M e l o d y  H e a p s ,  U n i t e d  S t a t e s  
−  E u r o p e a n  a c a d e m i c  e d u c a t i o n  a n d  t r a i n i n g  p r o g r a m s  f o r  
a d d i c t i o n  s p e c i a l i s t s :  a  G o o g l e  s u r v e y  a n d  c u r r e n t  c o n t e x t  
a n d  c o o r d i n a t i n g  c e n t r e  f o r  E u r o p e .  M i c h a l  M i o v s k ý  a n d  
A m a l i e  P a v l o v s k á ,  C z e c h  R e p u b l i c  
−  I C U D D R  a n d  i n t e r n a t i o n a l  n e t w o r k i n g  a n d  c o l l a b o r a t i o n  
b e t w e e n  ( n o t  o n l y )  u n i v e r s i t y  e d u c a t i o n  a n d  t r a i n i n g  
p r o v i d e r s  a n d  p r o f e s s i o n a l  s o c i e t y  I S S U P .  M i c h a l  M i o v s k ý ,  
C z e c h  R e p u b l i c ,  R o g e r  P e t e r s  a n d  M e l o d y  H e a p s ,  U n i t e d  
S t a t e s  a n d  J e f f  L e e ,  U n i t e d  K i n g d o m   
−  U S  a c a d e m i c  e d u c a t i o n  a n d  t r a i n i n g  p r o g r a m s  f o r  
a d d i c t i o n  s p e c i a l i s t s :  a  G o o g l e  s u r v e y  a n d  c u r r e n t  c o n t e x t  
a n d  c o o r d i n a t i n g  c e n t r e  f o r  N o r t h  A m e r i c a .  R o g e r  P e t e r s ,  
U n i t e d  S t a t e s  a n d  A m a l i e  P a v l o v s k á ,  C z e c h  R e p u b l i c  
−  U P C  c u r r i c u l u m .  Z i l i  S l o b o d a ,  U n i t e d  S t a t e s  
−  ' D r u g  t r e a t m e n t  e x p e n d i t u r e :  a  
m e t h o d o l o g i c a l  o v e r v i e w ' .  P a u l  G r i f f i t h s ,  
E M C D D A   
−  A  m e t h o d o l o g y  f o r  e s t i m a t i n g  h e a l t h  
e x p e n d i t u r e  o n  d r u g  t r e a t m e n t :  t h e  A u s t r a l i a n  
e x p e r i e n c e .  A l i s o n  R i t t e r ,  A u s t r a l i a  
−  E s t i m a t i n g  t h e  c o s t s  o f  s u b s t i t u t i o n  t h e r a p y  
f o r  h e r o i n  a n d  o p i o i d  a d d i c t i o n  i n  t h e  U n i t e d  
S t a t e s :  I n s i g h t s  a n d  c h a l l e n g e s .  R o s a l i e  P a c u l a ,  
U n i t e d  S t a t e s  
−  A  m e t h o d o l o g y  f o r  a n  E U  c r o s s - c o u n t r y  
c o m p a r i s o n :  p u b l i c  e x p e n d i t u r e  o n  d r u g  
t r e a t m e n t  i n  h o s p i t a l s .  F r e y a  V a n d e r  L a e n e n ,  
B e l g i u m  
−  S o c i a l  c o s t  i n  F r a n c e :  W h a t ’ s  n e w  i n  t h e  f i e l d  
o f  d e a t h  t o l l  a n d  i l l n e s s  c a l c u l a t i o n s .  P i e r r e  
K o p p ,  F r a n c e  
−  S e t t i n g  t h e  E u r o p e a n  s c e n e :  d r u g - r e l a t e d  
d e a t h s  i n  E u r o p e :  r e b o u n d  a n d  s h i f t s ?  
B r i e f  u p d a t e  o n  a  d i v e r s e  p i c t u r e .  I s a b e l l e  
G i r a u d o n ,  E M C D D A  
−  A  r e v i e w  o f  t r i g g e r s  a n d  d r i v e r s  o f  d r u g -
r e l a t e d  d e a t h s  i n  s e v e n  n o r t h e r n  
E u r o p e a n  c o u n t r i e s .  T i m  M i l l a r  a n d  
A n d r e w  M c A u l e y ,  U n i t e d  K i n g d o m  
−  E s t i m a t i o n s  o f  t r e n d s ,  e f f e c t s  o f  c h a n g e s  
i n  r e c o r d i n g  p r a c t i c e s  a n d  s t u d i e s  o f  
d r u g  p a t t e r n .  F o c u s  o n  S w e d e n .  H å k a n  
L e i f m a n ,  S w e d e n  
−  P r e v e n t i n g  d r u g - r e l a t e d  d e a t h s :  P o l i c y  
i m p l i c a t i o n s  a n d  w a y s  f o r w a r d .  F o c u s  o n  
N o r w a y .  T h o m a s  C l a u s e n ,  N o r w a y  
−  D i s c u s s a n t :  S h a n e  D a r k e ,  A u s t r a l i a  
−  D o e s  O S T  i n f l u e n c e  p r e g n a n c y  r a t e s  
i n  s u b s t a n c e  u s i n g  w o m e n ?  J a n - P e t e r  
S i e d e n t o p f ,  G e r m a n y  
−  S u p p o r t i n g  w o m e n  w h o  u s e  d r u g s  t o  
m a k e  r e p r o d u c t i v e  c h o i c e s .  M a r y  
H e p b u r n ,  S c o t l a n d   
−  R e p r o d u c t i v e  h e a l t h  i n  t r e a t m e n t  a n d  
r e c o v e r y .  M i s h k a  T e r p l a n ,  U n i t e d  
S t a t e s  
−  O p i o i d  u s i n g  p r e g n a n t  M a l t e s e  
w o m e n .  A n n a  M a r i a  V e l l a ,  M a l t a  
S T R U C T U R E D  S E S S I O N  3 5  
B e s t  p r a c t i c e s  i n  h e p a t i t i s  C  v i r u s  ( H C V )  p r e v e n t i o n ,  m a n a g e m e n t  a n d  
t r e a t m e n t  a m o n g  p e o p l e  w h o  i n j e c t  d r u g s  
C h a i r s :  A l e x i s  G o o s d e e l ,  E M C D D A  a n d  M a t t h e w  H i c k m a n ,  U n i t e d  K i n g d o m  
S T R U C T U R E D  S E S S I O N  3 6  
D r u g  r e s e a r c h  a n d  d r u g  m o n i t o r i n g  i n  p r i s o n  
C h a i r s :  H e i n o  S t ö v e r ,  W E P H R E N  a n d  L i n d a  M o n t a n a r i ,  
E M C D D A  
S T R U C T U R E D  S E S S I O N  3 7  
N i g h t l i f e :  n o  r i s k  n o  f u n ?  c h a l l e n g e s  f o r  d r u g  p r e v e n t i o n  a n d  
t r e n d s p o t t i n g  
C h a i r :  G r e g o r  B u r k h a r t ,  E M C D D A  
A u d i t o r i u m  I I I  R o o m  5 B  R o o m  1 . 0 8  
−  M o d e l  a n d  e m p i r i c a l  e v i d e n c e  o n  t h e  e f f e c t i v e n e s s  o f  i n t e r v e n t i o n s  t o  
p r e v e n t  H C V  a m o n g  p e o p l e  w h o  i n j e c t  d r u g s .  M a t t h e w  H i c k m a n ,  U n i t e d  
K i n g d o m  
−  D i r e c t - a c t i n g  i n t e r f e r o n - f r e e  t h e r a p i e s  a n d  r e i n f e c t i o n  a m o n g  p e o p l e  
w h o  i n j e c t  d r u g s .  J a s o n  G r e b e l y ,  A u s t r a l i a  
−  R e s t r i c t i o n s  f o r  r e i m b u r s e m e n t  o f  i n t e r f e r o n - f r e e  d i r e c t - a c t i n g  a n t i v i r a l  
t h e r a p i e s  f o r  H C V  i n f e c t i o n  i n  E u r o p e .  J e f f r e y  L a z a r u s ,  D e n m a r k  
−  W H O  m i n i m u m  p u b l i c  h e a l t h  d a t a  s e t  o n  p r i s o n  
h e a l t h .  L a r s  M ø l l e r ,  W H O - R e g i o n a l  O f f i c e  f o r  E u r o p e  
−  E u r o p e a n  Q u e s t i o n n a i r e  o n  D r u g  U s e  a m o n g  
P r i s o n e r s  –  E Q D P .  V i k t o r  M r a v č i k ,  C z e c h  R e p u b l i c  
−  S p a n i s h  s u r v e y  o n  h e a l t h  a n d  d r u g  u s e  a m o n g  
p r i s o n e r s .  E l e n a  A l a v a r e z ,  S p a i n  
−  M o n i t o r i n g  d r u g  u s e  i n  c u s t o d i a l  i n s t i t u t i o n s  f o r  
j u v e n i l e  o f f e n d e r s  i n  P o r t u g a l .  L u d m i l a  C a r a p i n h a ,  
−  D r u g  u s e  i n  E u r o p e a n  r e c r e a t i o n a l  s e t t i n g s :  m i x i n g  c o n t e x t s ,  
r i s k s  a n d  p l e a s u r e .  J o ã o  M a t i a s ,  E M C D D A  
−  E n v i r o n m e n t a l  p r e v e n t i o n  i n  n i g h t l i f e  s e t t i n g s .  J o h a n n a  
G r i p e n b e r g ,  S w e d e n  
−  P r o t e c t i n g  a n d  p r o m o t i n g  h e a l t h  i n  n i g h t l i f e  e n v i r o n m e n t s  
d u r i n g  t h e  l a s t  t h r e e  d e c a d e s .  A n d r e w  B e n n e t t ,  U n i t e d  
K i n g d o m  




STRUCTURED SESSION 31 
Promoting a new era in global training and education of 
addiction professionals: the International Consortium of 
Universities for Drug Demand Reduction 
Chair: Michal Miovský, Czech Republic 
STRUCTURED SESSION 32 
Costs of drug treatment 
Chair: Cláudia Costa Storti, EMCDDA 
STRUCTURED SESSION 33 
Why are there more drug-related deaths: 
challenges for monitoring, understanding 
and preventing – examples from Europe 
Chair: Isabelle Giraudon, EMCDDA 
STRUCTURED SESSION 34 
Addressing the unmet reproductive 
health needs of women with addiction 
Chair: Jan-Peter Siedentopf, Germany 
Room 1.06 Room 5A Auditorium IV Room 1.07 
Introduction and opening the symposium. Charlotte Sisson, 
United States 
− UTC curriculum. Melody Heaps, United States 
− European academic education and training programs for 
addiction specialists: a Google survey and current context 
and coordinating centre for Europe. Michal Miovský and 
Amalie Pavlovská, Czech Republic 
− ICUDDR and international networking and collaboration 
between (not only) university education and training 
providers and professional society ISSUP. Michal Miovský, 
Czech Republic, Roger Peters and Melody Heaps, United 
States and Jeff Lee, United Kingdom  
− US academic education and training programs for 
addiction specialists: a Google survey and current context 
and coordinating centre for North America. Roger Peters, 
United States and Amalie Pavlovská, Czech Republic 
− UPC curriculum. Zili Sloboda, United States 
− 'Drug treatment expenditure: a 
methodological overview'. Paul Griffiths, 
EMCDDA  
− A methodology for estimating health 
expenditure on drug treatment: the Australian 
experience. Alison Ritter, Australia 
− Estimating the costs of substitution therapy 
for heroin and opioid addiction in the United 
States: Insights and challenges. Rosalie Pacula, 
United States 
− A methodology for an EU cross-country 
comparison: public expenditure on drug 
treatment in hospitals. Freya Vander Laenen, 
Belgium 
− Social cost in France: What’s new in the field 
of death toll and illness calculations. Pierre 
Kopp, France 
− Setting the European scene: drug-related 
deaths in Europe: rebound and shifts? 
Brief update on a diverse picture. Isabelle 
Giraudon, EMCDDA 
− A review of triggers and drivers of drug-
related deaths in seven northern 
European countries. Tim Millar and 
Andrew McAuley, United Kingdom 
− Estimations of trends, effects of changes 
in recording practices and studies of 
drug pattern. Focus on Sweden. Håkan 
Leifman, Sweden 
− Preventing drug-related deaths: Policy 
implications and ways forward. Focus on 
Norway. Thomas Clausen, Norway 
− Discussant: Shane Darke, Australia 
− Does OST influence pregnancy rates 
in substance using women? Jan-Peter 
Siedentopf, Germany 
− Supporting women who use drugs to 
make reproductive choices. Mary 
Hepburn, Scotland  
− Reproductive health in treatment and 
recovery. Mishka Terplan, United 
States 
− Opioid using pregnant Maltese 
women. Anna Maria Vella, Malta 
STRUCTURED SESSION 35 
Best practices in hepatitis C virus (HCV) prevention, management and 
treatment among people who inject drugs 
Chairs: Alexis Goosdeel, EMCDDA and Matthew Hickman, United Kingdom 
STRUCTURED SESSION 36 
Drug research and drug monitoring in prison 
Chairs: Heino Stöver, WEPHREN and Linda Montanari, 
EMCDDA 
STRUCTURED SESSION 37 
Nightlife: no risk no fun? challenges for drug prevention and 
trendspotting 
Chair: Gregor Burkhart, EMCDDA 
Auditorium III Room 5B Room 1.08 
− Model and empirical evidence on the effectiveness of interventions to 
prevent HCV among people who inject drugs. Matthew Hickman, United 
Kingdom 
− Direct-acting interferon-free therapies and reinfection among people 
who inject drugs. Jason Grebely, Australia 
− Restrictions for reimbursement of interferon-free direct-acting antiviral 
therapies for HCV infection in Europe. Jeffrey Lazarus, Denmark 
− WHO minimum public health data set on prison 
health. Lars Møller, WHO-Regional Office for Europe 
− European Questionnaire on Drug Use among 
Prisoners – EQDP. Viktor Mravčik, Czech Republic 
− Spanish survey on health and drug use among 
prisoners. Elena Alavarez, Spain 
− Monitoring drug use in custodial institutions for 
juvenile offenders in Portugal. Ludmila Carapinha, 
− Drug use in European recreational settings: mixing contexts, 
risks and pleasure. João Matias, EMCDDA 
− Environmental prevention in nightlife settings. Johanna 
Gripenberg, Sweden 
− Protecting and promoting health in nightlife environments 
during the last three decades. Andrew Bennett, United 
Kingdom 
− Zurich’s integrated nightlife approach. Alexander Bücheli, 
 
Portugal 
− French system on drug monitoring in prison. Marie 
Jauffret-Roustide, France 
Switzerland 
− Emerging trends within nightlife settings: responses and 
innovation. Sarah Morton, Ireland 
 
Lunch boxes available between 12:30 and 14:00 
 
12:45 – 14:15 SPONSORED SESSIONS MSD (Merck Sharp & Dohme) 
Room 1.07 
− The importance of treating HCV in PWID 
 
12:45 – 14:15 PARALLEL SESSIONS   
PAPER SESSION 48  
Reducing risks  
Chair: Patrícia Pissarra, Portugal 
PAPER SESSION 49 
Spotlight on drug consumption 
rooms 
Chair: Freya Vander Laenen, Belgium 
PAPER SESSION 50 
Analysis to inform service     development 
and delivery 
Chair: Viktor Mravčik, Czech Republic 
PAPER SESSION 51 
Improving the evidence base on  
hepatitis C virus (HCV) 
Chair: Amy Peacock, Australia 
PAPER SESSION 52 
Innovating monitoring 
Chair: Dominique Lopez, India 
Room 5A Auditorium I Room 5B Auditorium II Auditorium IV 
− Factors predicting usage of low dead 
space syringes amongst people who 
inject drugs in the United Kingdom, 
and the association with hepatitis C 
prevalence. Adam Trickey, United 
Kingdom 
− Illegal and legal substance abuse 
amongst harm reduction program 
users – a case study from Croatia. 
Dalibor Dolezal, Croatia 
− Influencing drug policy: making the 
case for medically supervised injecting 
facilities in Dublin. Tony Duffin, Ireland 
− Modelling the role of incarceration in 
HCV transmission and prevention 
amongst people who inject drugs in 
rural Kentucky. Jack Stone, United 
Kingdom 
− HCV treatment as prevention in 
Europe: model projections and impact 
of current and scaled-up treatment 
− Drug consumption rooms: issues 
of social and political 
acceptability in French public 
debate. Marie Jauffret-Roustide, 
France 
− Drug consumption rooms in 
Porto, Portugal: listening to the 
concerned voices. Paula 
Meireles, Portugal 
− Frequency and severity of non-
fatal opioid overdoses among 
clients attending the Sydney 
medically supervised injecting 
centre. Amanda Roxburgh, 
Australia 
− Drug consumption rooms in 
Catalonia: major impact on HIV-
HCV risk behaviors and 
engagement in care. Cinta Folch, 
Spain 
− Factors concerning access to a 
− Improving treatment outcome by adding 
different structural elements to outpatient 
substance abuse treatment programs 
offered to Danish youth. Mads Uffe 
Pedersen and Sheila Jones, Denmark 
− The Portuguese DSM-IV-MR-J: validation 
of an instrument to measure youth 
problem gambling to the Portuguese 
language. Joana Alexandre, Portugal 
− Evaluating the integration of indigenous 
healing practices with principles of seeking 
safety for treatment of indigenous patients 
with a history of trauma and active 
substance use disorder. Teresa Marsh, 
Canada 
− The efficacy of mindfulness-based 
treatments for alcohol and drugs use 
disorders: a critical meta-analytic review of 
randomized and non-randomized 
controlled trials. Marco Cavicchioli, Italy 
− Screening of drug use in primary care 
− Detachable low dead-space 
syringes for the prevention of 
hepatitis C among people who 
inject drugs in Bristol, England: an 
economic evaluation. Peter 
Vickerman, United Kingdom 
− Early HCV treatment and HCV case 
finding in people who inject drugs 
(PWID): cost-effectiveness studies. 
Matthew Hickman, United 
Kingdom 
− Restrictions for reimbursement of 
interferon-free direct-acting 
antiviral therapies for HCV 
infection in Europe. Jeffrey Lazarus, 
Denmark 
− Documenting barriers to access 
HCV care and treatment: a peer-
led research. João Santa Maria, 
Portugal 
− SOF/VEL/VOX for 8 or 12 weeks is 
− Misuse of general population 
surveys. Peter Reuter, United 
States 
− Representativeness challenges 
for web surveys collecting 
information on drug users: a way 
for improving the cannabis 
market estimation in France. 
Stéphane Legleye, France 
− What can 20,000 people tell us 
about their recent nitrous oxide 
(N2O) use? Understanding the 
recreational use of N2O and the 
dose-response relationship with 
myeloneuropathy. Adam 
Winstock, United Kingdom 
− Temporal trends and subjective 
highness for alternative cannabis 
product use reported in an 
online cannabis community. 
Meredith Meacham, United States 
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r a t e s .  H a n n a h  F r a s e r ,  U n i t e d  K i n g d o m  p o t e n t i a l  d r u g  c o n s u m p t i o n  
r o o m  i n  D u b l i n ,  I r e l a n d .  E m m a  
A t k i n - B r e n n i n k m e y e r ,  I r e l a n d  
s e r v i c e s  i n  C a t a l o n i a ,  f e a s i b i l i t y  a n a l y s i s  o f  
t h e  a s s i s t  t o o l .  J o a n  C o l o m  i  F a r r a n ,  S p a i n  
w e l l  t o l e r a t e d  a n d  r e s u l t s  i n  h i g h  
S V R 1 2  r a t e s  i n  p a t i e n t s  r e c e i v i n g  
o p i o i d  s u b s t i t u t i o n  t h e r a p y .  J a s o n  
G r e b e l y ,  A u s t r a l i a  
−  P u b l i c  e x p e n d i t u r e  o n  d r u g  
t r e a t m e n t  a n d  a s s o c i a t e d  
c o m o r b i d i t i e s :  t h e  c a s e - s t u d y  o f  
B e r g a m o .  S a b r i n a  M o l i n a r o ,  I t a l y  
S T R U C T U R E D  S E S S I O N  3 8  
A y a h u a s c a  –  w h y  i s  
c l a s s i f i c a t i o n  s o  i m p o r t a n t ?  
C h a i r :  M á r i o  S i m õ e s ,  P o r t u g a l   
S T R U C T U R E D  S E S S I O N  3 9  
P r e v e n t i o n :  f r o m  e v i d e n c e  t o  a c t i o n  –  
h o w  w e  a r e  w o r k i n g  
C h a i r :  J o a q u i m  F o n s e c a ,  P o r t u g a l  
S T R U C T U R E D  S E S S I O N  4 0  
T h e  u n i v e r s a l  p r e v e n t i o n  c u r r i c u l u m  
( U P C )  a d a p t a t i o n  i n  E u r o p e :  i n t r o d u c t i o n  
a n d  d i s c u s s i o n  o n  s u b s t a n t i a l  c o n t e n t  
C h a i r :  A n n e m i e  C o o n e ,  B e l g i u m   
S T R U C T U R E D  S E S S I O N  4 1  
P r o m o t i n g  t h e  u s e  o f  e v i d e n c e -
b a s e d  p r o g r a m m e s  i n  E u r o p e :  a  
E u r o p e a n  r e g i s t r y  
C h a i r :  G r e g o r  B u r k h a r t ,  E M C D D A  
S T R U C T U R E D  S E S S I O N  4 2  
A n o n y m o u s  c o l l e c t i n g  a n d  t e s t i n g  o f  n e w  
p s y c h o a c t i v e  s u b s t a n c e s  s a m p l e s  a s  a  p a r t  
o f  n a t i o n a l  e a r l y  w a r n i n g  s y s t e m s  ( E W S )  
C h a i r :  S i m o n a  Š a b i ć ,  S l o v e n i a  
R o o m  1 . 0 6  R o o m  1 . 0 5  A u d i t o r i u m  I I I  R o o m  5 C  R o o m  1 . 0 9  
−  E t h n i c a l  u s e s  o f  A y a h u a s c a .  
P a u l o  R o b e r t o  S i l v a  e  S o u z a ,  
P o r t u g a l   
−  A y a h u a s c a ’ s  t h e r a p e u t i c  
p o t e n t i a l  i n  d r u g  a d d i c t i o n .  
M á r i o  S i m õ e s  a n d  J o s é  P a l m a ,  
P o r t u g a l  
−  E t h n o g r a p h i c  s t u d y  o n  
a y a h u a s c a ´ s  r i t u a l  h e a l i n g  
f r o m  a d d i c t i o n .  P i e r a  T a l i n ,  
N e t h e r l a n d s  a n d  E m i l i a  
S a n a b r i a ,  F r a n c e   
−  P h a r m a c o l o g y  o f  A y a h u a s c a .  
O l g a  S i l v a ,  P o r t u g a l  
−  A y a h u a s c a  u n c e r t a i n  l e g a l  
s t a t u s .  S o f i a  M a c h a d o  a n d  
L u í s  S a n t o s ,  P o r t u g a l  
−  S c h o o l - b a s e d  d r u g  u s e  p r e v e n t i o n  
m u l t i c o m p o n e n t  m o d e l :  a  L i s b o n  
a n d  T a g u s  V a l l e y  R e g i o n  
P e r s p e c t i v e .  I s a b e l  P r a t a ,  P o r t u g a l  
−  ‘ M e  a n d  O t h e r s ’  p r o g r a m m e :  
b u i l d i n g  s t a n d a r d s - b a s e d  n a r r a t i v e s  
f o r  p r e v e n t i o n .  R a ú l  M e l o ,  P o r t u g a l  
−  ‘ M e  a n d  O t h e r s ’  P r o g r a m m e  –  
O u t c o m e  E v a l u a t i o n :  L i s b o n  a n d  
T a g u s  V a l l e y  R e g i o n  s a m p l e  ( 2 0 1 5  
t o  2 0 1 7 ) .  P r e ,  p o s t  a n d  f o l l o w  u p .  
C a r l a  F r a z ã o ,  P o r t u g a l  
−  ‘ G u i d e l i n e s  t o  d e a l  w i t h  a d d i c t i v e  
b e h a v i o u r s ’ .  P r o j e c t ,  p r o c e s s  a n d  
o u t c o m e  e v a l u a t i o n .  R u i  P e d r o  S i l v a ,  
P o r t u g a l  
−  W h y  i s  a  c o m m o n  t r a i n i n g  c u r r i c u l u m  
f o r  E u r o p e  n e e d e d ?  A n n e m i e  C o o n e ,  
B e l g i u m  
−  G e t t i n g  t o  t h e  U P C - c u r r i c u l u m  a n d  
p r o j e c t i n g  t h i s  c o n t e n t  o n  t h e  
p a r t i c i p a n t s  o w n  c o n t e x t .  S a n e l a  T a l i č ,  
S l o v e n i a ,  K a t a r z y n a  O k u l i c z ,  P o l a n d  a n d  
M a r i a  A n t ó n i a  G o m i l a ,  S p a i n  
−  S u b s t a n c e  u s e  p r e v e n t i o n  t r a i n i n g  
n e e d s  f o u n d  i n  t h e  i n v o l v e d  c o u n t r i e s  
a n d  l o c a l  p r e v e n t i o n  t r a i n i n g  n e e d s  o f  
t h e  p a r t i c i p a n t s .  A n n e m i e  C o o n e ,  
B e l g i u m  a n d  K a t a r z y n a  O k u l i c z ,  P o l a n d  
−  A  E u r o p e a n  r e g i s t r y  o f  E B P .  M a r i c a  
F e r r i  a n d  G r e g o r  B u r k h a r t ,  
E M C D D A  
−  T h e  G e r m a n  r e g i s t r y  o f  E B P :  
e x p e r i e n c e s  w i t h  p r a c t i c e .  
F r e d e r i c k  G r o e g e r - R o t h ,  G e r m a n y  
−  R e v i e w i n g  a n d  r a t i n g  E B P  f o r  
c r i m e  a n d  d r u g s  p r e v e n t i o n  i n  
E u r o p e :  a p p r o a c h  a n d  
m e t h o d o l o g i c a l  c h a l l e n g e s .  N i c k  
A x f o r d  a n d  S h r e y a  S o n t h a l i a ,  
U n i t e d  K i n g d o m  a n d  F r e d e r i c k  
G r o e g e r - R o t h ,  G e r m a n y  
−  D i s c u s s i o n :  H o w  c a n  s u c h  
r e g i s t r i e s  i m p r o v e  r e s o u r c e  
a l l o c a t i o n  i n  p r e v e n t i o n ?  F a b r i z i o  
F a g g i a n o ,  I t a l y  a n d  Z i l i  S l o b o d a ,  
U n i t e d  S t a t e s  
−  A n o n y m o u s  c o l l e c t i o n  a n d  t e s t i n g  o f  
N P S  s a m p l e s  a s  a  p a r t  o f  n a t i o n a l  E W S :  
c h a l l e n g e s  a n d  a d v a n t a g e s .  A n d r e j a  D r e v ,  
S l o v e n i a  
−  E s t a b l i s h m e n t  o f  N G O  i n f o  p o i n t s  f o r  
N P S  s a m p l e  c o l l e c t i o n  w i t h i n  r e g i o n a l  
E W S  s y s t e m  i n  t h e  f r a m e w o r k  o f  I - S E E  
p r o j e c t .  A d a  H o č e v a r  G r o m ,  S l o v e n i a  
−  T h e  i n t e g r a t e d  d r u g  c h e c k i n g  s e r v i c e  a n d  
i t s  i m p o r t a n c e  f o r  d i f f e r e n t  t y p e s  o f  






rates. Hannah Fraser, United Kingdom potential drug consumption 
room in Dublin, Ireland. Emma 
Atkin-Brenninkmeyer, Ireland 
services in Catalonia, feasibility analysis of 
the assist tool. Joan Colom i Farran, Spain 
well tolerated and results in high 
SVR12 rates in patients receiving 
opioid substitution therapy. Jason 
Grebely, Australia 
− Public expenditure on drug 
treatment and associated 
comorbidities: the case-study of 
Bergamo. Sabrina Molinaro, Italy 
STRUCTURED SESSION 38 
Ayahuasca – why is 
classification so important? 
Chair: Mário Simões, Portugal  
STRUCTURED SESSION 39 
Prevention: from evidence to action – 
how we are working 
Chair: Joaquim Fonseca, Portugal 
STRUCTURED SESSION 40 
The universal prevention curriculum 
(UPC) adaptation in Europe: introduction 
and discussion on substantial content 
Chair: Annemie Coone, Belgium  
STRUCTURED SESSION 41 
Promoting the use of evidence-
based programmes in Europe: a 
European registry 
Chair: Gregor Burkhart, EMCDDA 
STRUCTURED SESSION 42 
Anonymous collecting and testing of new 
psychoactive substances samples as a part 
of national early warning systems (EWS) 
Chair: Simona Šabić, Slovenia 
Room 1.06 Room 1.05 Auditorium III Room 5C Room 1.09 
− Ethnical uses of Ayahuasca. 
Paulo Roberto Silva e Souza, 
Portugal  
− Ayahuasca’s therapeutic 
potential in drug addiction. 
Mário Simões and José Palma, 
Portugal 
− Ethnographic study on 
ayahuasca´s ritual healing 
from addiction. Piera Talin, 
Netherlands and Emilia 
Sanabria, France  
− Pharmacology of Ayahuasca. 
Olga Silva, Portugal 
− Ayahuasca uncertain legal 
status. Sofia Machado and 
Luís Santos, Portugal 
− School-based drug use prevention 
multicomponent model: a Lisbon 
and Tagus Valley Region 
Perspective. Isabel Prata, Portugal 
− ‘Me and Others’ programme: 
building standards-based narratives 
for prevention. Raúl Melo, Portugal 
− ‘Me and Others’ Programme – 
Outcome Evaluation: Lisbon and 
Tagus Valley Region sample (2015 
to 2017). Pre, post and follow up. 
Carla Frazão, Portugal 
− ‘Guidelines to deal with addictive 
behaviours’. Project, process and 
outcome evaluation. Rui Pedro Silva, 
Portugal 
− Why is a common training curriculum 
for Europe needed? Annemie Coone, 
Belgium 
− Getting to the UPC-curriculum and 
projecting this content on the 
participants own context. Sanela Talič, 
Slovenia, Katarzyna Okulicz, Poland and 
Maria Antónia Gomila, Spain 
− Substance use prevention training 
needs found in the involved countries 
and local prevention training needs of 
the participants. Annemie Coone, 
Belgium and Katarzyna Okulicz, Poland 
− A European registry of EBP. Marica 
Ferri and Gregor Burkhart, 
EMCDDA 
− The German registry of EBP: 
experiences with practice. 
Frederick Groeger-Roth, Germany 
− Reviewing and rating EBP for 
crime and drugs prevention in 
Europe: approach and 
methodological challenges. Nick 
Axford and Shreya Sonthalia, 
United Kingdom and Frederick 
Groeger-Roth, Germany 
− Discussion: How can such 
registries improve resource 
allocation in prevention? Fabrizio 
Faggiano, Italy and Zili Sloboda, 
United States 
− Anonymous collection and testing of 
NPS samples as a part of national EWS: 
challenges and advantages. Andreja Drev, 
Slovenia 
− Establishment of NGO info points for 
NPS sample collection within regional 
EWS system in the framework of I-SEE 
project. Ada Hočevar Grom, Slovenia 
− The integrated drug checking service and 
its importance for different types of 




14:30 – 16:00 PARALLEL SESSIONS   
PAPER SESSION 53 
Interconnected problems – spotlight   
on comorbidity 
Chair: Miguel Vasconcelos, Portugal 
PAPER SESSION 54 
Innovative methods in drug 
detection 
Chair: Félix Carvalho, Portugal 
PAPER SESSION 55 
Gambling – informing interventions 
Chair: Paula Marques, Portugal 
PAPER SESSION 56 
Innovation in harm reduction 
Chair: Rodrigo Coutinho, Portugal 
PAPER SESSION 57 
The challenge of responding in 
recreational settings 
Chair: Harry Sumnall, United Kingdom 
Room 5B Room 5A Auditorium IV Auditorium II Room 5C 
− Investigating possible causal 
associations of tobacco and cannabis 
use with mental health: a Mendelian 
randomisation analysis. Meg Fluharty, 
United Kingdom 
− Drug-related predictors of 
readmission for schizophrenia among 
patients admitted to treatment for 
drug use disorders. Kristine Rømer 
Thomsen, Denmark 
− Sex differences in psychiatric disorders 
among illicit drug users. Gail Gilchrist, 
United Kingdom 
− Alcohol- and drug-related problems 
among adolescents with psychiatric 
diagnoses: the role of psychiatric 
comorbidity. Ove Heradstveit, Norway 
− Father involvement and correlates of 
symptoms of depression and anxiety 
among fathers with drug addiction 
problems. João Barrocas, Portugal 
− The European drug emergencies 
network (Euro-DEN) project – a 
model for European data 
collection on acute drug and 
new psychoactive substance 
(NPS) toxicity. Paul Dargan, 
United Kingdom 
− The analysis of illicit drugs in 
Sydney wastewater. Anne 
Bannwarth, Switzerland 
− Wastewater analysis: source of 
information about the relation 
between frequently abused illicit 
drugs and music genre 
preferences. Paula 
Brandeburová, Slovakia 
− Teenagers and NPS in Poland – 
attitudes and behaviors. Tomasz 
Białas, Poland 
− Documenting the strategies and 
tactics used by the Australian 
gambling industry. A case study of 
clubs, casinos and the wagering 
industry. Samantha Thomas, Australia 
− Stigma and the involvement of 
people with gambling addiction in 
peer support and advocacy activities. 
Helen Miller, Australia 
− Parents, peers, or promotion? Which 
factors are the most influential in 
shaping children’s attitudes towards 
gambling? Hannah Pitt, Australia 
− Maladaptive metacognitive beliefs in 
pathological gambling: relationship 
with addictive behaviors and 
comorbid symptomatology. Paula 
Jauregui, Spain 
− The role of gambling advocacy 
strategies in gambling harm 
prevention and minimisation 
strategies. Samantha Thomas, 
Australia 
− Jegspiller.no – a new prevention tool 
for problems related to gambling and 
gaming. Camilla Bakkeng, Norway 
− Drug checking – an approach to 
prevent chemical anarchy: a 
scoping review. Helena Valente, 
Portugal 
− Chemsex, NPS and risk reduction 
management: preliminary results 
of a pilot study. Cécile Chevallier, 
France 
− Harm reduction 24/7: the supply 
of harm reduction materials via 
vending machines for drug users 
in Northrhine-Westfalia, Germany. 
Daniel Deimel, Germany 
− Disciplining pleasure through 
harm reduction policy: confronting 
drug users’ personal experience of 
injection in context with 
professionals’ public health 
expectations. Marie Jauffret-
Roustide, France 
− Alcohol consumption among party 
goers attending university parties. 
Samples from three years of harm 
reduction interventions in the field 
(2014 to 2016 in the region of 
Lisbon and Tagus valley). Marta 
Borges, Portugal 
− Social representations of drugs and 
drug abuse. Inquiry to the Portuguese 
youth present in three editions of 
Rock in Rio summer festival 
(2008/2012/2016). Elsa Lavado, 
Portugal 
− Stop SV: staff training on prevention 
of sexual violence. Fernando Mendes, 
Portugal 
− A randomized trial of assessment 
interventions to reduce drug use and 
HIV/STI sexual risk among young 
adults who use drugs in the club 
scene. Mance Buttram, United States 
− How often do ecstasy users in 
nightlife implement harm reduction 
strategies? Peggy van der Pol, 
Netherlands 
− Health consequences of substance 
use in nightlife settings in the 
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S T R U C T U R E D  S E S S I O N  4 3  
R e c o n c e p t u a l i z i n g  t h e  e t i o l o g y  o f  s u b s t a n c e  
u s e :  i m p l i c a t i o n s  f o r  p r e v e n t i o n  a n d  t r e a t m e n t  
C h a i r :  G r e g o r  B u r k h a r t ,  E M C D D A  
S T R U C T U R E D  S E S S I O N  4 4  
C o n t i n u u m  o f  c a r e  i n  t h e  p r i s o n  s e t t i n g ?  
R e s p o n s e s  t o  d r u g - r e l a t e d  i n f e c t i o n  t r a n s m i s s i o n  
i n  p r i s o n s  –  e x a m p l e s  f r o m  E u r o p e  
C h a i r :  D a g m a r  H e d r i c h ,  E M C D D A  
S T R U C T U R E D  S E S S I O N  4 5  
C r y s t a l  m e t h  a n d  t h e  f a m i l y  –  s t r e s s ,  s t r a i n ,  a n d  
i n t e r v e n t i o n s  
C h a i r :  M i c h a e l  K l e i n ,  G e r m a n y  
S T R U C T U R E D  S E S S I O N  4 6  
M u l t i d i s c i p l i n a r y  w o r k  i n  a  s c i e n t i f i c  
s o c i e t y  o f  a d d i c t i o n s  
C h a i r :  F r a n c i s c o  P a s c u a l ,  S p a i n  
R o o m  1 . 0 9  A u d i t o r i u m  I I I  R o o m  1 . 0 5  R o o m  1 . 0 6  
P a n e l  d i s c u s s i o n :  
−  P e r s o n a l i z i n g  a n d  o p t i m i z i n g  p r e v e n t i v e  
i n t e r v e n t i o n  m o d e l s  v i a  a  t r a n s l a t i o n a l  
n e u r o s c i e n c e  f r a m e w o r k .  D i a n a  F i s h b e i n ,  
U n i t e d  S t a t e s  
−  A  t r a n s l a t i o n a l  n e u r o s c i e n c e  f r a m e w o r k  –  
i m p l i c a t i o n s  f o r  u n d e r s t a n d i n g  e t i o l o g y  a n d  
p r e v e n t i o n  o f  s u b s t a n c e  u s e  a n d  s u b s t a n c e  
u s e  d i s o r d e r s .  Z i l i  S l o b o d a ,  U n i t e d  S t a t e s  
−  E t i o l o g y  o f  s u b s t a n c e  u s e :  i m p l i c a t i o n s  f o r  
t r e a t m e n t .  A l e s s a n d r o  P i r o n a ,  E M C D D A   
−  W r a p p i n g  u p :  g e n e t i c ,  e p i g e n e t i c  a n d  
e n v i r o n m e n t a l  f a c t o r s .  G i l b e r t o  G e r r a ,  
U N O D C  
−  D r u g  u s e  a n d  d r u g - r e l a t e d  i n f e c t i o n s  a m o n g  
p r i s o n e r s .  L i n d a  M o n t a n a r i ,  E M C D D A  
−  A c c e s s  t o  h a r m  r e d u c t i o n  –  t h e  e x a m p l e  o f  
F r a n c e .  L a u r e n t  M i c h e l ,  F r a n c e  
−  A c c e s s  t o  H C V  t r e a t m e n t  u n d e r  s p e c i a l  
c o n s i d e r a t i o n  i n  p r i s o n s  –  a c t i o n  r e s e a r c h  
A u s t r i a .  G a b r i e l e  F i s c h e r ,  A u s t r i a  
−  N e w  j o i n t  E u r o p e a n  g u i d a n c e  o n  r e s p o n d i n g  t o  
c o m m u n i c a b l e  d i s e a s e s  i n  p r i s o n  –  f o c u s  o n  
d r u g  u s e - r e l a t e d  i n f e c t i o n s .  L a r a  T a v o s c h i ,  E C D C  
−  E s t a b l i s h i n g  a n  i n t e g r a t e d  p e r i n a t a l  c a r e  p r o g r a m  f o r  
s u b s t a n c e - d e p e n d e n t  y o u n g  m o t h e r s .  U l r i c h  
Z i m m e r m a n n ,  G e r m a n y  
−  L i v i n g  s i t u a t i o n  o f  c h i l d r e n  f r o m  m e t h a m p h e t a m i n e -
i n v o l v e d  f a m i l i e s .  M i c h a e l  K l e i n ,  G e r m a n y  
−  P a r e n t i n g  s t r e s s  a n d  f a m i l i a l  c o p i n g  i n  t h e  c o n t e x t  o f  
p a r e n t a l  m e t h a m p h e t a m i n e  u s e .  J a n i n a  D y b a ,  
G e r m a n y  
−  S H I F T  –  A  p a r e n t i n g  i n t e r v e n t i o n  f o r  
m e t h a m p h e t a m i n e  a b u s i n g  m o t h e r s  a n d  f a t h e r s .  
D i a n a  M o e s g e n ,  G e r m a n y  
−  T r e a t m e n t  o f  m e t h a m p h e t a m i n e  a d d i c t s  i n  c l i n i c a l  
p r a c t i c e .  K a t h a r i n a  S c h o e t t ,  G e r m a n y  
−  A  s o c i o l o g i c a l  s t u d y  o n  a l c o h o l  a n d  
c a n n a b i s  u s e  a m o n g  y o u n g  p e o p l e  i n  
S p a i n .  G e r a r d o  F l o r e z ,  S p a i n  
−  S o c i d r o g a l c o h o l  S p a n i s h  n a t i o n a l  
s u r v e y  o n  p r e v a l e n c e  a n d  t r e a t m e n t  
o f  c o - o c u r r e n c e  o f  s u b s t a n c e  u s e  
d i s o r d e r  a n d  o t h e r  m e n t a l  h e a l t h  
d i s o r d e r .  J u a n  J o s é  F e r n á n d e z ,  S p a i n  
−  T h e  R I N C A  S t u d y  o n  t h e  R e d u c t i o n  o f  
N e g a t i v e  I n c i d e n c e s  a s s o c i a t e d  t o  
e x c e s s i v e  A l c o h o l  C o n s u m p t i o n .  J o s e p  
G u a r d i a ,  S p a i n  
  
1 6 : 0 0  –  1 6 : 3 0  C o f f e e  b r e a k  
 
1 6 : 3 0  
W R A P  U P  A N D  C L O S I N G  S E S S I O N  
 
A u d i t o r i u m  I  
 
 
P r o g r a m m e  C o m m i t t e e  m e m b e r s :    
M a n u e l  C a r d o s o ,  S I C A D  
P a u l  G r i f f i t h s ,  E M C D D A  
R o b e r t  W e s t ,  A d d i c t i o n / S o c i e t y  f o r  t h e  S t u d y  o f  A d d i c t i o n s  






STRUCTURED SESSION 43 
Reconceptualizing the etiology of substance 
use: implications for prevention and treatment 
Chair: Gregor Burkhart, EMCDDA 
STRUCTURED SESSION 44 
Continuum of care in the prison setting? 
Responses to drug-related infection transmission 
in prisons – examples from Europe 
Chair: Dagmar Hedrich, EMCDDA 
STRUCTURED SESSION 45 
Crystal meth and the family – stress, strain, and 
interventions 
Chair: Michael Klein, Germany 
STRUCTURED SESSION 46 
Multidisciplinary work in a scientific 
society of addictions 
Chair: Francisco Pascual, Spain 
Room 1.09 Auditorium III Room 1.05 Room 1.06 
Panel discussion: 
− Personalizing and optimizing preventive 
intervention models via a translational 
neuroscience framework. Diana Fishbein, 
United States 
− A translational neuroscience framework – 
implications for understanding etiology and 
prevention of substance use and substance 
use disorders. Zili Sloboda, United States 
− Etiology of substance use: implications for 
treatment. Alessandro Pirona, EMCDDA  
− Wrapping up: genetic, epigenetic and 
environmental factors. Gilberto Gerra, 
UNODC 
− Drug use and drug-related infections among 
prisoners. Linda Montanari, EMCDDA 
− Access to harm reduction – the example of 
France. Laurent Michel, France 
− Access to HCV treatment under special 
consideration in prisons – action research 
Austria. Gabriele Fischer, Austria 
− New joint European guidance on responding to 
communicable diseases in prison – focus on 
drug use-related infections. Lara Tavoschi, ECDC 
− Establishing an integrated perinatal care program for 
substance-dependent young mothers. Ulrich 
Zimmermann, Germany 
− Living situation of children from methamphetamine-
involved families. Michael Klein, Germany 
− Parenting stress and familial coping in the context of 
parental methamphetamine use. Janina Dyba, 
Germany 
− SHIFT – A parenting intervention for 
methamphetamine abusing mothers and fathers. 
Diana Moesgen, Germany 
− Treatment of methamphetamine addicts in clinical 
practice. Katharina Schoett, Germany 
− A sociological study on alcohol and 
cannabis use among young people in 
Spain. Gerardo Florez, Spain 
− Socidrogalcohol Spanish national 
survey on prevalence and treatment 
of co-ocurrence of substance use 
disorder and other mental health 
disorder. Juan José Fernández, Spain 
− The RINCA Study on the Reduction of 
Negative Incidences associated to 
excessive Alcohol Consumption. Josep 
Guardia, Spain 
  
16:00 – 16:30 Coffee break 
 
16:30 





Programme Committee members:   
Manuel Cardoso, SICAD 
Paul Griffiths, EMCDDA 
Robert West, Addiction/Society for the Study of Addictions 






 DAY 1  TUESDAY 24 OCTOBER 
 
11:30 – 13:00 POSTER SESSIONS Pavilions 4 and 5 
 
POSTER SESSION 1 
Reducing risks 
POSTER SESSION 2 
Clinical tools 
− Analysis and sociodemographic characterization of drug users in the 
context of harm reduction intervention in the north region of Portugal. 
Isabel Ponte, Portugal 
− Last party polysubstance use profiles: consequences and settings for use. 
Oscar Lozano-Rojas, Spain 
− Risk to heroin users of poly-drug use of pregabalin or gabapentin. 
Graeme Henderson, United Kingdom 
− Severity and management of drug interactions in the pharmacological 
management of alcohol use disorders. Lanfranco Pellesi, Italy 
− Alcohol misuse among low-threshold harm reduction clients: an action-
research group for alcohol risks. Ximene Rego, Portugal 
− Consequences of alcohol use in work-related settings: results from a 
survey among Norwegian employees. Inger Synnøve Moan, Norway 
− Benzodiazepine abuse in the elderly. Duarte Pinheiro, Portugal 
− Factors associated with the severity of cocaine dependence (smoked and 
snorted) among outpatients in a Brazilian sample. Sandra Cristina Pillon, 
Brazil 
− Health behaviors and addiction severity among users of cocaine and crack 
in a Brazilian sample. Sandra Cristina Pillon, Brazil 
− Vilnius primary school children wellbeing at school and their perception 
of health. Olga Ubartienė, Lithuania 
− Harm reduction by changing environment – considerations and 
evaluation of the implementation of safernightlife label in a nightlife 
district in Lisbon. Cristiana Vale Pires, Portugal 
− Nicotine abuse and parental influence: are there sex differences? Sonila 
Bitri, Albania  
− Co-occurrence of psychiatric diseases in patients with cannabis use 
disorders. Sonila Bitri, Albania 
− Brief multimedia intervention (BMI) video for reducing hazardous and harmful consumption. Tereza Barroso, 
Portugal 
− Game addiction scale: translation and adaptation among Portuguese adolescents. Tereza Barroso, Portugal 
− Motor learning alterations in chronic cannabis users. Laia Miquel, Spain 
− Compulsive sexual behaviour treatment, current state analysis: case report. Haifa Zalila, Tunisia 
− Sex differences in early withdrawal syndrome of patients with alcohol use disorder. Cohort study in the Spanish 
network on addictive disorders. Roberto Muga, Spain 
− Severity of dependence scale: diagnostic cut-off for pharmaceutical opioid dependence. Raimondo Bruno, Australia 
− How to identify food addiction. Duarte Pinheiro, Portugal 
− The effect of group therapy on abstinence of people addicted to alcohol and people addicted to gambling. Jana 
Bolkova, Czech Republic 
− Predicting early treatment termination (drop-out) from neuropsychological functions in abstinent substance use 
dependent (SUD) patients. Arne Holen, Norway 
− Psychopathological profile of drug users undergoing treatment in a residential detoxification. Sónia Esteves, 
Portugal 
− Therapeutic processes in dialectical behavior therapy skills training for alcohol use disorder treatment: motivation 
for change and coping skills. Marco Cavicchioli, Italy 
− Alcohol use disorders identification test (audit) and mortality risk in US Veterans and international population: a 
systematic review and meta-analysis. Sören Kuitunen-Paul, Germany 
− A portrait of the fellowship of alcoholics anonymous in Portugal. Mário Marques, Portugal 
− Contingency management for abstinence versus contingency management for shaping cessation among treatment–
seeking patients from the general population. Alba González-Roz, Spain 
− Buprenorphine for mood stability in dually diagnosed patients. Hassan Dinakar, United States 
− Motivations, cognitive distortions and impulsivity in a sample of male gamblers. Isabelle Varescon, France 
− Investigating the synergistic effects of aerobic exercise and rTMS on brain network plasticity and cognitive function. 
Joshua Hendrikse, Australia 
− Feasibility and effectiveness of a SBIRT program for hazardous drinkers in an emergency department: a randomized 
controlled trial. Pol Bruguera, Spain 
− Prevalence and therapy of methamphetamine dependence (“crystal”). Stefanie Neumann, Germany 
 
D A Y  1
1 3 : 1 5  –  1 4 : 1 5  
P O S T E R  S E S S I O N S  
P a v i l i o n s  4  a n d  5  
 
P O S T E R  S E S S I O N  3  
S p e c i f i c  t a r g e t  p o p u l a t i o n s  
P O S T E R  S E S S I O N  4  
U n d e r s t a n d i n g  h e a l t h  c o n s e q u e n c e s  
−  C o n t i n g e n c y  m a n a g e m e n t  f o r  d r u g  u s e  i n  t r e a t m e n t  f o r  o p i a t e  a d d i c t i o n :  a  s y s t e m a t i c  r e v i e w  
a n d  m e t a - a n a l y s i s .  T o m  A i n s c o g h ,  U n i t e d  K i n g d o m  
−  W h o  a r e  t h e  a b s t a i n e r s ?  R e s u l t s  f r o m  t h e  2 0 1 7  P o r t u g u e s e  g e n e r a l  p o p u l a t i o n  s u r v e y .  C l a r a  
V i t a l ,  P o r t u g a l  
−  C h a r a c t e r i z a t i o n  o f  u n d e r a g e  p a t i e n t s  w i t h  a l c o h o l  a n d  s u b s t a n c e - r e l a t e d  i n t o x i c a t i o n s  
a d m i t t e d  t o  a n  e m e r g e n c y  d e p a r t m e n t  i n  m e t r o p o l i t a n  B a r c e l o n a .  R o b e r t o  M u g a ,  S p a i n  
−  I s  d o s e  p e r  j o i n t  a  r e l i a b l e  c a n n a b i s  u s e  m e t r i c ?  I n v e s t i g a t i n g  c a n n a b i s  a n d  t o b a c c o  i n  j o i n t s  
a n d  i f  t h e y  a r e  i n f l u e n c e d  b y  a c u t e  d r u g  a d m i n i s t r a t i o n .  C h a n d n i  H i n d o c h a ,  U n i t e d  K i n g d o m  
−  S c r e e n i n g  f o r  c o n t i n u e d  s u b s t a n c e  u s e  a m o n g  s u b j e c t s  o n  b u p r e n o r p h i n e  m a i n t e n a n c e  
t r e a t m e n t :  a  c r o s s - s e c t i o n a l  s t u d y .  S u r e s h  T h a p a l i y a ,  N e p a l  
−  M o t i v e s  t o  u s e  a l c o h o l  a m o n g  P o r t u g u e s e  a d o l e s c e n t s .  C á t i a  B r a n q u i n h o ,  P o r t u g a l  
−  B e h a v i o r a l  d e t e r m i n a n t s  o f  r i s k y  a l c o h o l  u s e  i n i t i a t i o n  i n  a t - r i s k  a d o l e s c e n t s .  P a u l a  D i a s ,  
P o r t u g a l  
−  W h i c h  a n s w e r s  t o  t h e  c o n s u m p t i o n  o f  c a n n a b i s  i n  a d o l e s c e n c e .  C A P P Y C  a  p o s s i b l e  s t r a t e g y .  
E l s a  F é ,  P o r t u g a l  
−  A D H D  a n d  H C V  p r e v a l e n c e  i n  a  s t a n d a r d i z e d  i n v e s t i g a t i o n  i n  A u s t r i a n  p r i s o n s  i n  o p i o i d  
m a i n t a i n e d  s u b j e c t s  a n d  i m p r i s o n e d  a d o l e s c e n t s .  M a r i s a  S i l b e r n a g l ,  A u s t r i a  
−  L i f e  s i t u a t i o n  o f  o l d e r  p a t i e n t s  i n  o p i o i d  m a i n t e n a n c e  t r e a t m e n t .  S v e r r e  M a r t i n  N e s v å g  a n d  
Z h a n n a  G a u l e n ,  N o r w a y  
−  C h a r a c t e r i s t i c s  o f  c u r r e n t  a n d  p o t e n t i a l  a t t e n d e r s  o f  d r u g  c o n s u m p t i o n  r o o m s  a m o n g  p e o p l e  
w h o  i n j e c t  d r u g s  ( P W I D )  f r o m  t h e  C O S I N U S  c o h o r t  s t u d y  –  e v a l u a t i o n  o f  h a r m  r e d u c t i o n  p o l i c y  
i n  F r a n c e .  M a r i e  J a u f f r e t - R o u s t i d e ,  F r a n c e  
−  A l c o h o l  m i s u s e  r i s k  f a c t o r s  a m o n g  y o u t h .  M i r j a m  T ü ü r ,  E s t o n i a  
−  C a n n a b i s  u s e  a n d  s c h i z o p h r e n i a :  c l i n i c a l  a n d  t h e r a p e u t i c  i m p a c t  o f  c o m o r b i d i t y .  E m i r a  K h e l i f a ,  
T u n i s i a  
−  T h e  e f f e c t s  o f  c o - a d m i n i s t r a t i o n  o f  m e p h e d r o n e  a n d  n i c o t i n e  o r  M D M A  o n  a n x i e t y - ,  
d e p r e s s i o n -  a n d  m e m o r y - r e l a t e d  b e h a v i o r s  i n  m i c e .  G r a ż y n a  B i a ł a ,  P o l a n d  
−  I n v e s t i g a t i n g  t h e  n a t u r e  a n d  s e v e r i t y  o f  d e p r e s s i v e  e x p e r i e n c e s  i n  a d u l t s  w h o  s e l f - m e d i c a t e  l o w  
m o o d  w i t h  a l c o h o l .  R a c h e l  M c  H u g h ,  U n i t e d  K i n g d o m  
−  A y a h u a s c a :  p a t t e r n s  o f  u s e ,  m e n t a l  h e a l t h  o f  u s e r s  a n d  s u b j e c t i v e  e f f e c t s  i n  a  l a r g e  
i n t e r n a t i o n a l  s a m p l e .  W i l l  L a w n ,  U n i t e d  K i n g d o m  
−  S y n t h e t i c  c a n n a b i n o i d s  u s e  a n d  i n c r e a s e  o f  c a n n a b i s  h y p e r e m e s i s  s y n d r o m e s :  i s  t h e r e  a  l i n k ?  
R e y n a l d  L e  B o i s s e l i e r ,  F r a n c e  
−  A n  o b s e r v a t i o n a l  s t u d y  o f  t h e  s e v e r i t y  o f  r e s p i r a t o r y  d e p r e s s i o n  i n  c h r o n i c  o p i o i d  d e p e n d e n c e .  
B a s a k  T a s ,  U n i t e d  K i n g d o m  
−  M o n i t o r i n g  d e a t h s  r e l a t e d  t o  d r u g  u s e  a n d  m o r t a l i t y  a m o n g  d r u g  u s e r s  i n  E u r o p e :  t h e  d r u g -
r e l a t e d  d e a t h s  i n d i c a t o r  ( D R D ) .  I s a b e l l e  G i r a u d o n ,  E M C D D A  
−  M o n i t o r i n g  i n f e c t i o u s  d i s e a s e s  a m o n g  d r u g  u s e r s :  t h e  d r u g - r e l a t e d  i n f e c t i o u s  d i s e a s e s  
i n d i c a t o r  ( D R I D ) .  I s a b e l l e  G i r a u d o n ,  E M C D D A  
−  S e x  a d d i c t i o n ,  p a t h o l o g i c a l  g a m b l i n g  a n d  i m p u l s i v e n e s s  t r a i t s  i n  a m o n g  d r u g  u s e r s  i n  a  
B r a z i l i a n  c o n t e x t .  S a n d r a  C r i s t i n a  P i l l o n ,  B r a z i l  
−  C o c a i n e  c o n s u m p t i o n  i n  n o n  i n j e c t a b l e  u s e r s :  i n t e r f a c e  w i t h  u s e r s ’  q u a l i t y  o f  l i f e .  S a n d r a  
C r i s t i n a  P i l l o n ,  B r a z i l  
−  M o r t a l i t y  a m o n g  h i g h  r i s k  d r u g  u s e r s  d i a g n o s e d  w i t h  o p i o i d - ,  s t i m u l a n t -  o r  p o l y d r u g  d i s o r d e r s :  
a  N o r w e g i a n  r e g i s t r y  f o l l o w - u p  s t u d y  o f  t h e  t o t a l  c o h o r t  s t a r t i n g  t r e a t m e n t  i n  2 0 0 9 – 1 0 .  A n n e -
K a r i n e  M a r k e n g  M e l s o m ,  N o r w a y  
−  S e l f - m a n a g e m e n t  e d u c a t i o n  f o r  w o m e n  w i t h  d r u g  a d d i c t i o n .  K a t h r i n e  N i l s e n ,  N o r w a y  
−  H e a l t h  l i t e r a c y  o f  e m p l o y e e s  o f  c h i l d r e n  e d u c a t i o n a l  i n s t i t u t i o n s .  O l g a  U b a r t i e n ė ,  L i t h u a n i a  
−  B e n z o d i a z e p i n e  a b u s e  a n d  d e p e n d e n c e  a m o n g  p a t i e n t s  w i t h  s e v e r e  m e n t a l  i l l n e s s .  J o a n a  I s a a c ,  
P o r t u g a l  
−  P r e l i m i n a r y  r e s u l t s  a n d  p u b l i c a t i o n  i m p a c t  o f  a  d e d i c a t e d  a d d i c t i o n  c l i n i c i a n  s c i e n t i s t  r e s e a r c h  
f e l l o w s h i p .  J a n  K l i m a s ,  I r e l a n d  





13:15 – 14:15 
POSTER SESSIONS 
Pavilions 4 and 5 
 
POSTER SESSION 3 
Specific target populations 
POSTER SESSION 4 
Understanding health consequences 
− Contingency management for drug use in treatment for opiate addiction: a systematic review 
and meta-analysis. Tom Ainscogh, United Kingdom 
− Who are the abstainers? Results from the 2017 Portuguese general population survey. Clara 
Vital, Portugal 
− Characterization of underage patients with alcohol and substance-related intoxications 
admitted to an emergency department in metropolitan Barcelona. Roberto Muga, Spain 
− Is dose per joint a reliable cannabis use metric? Investigating cannabis and tobacco in joints 
and if they are influenced by acute drug administration. Chandni Hindocha, United Kingdom 
− Screening for continued substance use among subjects on buprenorphine maintenance 
treatment: a cross-sectional study. Suresh Thapaliya, Nepal 
− Motives to use alcohol among Portuguese adolescents. Cátia Branquinho, Portugal 
− Behavioral determinants of risky alcohol use initiation in at-risk adolescents. Paula Dias, 
Portugal 
− Which answers to the consumption of cannabis in adolescence. CAPPYC a possible strategy. 
Elsa Fé, Portugal 
− ADHD and HCV prevalence in a standardized investigation in Austrian prisons in opioid 
maintained subjects and imprisoned adolescents. Marisa Silbernagl, Austria 
− Life situation of older patients in opioid maintenance treatment. Sverre Martin Nesvåg and 
Zhanna Gaulen, Norway 
− Characteristics of current and potential attenders of drug consumption rooms among people 
who inject drugs (PWID) from the COSINUS cohort study – evaluation of harm reduction policy 
in France. Marie Jauffret-Roustide, France 
− Alcohol misuse risk factors among youth. Mirjam Tüür, Estonia 
− Cannabis use and schizophrenia: clinical and therapeutic impact of comorbidity. Emira Khelifa, 
Tunisia 
− The effects of co-administration of mephedrone and nicotine or MDMA on anxiety-, 
depression- and memory-related behaviors in mice. Grażyna Biała, Poland 
− Investigating the nature and severity of depressive experiences in adults who self-medicate low 
mood with alcohol. Rachel Mc Hugh, United Kingdom 
− Ayahuasca: patterns of use, mental health of users and subjective effects in a large 
international sample. Will Lawn, United Kingdom 
− Synthetic cannabinoids use and increase of cannabis hyperemesis syndromes: is there a link? 
Reynald Le Boisselier, France 
− An observational study of the severity of respiratory depression in chronic opioid dependence. 
Basak Tas, United Kingdom 
− Monitoring deaths related to drug use and mortality among drug users in Europe: the drug-
related deaths indicator (DRD). Isabelle Giraudon, EMCDDA 
− Monitoring infectious diseases among drug users: the drug-related infectious diseases 
indicator (DRID). Isabelle Giraudon, EMCDDA 
− Sex addiction, pathological gambling and impulsiveness traits in among drug users in a 
Brazilian context. Sandra Cristina Pillon, Brazil 
− Cocaine consumption in non injectable users: interface with users’ quality of life. Sandra 
Cristina Pillon, Brazil 
− Mortality among high risk drug users diagnosed with opioid-, stimulant- or polydrug disorders: 
a Norwegian registry follow-up study of the total cohort starting treatment in 2009–10. Anne-
Karine Markeng Melsom, Norway 
− Self-management education for women with drug addiction. Kathrine Nilsen, Norway 
− Health literacy of employees of children educational institutions. Olga Ubartienė, Lithuania 
− Benzodiazepine abuse and dependence among patients with severe mental illness. Joana Isaac, 
Portugal 
− Preliminary results and publication impact of a dedicated addiction clinician scientist research 
fellowship. Jan Klimas, Ireland 
− Payers and patient segmentation.  Mark Gilman, United Kingdom 
 
 
14:30 – 16:00 POSTER SESSIONS Pavilions 4 and 5 
 
POSTER SESSION 5 
Prevention: theory and practice 
POSTER SESSION 6 
Constructing addictions: theories, methodology and measurement 
− A systematic review of internet addiction prevention interventions. Roman Gabrhelík, Czech 
Republic 
− Eastern Porto school survey project on tobacco, alcohol and cannabis. Ana Tavares, Portugal 
− Lifestyle and psychosocial factors in risk consumption of cannabis. Cátia Coutinho, Portugal 
− The utilization of a creative strategy in the prevention of the use of psychoactive substances 
with children and adolescents. Jorge Jaber Filho, Brazil 
− Prevention program for children and adolescents at the age of 8-15 years old who grow up in 
a problematic family environment. Maria Prodromou, Cyprus 
− Differences in gambling motives by gambling severity and activities in adolescents. Aris 
Grande-Gosende, Spain 
− Alcohol quiz: truth or dare?!! Interactive game to develop knowledge about alcohol among 
adolescents. Tereza Barroso, Portugal 
− Internet and gambling among students of Porto eastern zone. Anabela Monteiro, Portugal 
− Riscos & Desafios Program: process evaluation. Carla Rocha, Portugal. 
− Prevention in higher education context: the Riscos & Desafios Program. Carla Rocha and Gizela 
Cardoso, Portugal and Elisardo Becoña, Spain 
− Conception, implementation and evaluation of a model promoting the prevention of risk 
behaviours, associated to the consumption of psychoactive substances, among young people. 
Paula Costa, Portugal 
− Polydrug users’ consumption profiles and their relationship with dsm-5 personality facets. 
Oscar Lozano-Rojas, Spain 
− The gaming disorder symptoms: DSM-5 vs. ICD 11. Seung-Yup Lee, South Korea 
− Craving in the diagnoses of alcohol use disorder. Emeline Chauchard, France 
− Estimating high-risk opioid use in Europe within the PDU indicator. Thomas Seyler, EMCDDA 
− Pedagogical and legal activities conduct in Poland for people addicted to alcohol. Joanna 
Rajewska de Mezer, Poland 
− Spirituality behind the bars: meditation as a treatment of drug addiction in a correctional 
setting. Felice Nava, Italy 
− Psychopathological profile of gamblers on treatment. Juan Lamas, Spain 
− Understanding gambling addiction. An analysis of the discourses produced by psychologists, 
psychiatrists and general practitioners. Tiziana Marinaci, Italy 
− Physical activity and sports practice associated with substance use by adolescents. Sandra 
Reinolds Rebolo, Portugal 
− Personality profiles in substance use disorders: do they differ on clinical symptomatology, 
personality disorders and coping? Els Santens, Belgium 
− Stigmatizing attitudes among healthcare professionals in the Middle East: a randomized study 
of medical students’ attitudes toward persons with alcohol and tobacco use disorders. Salman 
Alzayani, Bahrain 
− Drugs in combat: uses and meanings of psychoactive substances in the Portuguese colonial 
war. Vasco Calado, Portugal 
− Adaptation and psychometric properties of the marijuana effect expectancy questionnaire 
(MEEQ) in Peruvian adolescents. Fiorella Otiniano, Peru 
− Pathological gambling and impulsivity: comparison of the different. Pinhas Dannon, Israel 
− Marijuana consumption in Lima teenagers: the role of expectations and other risk factors. 









D A Y  1
1 6 : 3 0  –  1 8 : 0 0  
P O S T E R  S E S S I O N S   
P a v i l i o n s  4  a n d  5  
 
P O S T E R  S E S S I O N  7  
D e m o g r a p h i c  c h a l l e n g e s  
P O S T E R  S E S S I O N  8  
R e s e a r c h :  e t h i c s ,  m e t h o d s  a n d  p r a c t i c e  
−  S t a t e  a n d  t r a i t  a n x i e t y  a n d  d e p r e s s i o n ,  e v a l u a t i o n  o f  t h e  t i m e  p e r s p e c t i v e s  o f  o p i a t e  a d d i c t s  
w h o  a r e  o n  a  s u b s t i t u t i o n  m e t h a d o n e  a n d  b u p r e n o r p h i n e  t h e r a p y .  K a r l o  K a r h e r ,  S e r b i a  
−  V i o l e n t  s i t u a t i o n s  i n  a  p s y c h o s o c i a l  a t t e n t i o n  c e n t e r  f o r  a l c o h o l  a n d  o t h e r  d r u g s .  F e r n a n d a  
S i l v e i r a  d e  S o u z a ,  B r a z i l  
−  I n v e s t i g a t i n g  d r u g  u s e r s  s e e k i n g  t r e a t m e n t  t h r o u g h  e c o n o m i c  r e s t r a i n s  i n  G r e c e :  a  1 0  y e a r  
l o n g i t u d i n a l  s t u d y .  G e r a s i m o s  P a p a n a s t a s a t o s ,  G r e e c e  
−  T h e  o p i o i d  d e p e n d e n c e  i n  t h e  e l d e r l y  –  t h e  n e w  o l d  a g e .  C a r l o s  V a s c o n c e l o s ,  P o r t u g a l  
−  D e v e l o p m e n t  o f  H e p f r i e n d ;  a  D u b l i n  c o m m u n i t y  h e p a t i t i s  C  p e e r  s u p p o r t  m o d e l  f o r  P W I D ' s .  
J o h n  L a m b e r t ,  I r e l a n d  
−  T o b a c c o  u s e  d i s o r d e r s  i n  A l b a n i a n  p o p u l a t i o n .  S o n i l a  B i t r i ,  A l b a n i a  
−  A d d i c t e d  s o m e w h e r e ,  a d d i c t e d  e v e r y w h e r e .  H a i f a  Z a l i l a ,  T u n i s i a  
−  F a m i l y  e c o n o m i c  c i r c u m s t a n c e s  i n  c h i l d h o o d  a n d  s u b s t a n c e  u s e  i n  a d o l e s c e n c e .  J e n s  C h r i s t o f f e r  
S k o g e n ,  N o r w a y  
−  C o n s u m p t i o n  i n  r e c r e a t i o n a l  c o n t e x t s :  y o u n g  p e o p l e ´ s  i n q u i r i e s  i n  a  y o u t h  f e s t i v a l  –  “ V i l a “  
( L o u s a d a ) .  J o r g e  B a r b o s a ,  P o r t u g a l  
−  B i b l i o m e t r i c  b e n c h m a r k i n g  o n  s u b s t a n c e  a b u s e  a m o n g  E u r o p e a n  U n i o n  v s .  U n i t e d  S t a t e s  
( 2 0 0 8 – 2 0 1 2 ) .  R a f a e l  A l e i x a n d r e - B e n a v e n t ,  S p a i n  
−  T h e  1 0 0  m o s t  c i t e d  E u r o p e a n  U n i o n  p a p e r s  i n  s u b s t a n c e  a b u s e  j o u r n a l s .  R a f a e l  A l e i x a n d r e -
B e n a v e n t ,  S p a i n  
−  P r e v a l e n c e  a n d  p a t t e r n s  o f  d r u g  u s e  i n  t h e  g e n e r a l  p o p u l a t i o n  i n  i n d i c a t o r  ( “ G P S ” ) .  J o ã o  M a t i a s ,  
E M C D D A  
−  T h e  e f f e c t  o f  t h e  m o d e s  o f  r e s p o n s e  o n  t h e  s t r u c t u r e  o f  a  s o c i a l  r e p r e s e n t a t i o n :  t h e  e x a m p l e  o f  
t h e  r e p r e s e n t a t i o n s  o n  a t t i t u d e s  t o w a r d s  r i s k  b e h a v i o u r s .  C l a u d i a  U r b a n o ,  P o r t u g a l  
−  F i r s t  n a t i o n a l  s t u d y  o n  p r o b l e m a t i c  d r u g  u s e r s  i n  A l b a n i a  2 0 1 5 .  S i z e  e s t i m a t e s  a n d  p a t t e r n s  o f  




16:30 – 18:00 
POSTER SESSIONS  
Pavilions 4 and 5 
 
POSTER SESSION 7 
Demographic challenges 
POSTER SESSION 8 
Research: ethics, methods and practice 
− State and trait anxiety and depression, evaluation of the time perspectives of opiate addicts 
who are on a substitution methadone and buprenorphine therapy. Karlo Karher, Serbia 
− Violent situations in a psychosocial attention center for alcohol and other drugs. Fernanda 
Silveira de Souza, Brazil 
− Investigating drug users seeking treatment through economic restrains in Grece: a 10 year 
longitudinal study. Gerasimos Papanastasatos, Greece 
− The opioid dependence in the elderly – the new old age. Carlos Vasconcelos, Portugal 
− Development of Hepfriend; a Dublin community hepatitis C peer support model for PWID's. 
John Lambert, Ireland 
− Tobacco use disorders in Albanian population. Sonila Bitri, Albania 
− Addicted somewhere, addicted everywhere. Haifa Zalila, Tunisia 
− Family economic circumstances in childhood and substance use in adolescence. Jens Christoffer 
Skogen, Norway 
− Consumption in recreational contexts: young people´s inquiries in a youth festival – “Vila“ 
(Lousada). Jorge Barbosa, Portugal 
− Bibliometric benchmarking on substance abuse among European Union vs. United States 
(2008–2012). Rafael Aleixandre-Benavent, Spain 
− The 100 most cited European Union papers in substance abuse journals. Rafael Aleixandre-
Benavent, Spain 
− Prevalence and patterns of drug use in the general population in indicator (“GPS”). João Matias, 
EMCDDA 
− The effect of the modes of response on the structure of a social representation: the example of 
the representations on attitudes towards risk behaviours. Claudia Urbano, Portugal 
− First national study on problematic drug users in Albania 2015. Size estimates and patterns of 




 DAY 2 WEDNESDAY 25 OCTOBER 
 
11:00 – 12:30 POSTER SESSIONS Pavilions 4 and 5 
POSTER SESSION 9 
New methods and analyses 
POSTER SESSION 10 
Impact of new technologies 
POSTER SESSION 11 
Dynamics and change 
− Alternative to coercive measures for drug-related minor offences: the 
principle of proportionate sentencing in effective policies. Gerasimos 
Papanastasatos, Greece 
− Registration of treatment demands for substance use disorders in 
Belgium: what are the factors linked with the utilisation of the client´s 
national register number? Jérôme Antoine, Belgium 
− Investigating possible causal associations of tobacco and cannabis use 
with mental health: a Mendelian randomisation analysis. Meg Fluharty, 
United Kingdom 
− Self-administration of cocaine and methamphetamine in drosophila 
melanogaster. Ana Filošević, Croatia 
− Innovative methods for exploring new drug-related trends and threats: 
the EMCDDA Trendspotter methodology. Manuel Jesús Ruiz Muñoz, 
Spain 
− Searching across diagnostic silos: phenotyping compulsive behaviours 
via online crowdsourcing. Rico Lee, Australia 
− Testing a festival’s wastewater. Lisa Benaglia, Switzerland 
− Methamphetamine, venlafaxine and tramadol – potential threat to 
aquatic environment. Paula Brandeburová, Slovakia 
− Gamification: the future of cognitive testing? Rico Lee, Australia 
− Is problematic internet use associated with loneliness, 
relationship status, and family functioning? A study in 
Portuguese adolescents and young adults. Ivone Patrão, 
Portugal 
− The relationship between smartphone addiction and 
personality characteristics in a Portuguese sample. Ivone 
Patrão, Portugal 
− Gambling behaviour on mobile devices in Switzerland. 
Raoul Bitar, Switzerland 
− Family life appropriated by the virtual space. Sharenting as a 
new form of internet addiction. Joanna Sikorska, Poland 
− Internet pornography: an addiction disorder without 
substance. Hugo Afonso, Portugal 
− Long-term safety, tolerability and effectiveness of weekly 
and monthly buprenorphine depot (CAM2038) for opioid 
use disorder. Adrian Dunlop, Australia 
− Internet gaming disorder symptom severity predicts 
dysfunctional decision-making. Anja Kräplin, Germany 
− Relationship of smartphone use severity, sleep quality and 
depression in university students. Emira Khelifa, Tunisia 
− Two intensity patterns of drug use within the Portuguese 
population – cross national and longitudinal analysis. 
Casimiro Balsa, Portugal 
− Changes over time (1995-2015), across Europe, in global 
substance use patterns, among teenagers, and its 
relations with perceptions of availability, risk and 
parental attitudes toward substance use. Fernanda 
Feijão, Portugal 
− The influence of progesterone in cigarette smoking and 
possible uses in nicotine addiction. Guadalupe Marinho, 
Portugal 
− Prevalence and psychosocial predictors of performance 
enhancing substances use in physical activity settings: a 
systematic review. Ana Tavares, Portugal 
− Women’s psychotropic trajectories: life events and drug 
use patterns. Ximene Rego, Portugal 
− Trends in drug and alcohol treatment in prison from 
2009 to 2014 in Ireland. Aoife Cannon, Ireland 
 
 
12:45 – 14:15 POSTER SESSIONS Pavilions 4 and 5 
 
POSTER SESSION 12 
Policy and programme evaluation 
POSTER SESSION 13 
Multiple voices 
− Evaluation of a non-smoking program in psychiatric clinic. Jorge Jaber Filho, Brazil 
− Cost-benefit analysis of medication assisted treatment and needle-syringe programs in 
Georgia. Irma Kirtadze, Georgia 
− Drug policy impact assessment for change. Daria Matyushina, Lithuania 
− Deployment of the needle exchange program (NEP) in primary care centres and pharmacies: 
the experience and future proposal of public health agency of Catalonia (ASPCAT) in Girona. 
− Patient participation in guideline development: the Dutch experience. Elske Wits, Netherlands 
− ‘vi(r)agem’. Natércia Rodrigues, Portugal 
− Suit model & methodology of peer led empowerment. Sunny Dhadley, United Kingdom 
− Only variety (complexity) can respond to variety (complexity) - W. Ross Ashby. Ilinka  Serdarević, 
Croatia 
− When recovery meets desistance. Charlotte Colman, Belgium 
33
D A Y  2
 
 
1 4 : 3 0  –  1 6 : 0 0  
P O S T E R  S E S S I O N S  
P a v i l i o n s  4  a n d  5  
 
P O S T E R  S E S S I O N  1 4  
D r u g - r e l a t e d  c r i m e  a n d  t h e  i l l i c i t  m a r k e t  
P O S T E R  S E S S I O N  1 5  
R e s p o n d i n g  t o  d i v e r s i t y  
P O S T E R  S E S S I O N  1 6  
I n t e g r a t i n g  c a r e  m o d e l s  a n d  p a r t n e r s h i p s  
P O S T E R  S E S S I O N  1 7  
M e t h o d s  f o r  m o n i t o r i n g  
−  D i a l e c t i c a l - b a s e d  g r o u p  t h e r a p y  a n d  s e x u a l i t y  o f  
p e o p l e  w i t h  s u b s t a n c e  u s e  d i s o r d e r s  o n  
m e t h a d o n e  m a i n t e n a n c e  t h e r a p y :  a  c l i n i c a l  t r i a l .  
E f f a t  M e r g h a t i  K h o e i ,  I r a n  
−  C a n n a b i s  a n d  c r i m e :  f i n d i n g s  f r o m  l o n g i t u d i n a l  
r e g i s t e r  d a t a .  S o l v e i g  C h r i s t i a n s e n ,  N o r w a y  
−  R e c i d i v i s m  i n  d r u g - r e l a t e d  c r i m e s  i n  S w e d e n  
1 9 9 3 - 2 0 1 3 .  J o h a n  A h l n e r ,  S w e d e n  
−  E x a m p l e  o f  a l e r t  a n d  r e p o r t i n g  s y s t e m  o f  
s c o p o l a m i n e  p o i s o n i n g  a m o n g  P a r i s i a n  c o c a i n e  
u s e r s  a t  r e g i o n a l ,  n a t i o n a l  a n d  E u r o p e a n  l e v e l s .  
C é c i l e  C h e v a l l i e r ,  F r a n c e   
−  T h e  u s e  o f  a l t e r n a t i v e s  t o  p r i s o n  f o r  d r u g  
o f f e n d e r s  i n  B e l g i u m .  E l s  P l e t t i n c k x ,  B e l g i u m  
−  D r u g  u s e  a m o n g  P e r u v i a n  y o u n g  o f f e n d e r s :   a n  
e v a l u a t i v e  r e s e a r c h  f r o m  a  d e v e l o p m e n t a l  
a p p r o a c h .  H u g o  M o r a l e s ,  P o r t u g a l  
−  A g e n c y ,  s o c i a l  r e l a t i o n s h i p s  a n d  d e s i s t a n c e  o f  
o f f e n d e r s  w i t h  d r u g  h i s t o r y  i n  t h e  S i n g a p o r e  
−  G e n d e r - s e n s i t i v e  t r e a t m e n t  a n d  p r e v e n t i o n  s e r v i c e s  f o r  
a l c o h o l  a n d  d r u g  u s e r s :  d o e s  g e n d e r  i n f l u e n c e  s u b s t a n c e  
a b u s e  a n d  t r e a t m e n t  t r a j e c t o r i e s ?  S a r a h  S i m o n i s ,  
B e l g i u m  
−  W h a t  w o r k s  i n  t h e  t r e a t m e n t  o f  w o m e n  w i t h  a l c o h o l - u s e  
p r o b l e m s ?  S y s t e m a t i c  r e v i e w  o f  e v i d e n c e - b a s e d  s t u d i e s .  
E v a  H o c h ,  G e r m a n y  
−  Q u a l i t y  o f  l i f e  a n d  i t s  d e t e r m i n a n t s  i n  H I V - p o s i t i v e  a n d  
H I V - n e g a t i v e  d r u g  u s e r s  i n  t h e  n o r t h  a n d  c e n t r a l  r e g i o n s  
o f  P o r t u g a l ,  2 0 0 9  a n d  2 0 1 0 .  V a l é r i a  A r a n t e s ,  P o r t u g a l  
−  G e n d e r  d i f f e r e n c e s  i n  H I V  p r e v a l e n c e  a n d  r i s k  b e h a v i o r  
a m o n g  p e o p l e  w h o  i n j e c t  d r u g s  i n  K o h t l a - J ä r v e ,  E s t o n i a .  
M a r i s  S a l e k e s i n ,  E s t o n i a  
−  M i g r a t i o n ,  d r u g  u s e  a n d  h a r m  r e d u c t i o n :  a n  e x p l o r a t o r y  
c a s e  s t u d y  o f  N e p a l e s e  p e o p l e  w h o  u s e  d r u g s  l i v i n g  i n  
L i s b o n ,  P o r t u g a l .  R i c a r d o  F u e r t e s ,  P o r t u g a l  
−  P r e g n a n t  w o m e n ’ s  p e r c e p t i o n s  o f  i n f o r m a t i o n  a b o u t  
a l c o h o l  u s e  d u r i n g  p r e g n a n c y :  a  q u a l i t a t i v e  s t u d y .  K e r s t i n  
H o f f m e i s t e r ,  P o r t u g a l  
−  F a c i l i t a t o r s  a n d  b a r r i e r s  i n  s e e k i n g  t r e a t m e n t  
f o r  s u b s t a n c e  u s e  d i s o r d e r s  a m o n g  I n d i a ’ s  
p a t i e n t s :  f i n d i n g s  f r o m  a  m i x e d - m e t h o d  
s u r v e y  r e s e a r c h  f o c u s i n g  o n  I n d i a ’ s  c l i n i c a l  
t r e a t m e n t  p r o f e s s i o n a l s .  S e b a s t i a n  
P e r u m b i l l y ,  U n i t e d  S t a t e s  
−  P e o p l e  w i t h  s e v e r e  s c h i z o p h r e n i a  a n d  
s u b s t a n c e  a b u s e :  c l i n i c a l  a n d  f u n c t i o n a l  
o u t c o m e s  a f t e r  p r o l o n g e d ,  i n t e g r a t e d  
t r e a t m e n t .  J u a n  F e r n a n d e z - M i r a n d a ,  S p a i n  
−  S e v e r e  m e n t a l l y  i l l  d r u g  a b u s e r s  u n d e r g o i n g  
i n t e g r a t e d ,  c a s e - m a n a g e d  t r e a t m e n t :  
o u t c o m e s  a f t e r  s i x  y e a r s .  J u a n  F e r n a n d e z -
M i r a n d a ,  S p a i n  
−  A l c o h o l  u s e  r e l a t e d  p r o b l e m s  i n  p r i m a r y  
h e a l t h  c a r e :  a t t i t u d e s  a n d  e x p x e r i e n c e s  o f  
C z e c h  g e n e r a l  p r a c t i t i o n e r s .  L a d i s l a v  C s é m y ,  
C z e c h  R e p u b l i c   
−  W a s t e w a t e r - b a s e d  e p i d e m i o l o g y  –  
n o v e l  m e a n s  t o  a s s e s s  n a t i o n w i d e  
d r u g  a b u s e ?  A i n o  K a n k a a n p ä ä ,  
F i n l a n d  
−  D r u g  a n a l y s i s  o f  r e s i d u a l  c o n t e n t  
o f  u s e d  s y r i n g e s :  a  n e w  
m o n i t o r i n g  a p p r o a c h  o f  i n j e c t i n g  
u s e r s  c o n s u m p t i o n .  E l o d i e  
L e f r a n ç o i s ,  S w i t z e r l a n d  
−  S y m p t o m a t i c  c o n t a m i n a t i o n  i n  
d u a l  p a t h o l o g y ,  n e t w o r k  s t r u c t u r e  
o f  t h e  S y m _ C o n  s a m p l e .  F r a n c i s c o  
J a v i e r  P i n o  C a l d e r o n ,  S p a i n  
−  P r e d i c t i n g  t h e  p r e v a l e n c e  o f  
c a n n a b i s  u s e  f o r  t h e  n e x t  d e c a d e s :  
a  b a s e l i n e  s c e n a r i o  f o r  e v a l u a t i n g  
e f f e c t s  o f  c h a n g e s  i n  c a n n a b i s  
l e g i s l a t i o n .  M a r c  V o g e l ,  
S w i t z e r l a n d  
F r a n  C a l v o ,  S p a i n  
−  “ I t ' s  o n l y  w e e d ” :  c h a n g i n g  c o m m u n i t y  a t t i t u d e s  a n d  d e v e l o p i n g  i n t e r - a g e n c y  r e s p o n s e s  t o  
y o u n g  p e o p l e ’ s  c a n n a b i s  u s e  w i t h i n  a  s o c i a l l y  e x c l u d e d  c o m m u n i t y .  K a r l  O ’ B r i e n ,  I r e l a n d  
−  H C V  m a n a g e m e n t  a m o n g  E u r o p e a n  p h y s i c i a n s  p r e s c r i b i n g  o p i o i d  a g o n i s t  t h e r a p y :  s e l f -
r e p o r t e d  c o m p e t e n c y  a n d  b a r r i e r s  f r o m  t h e  C - S C O P E  s t u d y .  M a r t a  T o r r e n s ,  S p a i n  
−  T r e a t m e n t  o f  d r u g  u s e r s  i n  C z e c h  p r i s o n s :  a  r i g h t  t i m e  f o r  s y s t e m a t i c  e v a l u a t i o n ?  P e t r  Z e m a n ,  
C z e c h  R e p u b l i c  
−  T h e  c o s t - e f f e c t i v e n e s s  o f  i n t e r v e n t i o n s  t o  i m p r o v e  c a s e  f i n d i n g  a n d  e n g a g e m e n t  w i t h  H C V  
t r e a t m e n t  f o r  p e o p l e  w h o  i n j e c t  d r u g s  i n  t h e  U K .  Z o e  W a r d ,  U n i t e d  K i n g d o m  
−  M u n i c i p a l  i n t e r v e n t i o n  p r o g r a m  i n  t h e  a r e a  o f  a d d i c t i v e  b e h a v i o u r s  a n d  d e p e n d e n c i e s  f o r  
t h e  c i t y  o f  L i s b o n  ( P M I C A D  L X ) .  P a u l a  R o d r i g u e s ,  P o r t u g a l  
−  B e n z o d i a z e p i n e  m a i n t e n a n c e  i n  o p i a t e  s u b s t i t u t i o n  t r e a t m e n t :  g o o d  o r  b a d ?  A d a m  B a k k e r ,  
U n i t e d  K i n g d o m  
−  Y o u n g  r e c r e a t i o n a l  c o n s u m e r s :  p r e v e n t i v e  a n d  r i s k  m a n a g e m e n t  p r a c t i c e s  w h e n  u s i n g  
p s y c h o a c t i v e  s u b s t a n c e s  ( P S ) .  M a r a  S i l v a ,  P o r t u g a l  
−  N o  o n e  g e t s  l e f t  b e h i n d :  a d d r e s s i n g  t h e  h i d d e n  b u r d e n  o f  h e p a t i t i s  C  r e l a t e d  a d v a n c e d  l i v e r  
d i s e a s e  i n  P W I D  i n  t h e  c o m m u n i t y .  J o h n  L a m b e r t ,  I r e l a n d  
−  R e a c h i n g  p a t i e n t s  w i t h  a n t i s o c i a l  p e r s o n a l i t y  i n  S U D  t r e a t m e n t   B i r g i t t e  T h y l s t r u p ,  D e n m a r k   
−  M a p p i n g  s t o r y t e l l i n g  m e t h o d  i n  a d d i c t i o n  r e s e a r c h :  a  s y s t e m a t i c  r e v i s i o n .  I s a b e l  H e r r e r a - S á n c h e z ,  
S p a i n  
−  “ J u s t  l i s t e n ” -  w o m e n ’ s  e x p e r i e n c e s  o f  s u b s t a n c e  u s e ,  d o m e s t i c  a b u s e  a n d  s u p p o r t .  S a r a h  F o x ,  





14:30 – 16:00 
POSTER SESSIONS 
Pavilions 4 and 5 
 
POSTER SESSION 14 
Drug-related crime and the illicit market 
POSTER SESSION 15 
Responding to diversity 
POSTER SESSION 16 
Integrating care models and partnerships 
POSTER SESSION 17 
Methods for monitoring 
− Dialectical-based group therapy and sexuality of 
people with substance use disorders on 
methadone maintenance therapy: a clinical trial. 
Effat Merghati Khoei, Iran 
− Cannabis and crime: findings from longitudinal 
register data. Solveig Christiansen, Norway 
− Recidivism in drug-related crimes in Sweden 
1993-2013. Johan Ahlner, Sweden 
− Example of alert and reporting system of 
scopolamine poisoning among Parisian cocaine 
users at regional, national and European levels. 
Cécile Chevallier, France  
− The use of alternatives to prison for drug 
offenders in Belgium. Els Plettinckx, Belgium 
− Drug use among Peruvian young offenders:  an 
evaluative research from a developmental 
approach. Hugo Morales, Portugal 
− Agency, social relationships and desistance of 
offenders with drug history in the Singapore 
− Gender-sensitive treatment and prevention services for 
alcohol and drug users: does gender influence substance 
abuse and treatment trajectories? Sarah Simonis, 
Belgium 
− What works in the treatment of women with alcohol-use 
problems? Systematic review of evidence-based studies. 
Eva Hoch, Germany 
− Quality of life and its determinants in HIV-positive and 
HIV-negative drug users in the north and central regions 
of Portugal, 2009 and 2010. Valéria Arantes, Portugal 
− Gender differences in HIV prevalence and risk behavior 
among people who inject drugs in Kohtla-Järve, Estonia. 
Maris Salekesin, Estonia 
− Migration, drug use and harm reduction: an exploratory 
case study of Nepalese people who use drugs living in 
Lisbon, Portugal. Ricardo Fuertes, Portugal 
− Pregnant women’s perceptions of information about 
alcohol use during pregnancy: a qualitative study. Kerstin 
Hoffmeister, Portugal 
− Facilitators and barriers in seeking treatment 
for substance use disorders among India’s 
patients: findings from a mixed-method 
survey research focusing on India’s clinical 
treatment professionals. Sebastian 
Perumbilly, United States 
− People with severe schizophrenia and 
substance abuse: clinical and functional 
outcomes after prolonged, integrated 
treatment. Juan Fernandez-Miranda, Spain 
− Severe mentally ill drug abusers undergoing 
integrated, case-managed treatment: 
outcomes after six years. Juan Fernandez-
Miranda, Spain 
− Alcohol use related problems in primary 
health care: attitudes and expxeriences of 
Czech general practitioners. Ladislav Csémy, 
Czech Republic  
− Wastewater-based epidemiology – 
novel means to assess nationwide 
drug abuse? Aino Kankaanpää, 
Finland 
− Drug analysis of residual content 
of used syringes: a new 
monitoring approach of injecting 
users consumption. Elodie 
Lefrançois, Switzerland 
− Symptomatic contamination in 
dual pathology, network structure 
of the Sym_Con sample. Francisco 
Javier Pino Calderon, Spain 
− Predicting the prevalence of 
cannabis use for the next decades: 
a baseline scenario for evaluating 
effects of changes in cannabis 
legislation. Marc Vogel, 
Switzerland 
Fran Calvo, Spain 
− “It's only weed”: changing community attitudes and developing inter-agency responses to 
young people’s cannabis use within a socially excluded community. Karl O’Brien, Ireland 
− HCV management among European physicians prescribing opioid agonist therapy: self-
reported competency and barriers from the C-SCOPE study. Marta Torrens, Spain 
− Treatment of drug users in Czech prisons: a right time for systematic evaluation? Petr Zeman, 
Czech Republic 
− The cost-effectiveness of interventions to improve case finding and engagement with HCV 
treatment for people who inject drugs in the UK. Zoe Ward, United Kingdom 
− Municipal intervention program in the area of addictive behaviours and dependencies for 
the city of Lisbon (PMICAD LX). Paula Rodrigues, Portugal 
− Benzodiazepine maintenance in opiate substitution treatment: good or bad? Adam Bakker, 
United Kingdom 
− Young recreational consumers: preventive and risk management practices when using 
psychoactive substances (PS). Mara Silva, Portugal 
− No one gets left behind: addressing the hidden burden of hepatitis C related advanced liver 
disease in PWID in the community. John Lambert, Ireland 
− Reaching patients with antisocial personality in SUD treatment  Birgitte Thylstrup, Denmark  
− Mapping storytelling method in addiction research: a systematic revision. Isabel Herrera-Sánchez, 
Spain 
− “Just listen”- women’s experiences of substance use, domestic abuse and support. Sarah Fox, 
United Kingdom 
 
context. April Lin Liangyu, Singapore 
− Incarcerated Syrians and drug-related offences: 
the situation in Lebanon. Joanna Imad, Lebanon 
− Protective and criminogenic risk factors in drug 
use among Peruvian young offenders: a 
qualitative study from a developmental 
perspective. Hugo Morales Córdova, Peru 
− Gender differences on heavy episodic drinking among 
southern European youth and young adults: drinking 
patterns, risky and protective behaviours, consequences 
and effects. Cristiana Vale Pires, Portugal 
− Patterns of injecting and non-injecting drug use by 
sexual orientation in people who inject drugs in England, 
Wales and Northern Ireland, 2013-2016. Ellen 








1 1 : 0 0  –  1 2 : 3 0  
P O S T E R  S E S S I O N S  
P a v i l i o n s  4  a n d  5  
 
P O S T E R  S E S S I O N  1 8  
N e w  d e v e l o p m e n t s  i n  n e w  p s y c h o a c t i v e  s u b s t a n c e s  
P O S T E R  S E S S I O N  1 9  
U n d e r s t a n d i n g  a n d  r e g u l a t i n g  d r u g  m a r k e t s  
P O S T E R  S E S S I O N  2 0  
E - h e a l t h  
−  T y p o l o g y  o f  n e w  p s y c h o a c t i v e  s u b s t a n c e  u s e  a m o n g  i l l i c i t  d r u g  c o n s u m e r s  i n  t h e  A u s t r a l i a n  
g e n e r a l  p o p u l a t i o n .  R a c h e l  S u t h e r l a n d ,  A u s t r a l i a  
−  A r e  o r e x i n s  t h e  m i r a c l e  s o l u t i o n  f o r  a l c o h o l  u s e  d i s o r d e r s ?  G u a d a l u p e  M a r i n h o ,  P o r t u g a l  
−  C h e m s e x  a n d  h e a l t h  b e h a v i o r  a m o n g  m e n  w h o  h a v e  s e x  w i t h  m e n  i n  G e r m a n y .  R e s u l t s  f r o m  
a  m u l t i c e n t e r  q u a l i t a t i v e  s t u d y .  D a n i e l  D e i m e l ,  G e r m a n y  
−  C o m p o s i t i o n  o f  p a r t y  d r u g s  i n  B e l g i u m :  n o t  w h a t  y o u  w o u l d  e x p e c t .  E l s  P l e t t i n c k x ,  B e l g i u m  
−  E f f e c t  o f  a  l e g i s l a t i v e  b a n  o f  s y n t h e t i c  c a n n a b i n o i d s  o n  t h e  U K  m a r k e t :  a n  o v e r v i e w  b a s e d  o n  
m a s s  s p e c t r o m e t r i c  i d e n t i f i c a t i o n  o f  t h e s e  c o m p o u n d s  i n  ` s p i c e ´ .  L u b e r t u s  B i j l s m a ,  S p a i n  
−  A  n e w  c o n c e p t u a l  a p p r o a c h  f o r  s y n t h e t i c  c a n n a b i n o i d  d r u g  t e s t i n g .  L u b e r t u s  B i j l s m a ,  S p a i n  
−  D i s c o u r s e s  a b o u t  n e w  p s y c h o a c t i v e  s u b s t a n c e s  o n  g e n e r a l i s t  a n d  s p e c i a l i s t  f o r u m s .  F r a n c a  
B e c c a r i a ,  I t a l y  
−  “ C h a r l i e ”  ( b u p h e d r o n e / e t h c a t h i n o n e )  b e h a v i o u r a l  p a t t e r n s  a f t e r  s t i m u l a t e d  b i n g e  
a d m i n i s t r a t i o n .  S o f í a  S o l a ,  P o r t u g a l  
−  T h e  f u t u r e  o f  d r u g  s u p p l y  m o n i t o r i n g  i n  E u r o p e .  
T e o d o r a  G r o s h k o v a ,  E M C D D A  
−  S y n t h e s i s  o f  4 - m e t h o x y m e t h a m p h e t a m i n e  
h y d r o c h l o r i d e  a n d  i t s  p r e c u r s o r s  f r o m  u n r e s t r i c t e d  
c h e m i c a l s  a n d  o r g a n i c  i m p u r i t y  p r o f i l e s  e x a m i n e d .  
R o n a l d  S h i m m o n ,  A u s t r a l i a  
−  E v o l u t i o n  a n d  t r e n d  o f  n a r c o t i c  s u b s t a n c e s ,  c o c a i n e ,  
h e r o i n  a n d  c a n n a b i s  i n  n o r t h e r n  P o r t u g a l .  A n a  A l v e s ,  
P o r t u g a l  
−  B u p r e n o r p h i n e ,  a  n o n - t h e r a p e u t i c  u s e !  H a i f a  Z a l i l a ,  
T u n i s i a  
−  D r u g  s i t u a t i o n  i n  c e n t r a l  A s i a  a n d  i t s  i m p a c t  o n  
E u r o p e .  I n g o  I l j a  M i c h e l s ,  G e r m a n y  
−  E x p a n d i n g  a c c e s s  t o  b u p r e n o r p h i n e  
t r e a t m e n t  i n  r u r a l  a r e a s  w i t h  t h e  u s e  o f  
t e l e m e d i c i n e .  E r i c  W e i n t r a u b ,  U n i t e d  
S t a t e s  
−  E v a l u a t i v e  c o n d i t i o n i n g :  a  b r i e f  
c o m p u t e r - d e l i v e r e d  i n t e r v e n t i o n  t o  
r e d u c e  c o l l e g e  s t u d e n t  d r i n k i n g .  N i n a  
T e l l o ,  F r a n c e  
 
1 2 : 4 5  –  1 4 : 1 5  
P O S T E R  S E S S I O N S  
P a v i l i o n s  4  a n d  5  
 
P O S T E R  S E S S I O N  2 1  
L e s s o n s  f o r  c l i n i c a l  p r a c t i c e  
P O S T E R  S E S S I O N  2 2  
P u b l i c  h e a l t h  p o l i c i e s  
−  T h e  b e n e f i t s  o f  p h y s i c a l  a c t i v i t i e s  i n  p a t i e n t s  w i t h  d u a l  d i a g n o s i s .  J o r g e  J a b e r  F i l h o ,  B r a z i l  
−  P r e g a b a l i n  a b u s e  a m o n g  i n t r a v e n o u s  d r u g  u s e r s  i n  s o u t h  w e s t e r n  F i n l a n d .  A  t i m e - t r e n d  
s t u d y  2 0 0 8 – 2 0 1 1 – 2 0 1 4 .  S o l j a  N i e m e l ä ,  F i n l a n d  
−  A l c o h o l  u s e ,  a l c o h o l i s m  a n d  s l e e p  d i s t u r b a n c e .  J o a n a  I s a a c ,  P o r t u g a l  
−  P h a r m a c o l o g i c a l  t r e a t m e n t  o f  g a m b l i n g  d i s o r d e r s :  a  r e v i e w .  J o c h e n  M u t s c h l e r ,  S w i t z e r l a n d  
−  P h a r m a c o k i n e t i c s  a n d  c l i n i c a l  e f f e c t s  o f  T H C  a n d  C B D  t a k e n  o r a l l y  a s  a n  h e r b a l  t e a  o r  o i l y  
s o l u t i o n  i n  p a t i e n t s  w i t h  c h r o n i c  n e u r o p a t h i c  p a i n .  L a n f r a n c o  P e l l e s i ,  I t a l y  
−  D o  a r t s  t h e r a p i e s  r e d u c e  s u b s t a n c e  m i s u s e ?  A  s y s t e m a t i c  r e v i e w .  K a r e n  M e g r a n a h a n ,  U n i t e d  
K i n g d o m  
−  E v a l u a t i o n  o f  t h e  i n p a t i e n t  M i n n e s o t a  p r o g r a m  a t  L i s b o n  a l c o h o l o g y  u n i t  –  a  c o m p a r i s o n  
s t u d y  b e t w e e n  p a t i e n t s ’  a n d  p r a c t i t i o n e r s ’  p e r s p e c t i v e s .  M a r a  J o r g e ,  P o r t u g a l  
−  S a t i s f a c t i o n  a n d  p e r c e p t i o n s  o f  t r e a t m e n t  w i t h  i n j e c t a b l e  d i a c e t y l m o r p h i n e  a n d  
h y d r o m o r p h o n e  f o r  l o n g - t e r m  o p i o i d  d e p e n d e n c e .  K i r s t e n  M a r c h a n d ,  C a n a d a  
−  T h e  P o r t u g u e s e  d e c r i m i n a l i z a t i o n  m o d e l  a n d  t h e  i n t e r v e n t i o n  o n  d i s s u a s i o n  o f  t h e  C o m m i s s i o n  
o f  D i s s u a s i o n  o f  D r u g  A d d i c t i o n  o f  P o r t o .  C a r l a  L o p e s ,  P o r t u g a l  
−  T h e  P o r t u g u e s e  s e r v i c e  n e t w o r k  o f  a d d i c t i v e  b e h a v i o r s  a n d  d e p e n d e n c i e s :  c o n t r i b u t i o n s  t o  t h e  
B r a z i l i a n  m o d e l .  C l a y t o n  d o s  S a n t o s ,  B r a z i l  
−  T h e  R e i t o x  d e v e l o p m e n t  f r a m e w o r k :  n e w  p e r s p e c t i v e s  f o r  t h e  n e t w o r k .  S a n d r i n e  S l e i m a n ,  
E M C D D A  
−  M o n i t o r i n g  d e m a n d  f o r  d r u g  t r e a t m e n t  i n  E u r o p e :  t h e  t r e a t m e n t  d e m a n d  i n d i c a t o r  ( T D I ) .  L i n d a  
M o n t a n a r i ,  E M C D D A  
−  S e x u a l  d e s i r e  a n d  i n t e r c o u r s e  f r e q u e n c y :  c o m p a r i n g  s m o k e r s  a n d  n o n - s m o k e r s .  R u i  C o s t a ,  P o r t u g a l  
−  H o w  t o  i n f o r m  p o l i c y –  a n d  d e c i s i o n - m a k e r s  a b o u t  e v i d e n c e - b a s e d  a l c o h o l / t o b a c c o  p o l i c y .  M a t e j  
K o š i  a n d  S a n e l a  T a l i ć ,  S l o v e n i a  
−  P r e d i c t i n g  f r e q u e n t  a l c o h o l  a d m i s s i o n s  t o  h o s p i t a l  u s i n g  r o u t i n e l y  c o l l e c t e d  h o s p i t a l  d a t a  i n  
s o u t h  L o n d o n .  R o s  B l a c k w o o d ,  U n i t e d  K i n g d o m  






11:00 – 12:30 
POSTER SESSIONS 
Pavilions 4 and 5 
 
POSTER SESSION 18 
New developments in new psychoactive substances 
POSTER SESSION 19 
Understanding and regulating drug markets 
POSTER SESSION 20 
E-health 
− Typology of new psychoactive substance use among illicit drug consumers in the Australian 
general population. Rachel Sutherland, Australia 
− Are orexins the miracle solution for alcohol use disorders? Guadalupe Marinho, Portugal 
− Chemsex and health behavior among men who have sex with men in Germany. Results from 
a multicenter qualitative study. Daniel Deimel, Germany 
− Composition of party drugs in Belgium: not what you would expect. Els Plettinckx, Belgium 
− Effect of a legislative ban of synthetic cannabinoids on the UK market: an overview based on 
mass spectrometric identification of these compounds in `spice´. Lubertus Bijlsma, Spain 
− A new conceptual approach for synthetic cannabinoid drug testing. Lubertus Bijlsma, Spain 
− Discourses about new psychoactive substances on generalist and specialist forums. Franca 
Beccaria, Italy 
− “Charlie” (buphedrone/ethcathinone) behavioural patterns after stimulated binge 
administration. Sofía Sola, Portugal 
− The future of drug supply monitoring in Europe. 
Teodora Groshkova, EMCDDA 
− Synthesis of 4-methoxymethamphetamine 
hydrochloride and its precursors from unrestricted 
chemicals and organic impurity profiles examined. 
Ronald Shimmon, Australia 
− Evolution and trend of narcotic substances, cocaine, 
heroin and cannabis in northern Portugal. Ana Alves, 
Portugal 
− Buprenorphine, a non-therapeutic use! Haifa Zalila, 
Tunisia 
− Drug situation in central Asia and its impact on 
Europe. Ingo Ilja Michels, Germany 
− Expanding access to buprenorphine 
treatment in rural areas with the use of 
telemedicine. Eric Weintraub, United 
States 
− Evaluative conditioning: a brief 
computer-delivered intervention to 
reduce college student drinking. Nina 
Tello, France 
 
12:45 – 14:15 
POSTER SESSIONS 
Pavilions 4 and 5 
 
POSTER SESSION 21 
Lessons for clinical practice 
POSTER SESSION 22 
Public health policies 
− The benefits of physical activities in patients with dual diagnosis. Jorge Jaber Filho, Brazil 
− Pregabalin abuse among intravenous drug users in south western Finland. A time-trend 
study 2008–2011–2014. Solja Niemelä, Finland 
− Alcohol use, alcoholism and sleep disturbance. Joana Isaac, Portugal 
− Pharmacological treatment of gambling disorders: a review. Jochen Mutschler, Switzerland 
− Pharmacokinetics and clinical effects of THC and CBD taken orally as an herbal tea or oily 
solution in patients with chronic neuropathic pain. Lanfranco Pellesi, Italy 
− Do arts therapies reduce substance misuse? A systematic review. Karen Megranahan, United 
Kingdom 
− Evaluation of the inpatient Minnesota program at Lisbon alcohology unit – a comparison 
study between patients’ and practitioners’ perspectives. Mara Jorge, Portugal 
− Satisfaction and perceptions of treatment with injectable diacetylmorphine and 
hydromorphone for long-term opioid dependence. Kirsten Marchand, Canada 
− The Portuguese decriminalization model and the intervention on dissuasion of the Commission 
of Dissuasion of Drug Addiction of Porto. Carla Lopes, Portugal 
− The Portuguese service network of addictive behaviors and dependencies: contributions to the 
Brazilian model. Clayton dos Santos, Brazil 
− The Reitox development framework: new perspectives for the network. Sandrine Sleiman, 
EMCDDA 
− Monitoring demand for drug treatment in Europe: the treatment demand indicator (TDI). Linda 
Montanari, EMCDDA 
− Sexual desire and intercourse frequency: comparing smokers and non-smokers. Rui Costa, Portugal 
− How to inform policy– and decision-makers about evidence-based alcohol/tobacco policy. Matej 
Koši and Sanela Talić, Slovenia 
− Predicting frequent alcohol admissions to hospital using routinely collected hospital data in 
south London. Ros Blackwood, United Kingdom 
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− How to deal with patients whose problem is over sex? Guadalupe Marinho, Portugal 
− Practitioners’ experiences of working with dual users of heroin and crack in community drug 
services. A thematic analysis. Felicia Heidebrecht, United Kingdom 
− Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual 
users of heroin and crack. Felicia Heidebrecht, United Kingdom 
− Dual diagnosis and treatment: the experience of a multiprofessional team in mental health. 
Jorge Jaber Filho, Brazil 
− Anabolic-androgenic steroid use in substance use disorder treatment. Marie Jørstad, Norway 
− Reconsidering examining cannabis subtypes together due to opposing effects on brain, 
cognition and behavior. Kristine Rømer Thomsen, Denmark 
− Characterization of night care beds in a psychosocial care center for alcohol and other drug 
treatment. Gabriella Boska, Brazil 
− A review of the factors affecting the development and outcome of the treatment of 
psychotropic substances addiction. Katerina Flora, Cyprus 
− Understanding the characteristics and drinking profile of patients with alcohol use disorders 
presenting at hospital. Sophia Chambers, United Kingdom 
− Testing the S-O-S initiative: randomized trial of community-based naloxone coverage with 
sequential roll-out. Rebecca McDonald, United Kingdom 
− Substance misuse and risk factors among school adolescents. Vera Lucia Mediondo Osinaga, 
Brazil 
− Alcohol consumption and health promotion among nursing staff in a Brazilian sample. Vera 
Lucia Mediondo Osinaga, Brazil 
− Heavy drinking and consequences among polydrug users under treatment in a Brazilian 
context. Vera Lucia Mediondo Osinaga, Brazil 
− Effect of tobacco cessation policies in the consumption of anti-smoking medicines in Portugal. 
Ana Araújo, Portugal 
− Recommendations based on a pilot survey of experts in drug treatment service commissioning: 
current readiness to address hepatitis C in people with opioid use disorders in England. Mark 
Gilman, United Kingdom 
− Portuguese commissions for the dissuasion of drug addiction: perspectives of indicted drug users 
on their role in drug use. Ludmila Carapinha, Portugal 
− Cap Vila Roja primary care health centre is the first most active centre of the needle exchange 
program centres of Catalonia. Fran Calvo, Spain 
 
14:30 – 16:00 POSTER SESSIONS Pavilions 4 and 5 
 
POSTER SESSION 23 
Developments in basic research 
POSTER SESSION 24 
Education and training in addictions 
− Impairing inhibitory control increases ad libitum alcohol consumption - a transcranial 
magnetic stimulation study. Adam McNeill, United Kingdom 
− Oxycodone-induced tolerance to respiratory depression: reversal by ethanol and PKC 
inhibition. Rob Hill, United Kingdom 
− Characterisation of tolerance development to rewarding effects of opioids. Sarah Barrett, 
United Kingdom 
− A buprenorphine/naloxone sublingual tablet (Zubsolv®) for opioid substitution therapy: 
relative bioavailability and pharmaceutical properties compared with Suboxone® tablet. Gill 
− Comprehensive education in addiction science: case study of the addictology university study 
programme in the Czech Republic. Amalie Pavlovská, Czech Republic 
− Mainstream movies as a medium to teach diagnostic criteria for substance use disorders: an 
exploratory study. Daniele Zullino, Switzerland 
− Employability of healthcare addiction specialists in the Czech Republic from the point of view of 
graduates of the academic programmes in addictology and possible employers. Amalie 
Pavlovská, Czech Republic 
− Creation and work from an addiction online magazine. Mireia Pascual, Spain 
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M u n d i n ,  U n i t e d  K i n g d o m  
−  B r a i n  a c t i v i t y  o f  p o r n  a d d i c t  a d o l e s c e n t s  a n d  f a k i n g  g o o d  i n  p o r n o g r a p h y  s e l f - r e p o r t  
q u e s t i o n n a i r e .  R i z k i  E d m i  E d i s o n ,  I n d o n e s i a  
−  I n f l u e n c e  o f  c .  1 1 8 A > G  O P R M 1  a n d  p . V a l 1 5 8 M e t  c o m t  p o l y m o r p h i s m  i n  d r u g  a d d i c t s  –  a  
p i l o t  s t u d y .  C a r o l i n a  R i b e i r o ,  P o r t u g a l  
−  C h r o n i c  c o c a i n e  u s e  m o d i f i e s  n e t w o r k  a c t i v i t y  i n  t h e  n u c l e u s  a c c u m b e n s  i n  v i v o .  C a t a r i n a  
L u í s ,  G e r m a n y  
−  M e t h y l p h e n i d a t e  e v o k e s  h e a r t  a n d  k i d n e y  t o x i c i t y  i n  a d o l e s c e n t  r a t s  e x p o s e d  o n e - w e e k  t o  
r e l e v a n t  o r a l  d o s e s .  J o ã o  P a u l o  C a p e l a ,  P o r t u g a l  
−  I n  v i t r o  n e p h r o t o x i c i t y  o f  s y n t h e t i c  c a n n a b i n o i d s .  J o ã o  P e d r o  S i l v a ,  P o r t u g a l  
−  A t t e n u a t i n g  t h e  r e i n f o r c i n g  p r o p e r t i e s  o f  c o c a i n e  w i t h  c a n n a b i d i o l :  a  r o l e  f o r  a d u l t  
h i p p o c a m p a l  n e u r o g e n e s i s .  M i g u e l  L u j á n ,  S p a i n  
−  A  s u r v e y  o f  t h e  E n g l i s h  s u b s t a n c e  m i s u s e  w o r k f o r c e :  t r a i n i n g  p r e f e r e n c e s ,  d i g i t a l  l i t e r a c y  a n d  
w o r k  e x p e r i e n c e .  R o b e r t  C a l d e r ,  U n i t e d  K i n g d o m  
−  H o w  t o  c o m m u n i c a t e  f r o m  a  p r e s s  o f f i c e  i n  a  s c i e n t i f i c  s o c i e t y .  M i r e i a  P a s c u a l ,  S p a i n  
−  A  n e w  p l a t f o r m  f o r  e x c h a n g e :  p r o f e s s i o n a l i z a t i o n ,  b e s t  p r a c t i c e  a n d  ‘ k n o w l e d g e  s h a r e ’  i n  
s u b s t a n c e  u s e  p r e v e n t i o n  a n d  t r e a t m e n t .  L i v i a  E d e g g e r ,  U n i t e d  K i n g d o m  
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